Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Suspect Hepatitis C (HCV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Suspect Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Suspect Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 777 of 777 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Diagnosis | Is Pregnant | Symptoms | Western Blot | Abbott Architect | Risk Categories | Vaccinated for Hepatitis A | Vaccinated for Hepatitis B | Vaccinated for Influenza within 60 days prior to phlebotomy | Subject Taking Vitamin B7 (Biotin) | Is Subject Taking a Multivitamin Supplement | Trimester Information | Additional Medications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | United States | Plasma | 1.00 | 4.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0000-A0900107210070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 69 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hypokalemia, Unspecified protein-calorie malnutrition, Hypotension of hemodialysis | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Colchicine, Metoprolol, Zantac | U/A | Yes Date of Vaccination: 3/19/2019 | No | No | |||||||||||||||||
| BBS0000-A0900107211070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Hypocalcemia, Hypotension of hemodialysis, Constipation, Fever, Other disorders of calcium metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Peritonitis, Diabetes mellitus type 2, Hypercalcemia, Hypokalemia, Hypoxemia, Other disorders of phosphorus metabolism, Hypertensi | Liquacel, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Levetiracetam, Ammonium lactate, Lexapro, Bentyl, Metoprolol, Celebrex, Midodrine, Chlorzoxazone, Colace, Omeprazole, Dialyvite, Dicyclomine, Albuterol, Diprolene, Doxepin, Polycarbophil, EMLA, Pregabalin, Fioricet, Protonix, Flomax, Renvela, Flovent, Spiriva, Gabapentin, Ultram, Lactulose, Zocor | U/A | Yes Date of Vaccination: 2/14/2007 | No | No | |||||||||||||||||
| BBS0000-A0900107219070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypercalcemia, Other fluid overload, Vomiting | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Promethazine, Allopurinol, Cinacalcet, Amlodipine, Fosrenol, Atorvastatin, Furosemide, Cardura, Minoxidil, Carvedilol, Terazosin | U/A | Yes Date of Vaccination: 10/12/2016 | No | No | |||||||||||||||||
| BBS0000-A0900107220070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 39 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of calcium metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypercalcemia, Hypocalcemia, Other fluid overload, Bacteremia, Calcinosis cutis, Cough, Hypoglycemia, Local infection due to central venous catheter, Nausea, Strepotococcus group B, Diabetes mellitus ty | Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Apixiban, Clonazepam, Dilaudid, Glucagon, Plavix, Insulin Lantus, Primidone, Atorvastatin, Protonix, Lopressor, Requip, Melatonin, Senna | No | Yes Date of Vaccination: 4/12/2012 | No | No | |||||||||||||||||
| BBS0000-A0900107221070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypokalemia, Fluid overload, Shortness of breath, Headache | Epogen, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acyclovir cream, Aspirin, Carvedilol, Colace, EMLA, Fentanyl, Flexeril, Hydralazine, Lidocaine, Losartan, PhosLo, Minoxidil, Synthroid, Nephro-Vite, Valtrex, Nepro, Voltaren, Zyrtec | No | Yes Date of Vaccination: 6/16/2016 | No | No | |||||||||||||||||
| BBS0000-A0900107222070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Fluid overload, Shortness of breath | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Calcium acetate, Minoxidil, Carvedilol, Norvasc | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | |||||||||||||||||
| BBS0000-A0900107229082919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 34 Y | Female | Non-Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease on dialysis, Lupus, Asthma | Epoetin alfa, Metoclopramide, Ondansetron, Pantoprazole | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900107232082719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 44 Y | Male | Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 164 U/L | ALT: 141 U/L | ALP: 626 U/L | $450.00 | Unknown | Biliary obstruction status post biliary drain and stent placement, Cholecystectomy | Acyclovir, Docusate sodium, Hydrocodone-acetaminophen, Polyethylene glycol, Senna | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900107234091019DD | Suspect Hepatitis C (HCV) | Serum | 6.00 | $450.00 | 47 Y | Female | Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | ALP: 257 U/L | 9-Sep-19 | $450.00 | Unknown | Diabetes mellitus, Cirrhosis, End stage renal disease on hemodialysis, Hypertension, Pulmonary embolism | Albuterol, Hydrocodone-acetaminophen, Insulin glargine, Lidocaine, Metoprolol tartrate, Apixaban | No | No | No | Yes | ||||||||||||||||||
| BBS0000-A0900107235090319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | 46 Y | Male | Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Kidney transplant 2009 which failed | Acetaminophen, Amlodipine, Calcium acetate, Diclofenac sodium, Nicotine | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900107304070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 2.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Fluid overload, Iron deficiency anemia, Renal osteodystrophy, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance | Hectoral, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Aspirin, Atorvastatin, Pioglitazone, Colace, Renvela, Midodrine, Toprol XL | U/A | Yes Date of Vaccination: 5/18/2019 | No | No | |||||||||||||||||
| BBS0000-A0900107317070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Hyperkalemia, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Aspirin, Bumetanide, Carvedilol, Fish oil, Furosemide, Hydralazine, Isosorbide mononitrate, Vitamin D3, Acetaminophen, Diphenhydramine, Nitroglycerin, Loperamide, Ondansetron, Promethazine, Losartan, Renvela, Vitamin B complex | U/A | Yes Date of Vaccination: 19-Feb-2019 | No | Yes | |||||||||||||||||
| BBS0000-A0900107318070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 5.00 | $450.00 | 67 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Anemia, Chronic kidney disease stage 4, Dependence on renal dialysis, Hypoxemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Unspecified protein-calorie malnutrition, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Shortness of breath | Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Losartan, Atorvastatin, Nifedipine, Budesonide, PhosLo, Bumetanide, Sevelamer, Ipratropium inhaler | No | Yes Date of Vaccination: 16-Oct-2018 | No | No | |||||||||||||||||
| BBS0000-A0900107319070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 68 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Atorvastatin, Flonase, Paricalcitol, Folic acid, Tamsulosin, Lorazepam, Torsemide, NovoLog insulin, Warfarin, Insulin degludec | No | No | No | No | |||||||||||||||||
| BBS0000-A0900107320070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 65 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Anorexia, Hypercalcemia, Hypocalcemia | Epogen, Hectorol, Liquacel, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acetaminophen, Amlodipine, Vitamin C, Aspirin, Plavix, Atorvastatin, Protonix, Carvedilol, Tums, Cinacalcet, Vitamin B complex | No | No | No | No | |||||||||||||||||
| BBS0000-A0900107321070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 62 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Chills | Hectoral, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Ondansetron, Calcium acetate, Furosemide, Coumadin | U/A | Yes Date of Vaccination: 2/19/2018 | No | No | |||||||||||||||||
| BBS0000-A0900107835070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Cardiomegaly, Disorders of phosphorus metabolism, Hypercalcemia, Hypertension, Iron deficiency anemia, Obesity, Pure hypercholestrolemia, Renal osteodystrophy, Vitamin D deficiency, Secondary hyperparathyroidism | Amlodipine, Aspirin, Dialyvite, Renvela, Sensipar | No | No | No | No | |||||||||||||||||
| BBS0000-A0900108389072919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 75 Y | Unknown | <-70C | 29-Jul-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Fever, Hypocalcemia, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Hyperkalemia, Hypokalemia, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atovaquone, Hydroxyzine, Cetirizine, Ketoconazole, Clindamycin, Levothyroxine, Cyanocobalamin, Cyclosporine, Midodrine, Desonide, Ergocalciferol, Rena-Vite, Fludrocortisone, Renvela, Fluticasone, Tums, Gabapentin, Ursodeoxycholic acid, Hydrocortisone, Warfarin | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900108389101119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 42 Y | Unknown | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Unspecified protein-calorie malnutrition, Iron deficiency anemia, Secondary Hyperparathyroidism of renal origin | Epogen, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Isosorbide, Metoprolol, PhosLo, Iron sucrose, Levofloxacin, Tylenol | No | yes 11-Oct-19 | No | No | |||||||||||||||||||
| BBS0000-A0900109655082719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 60 Y | Male | Non-Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 U/L | ALP: 299 U/L | $450.00 | Unknown | Hypertension, Atrial fibrillation, Congestive heart failure, Venous stasis, Pneumonia | Bumetanide, Carvedilol, Metolazone, Potassium chloride, Rivaroxaban, Vitamin A & D ointment | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900109699070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 69 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Alcohol abuse, Cardiomegaly, Fluid overload, Hyperkalemia, Idiopathic gout, Localized edema, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Heart failure, Nicotine dependence, Hypertensive chronic kidney disease with stage 5 chronic kidney disease | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Furosemide, Atrovent, Metoprolol, Cinacalcet, Rena-Vite, Cozaar, Renvela | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | |||||||||||||||||
| BBS0000-A0900109700070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypocalcemia, Hyperkalemia | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Hydralazine, Amlodipine, Insulin lantus, Aspirin, Plavix, Atorvastatin, Renvela, Clonidine, Tobramycin, Enalapril | U/A | Yes Date of Vaccination: 1/16/2018 | No | No | |||||||||||||||||
| BBS0000-A0900109701070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Hypokalemia, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Calcium acetate, Niacin, Clonazepam, Garlique, Oxycodone, Glipizide, Rosuvastatin, Insulin lispro, Sertraline, Insulin lantus, Sildenafil, Metoprolol | U/A | Yes 24-Nov-18 | No | No | |||||||||||||||||
| BBS0000-A0900109702070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 62 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Anemia, Chronic kidney disease stage 4, End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Engerix, Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, NovoLog, Clopidogrel, EMLA, Guaifenesin, Albuterol sulfate, Hydralazine, Renvela, Lamictal, Senna, Insulin lantus, Sertraline, Levothyroxine, Triamcinolone, Lipitor, MiraLax | U/A | Yes Date of Vaccination: 4/16/2019 | No | No | |||||||||||||||||
| BBS0000-A0900109703070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 92 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Diabetes mellitus type 2, Hypertensive chronic kidney disease with stage 5 chronic kidney disease, Old myocardial infarction, Heart failure, Shortness of breath, Obstructive sleep apnea, Ather | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Metoprolol, Clopidogrel, Norvasc, Docusate, Omeprazole, Gabapentin, Voltaren gel, Humalog, PhosLo | U/A | Yes Date of Vaccination: 10/21/2016 | No | No | |||||||||||||||||
| BBS0000-A0900109704070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 72 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hypokalemia, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Furosemide, Losartan, Biotin, Metoprolol, PhosLo, Protonix | U/A | Yes Date of Vaccination: 8/19/2017 | No | Yes | |||||||||||||||||
| BBS0000-A0900109816070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 55 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Fluid overload, End stage renal disease, Hypokalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Shortness of breath | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Budesonide, Insulin humalog, Lac-Hydrin, Atorvastatin, Bumetanide, Hydralazine, Insulin lantus, Bupropion, Losartan, Calcium acetate, Metoprolol, Doxazosin, Nystatin, Duloxetine, Oxycodone, DuoNeb, Oxycontin, Famotidine, Ticagrelor, Ferrous gluconate, Furosemide | U/A | Yes Date of Vaccination: 6/17/2019 | No | No | |||||||||||||||||
| BBS0000-A0900109817070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 68 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypocalcemia, Hypercalcemia | Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acetaminophen, Metoprolol, Melatonin, Cinacalcet, Aspirin, Pantoprazole, Doxazosin, Pravastatin, Glipizide, Trazodone, Loratadine | U/A | Yes Date of Vaccination: 2/19/2019 | No | No | |||||||||||||||||
| BBS0000-A0900109818070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 60 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 1, Anemia in chronic kidney disease, Cellutiis of right finger, Fluid overload, End stage renal disease, Hyperkalemia, Hypercalcemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other disorders of electrolyte and fluid balance | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Alprazolam, Losartan, Amlodipine, Lumigan, Aspirin, Metoprolol, Atorvastatin, Biotin, Dorzolamide, Oxycodone, Insulin humalog, Pantoprazole, Insulin lantus, Renvela, Lidocaine | U/A | Yes Date of Vaccination: 7/14/2017 | No | No | |||||||||||||||||
| BBS0000-A0900109819070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other fluid overload | Engerix, Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Carvedilol, PhosLo, Pravastatin, Losartan, Prednisone, Sevelamer, Triphrocaps | U/A | Yes Date of Vaccination: 5/20/2019 | No | No | |||||||||||||||||
| BBS0000-A0900109820070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 38 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Other disorders of electrolyte and fluid balance, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Heparin, Liquacel, Venofer, Acetaminophen, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Methylphenidate, Atorvastatin, Metronidazole, Bupropion, Ondansetron, Dicyclomine, Dolutegravir, Doxycycline, Pantoprazole, Emtriva, Sevelamer, Flonase, Tenofovir, Loratadine | U/A | U/A | No | No | |||||||||||||||||
| BBS0000-A0900109821070219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 62 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Chills, End stage renal disease, Anemia in chronic kidney disease, Hypercalcemia, Iron deficiency anemia, Bacteremia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Fever, Hyperkalemia, Unspecified protein-calorie malnutrition, Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere, Other disorders of phosphorus metabolism | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Insulin lantus, Atorvastatin, Midodrine, Carvedilol, Pantoprazole, Clopidogrel, Renvela | No | Yes Date of Vaccination: 9/15/2016 | No | No | |||||||||||||||||
| BBS0000-A0900109887062419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 17.00 | $150.00 | 66 Y | Female | Non-Hispanic | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Autoimmune hepatitis, Venous stasis dermatitis, Hypokalemia, Normocytic anemia, Hypertension, Thrombocytopenia, Rheumatoid arthritis | Enalapril, Folic acid, Furosemide, Hydrocortisone ointment, Protonix, Prednisone, Spironolactone, Thiamine | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900109888090419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 04-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Former user of IV drugs | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Congestive heart failure, Diabetes mellitus, GERD, End stage renal disease on hemodialysis | Carvedilol, Clonidine, Docusate sodium, Furosemide, Hydralazine, Oxcarbazepine, Sevelamer hydrochloride | No | Yes 19-Aug-19 | No | No | ||||||||||||||||||
| BBS0000-A0900109889082919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 46 Y | Male | Non-Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 96 U/L | ALP: 166 U/L | $450.00 | Unknown | Liver cirrhosis 2nd stage due to alcohol abuse | Chlordiazepoxide, Fluoxetine, Folic acid, Gabapentin, Hydrocodone-acetaminophen, Mirtazapine, Nicotine, Ondansetron, Thiamine | Unknown | U/A | Yes | Unknown | ||||||||||||||||||
| BBS0000-A0900109890090519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 2.00 | $450.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 135 U/L | $450.00 | Unknown | Heart artery stent, Hypertension | Aspirin, Clopidogrel bisulfate, Hydrocodone-acetaminophen | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900109891082919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 4.00 | $450.00 | 57 Y | Male | Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 181 U/L | ALT: 83 U/L | $450.00 | Unknown | Congestive heart failure, Atrial flutter, Alcohol abuse | Aspirin, Atorvastatin, Benazepril, Carvedilol, furosemide, Magnesium chloride, Potassium chloride, Spironolactone, Warfarin | Yes U/A | U/A | No | Yes | ||||||||||||||||||
| BBS0000-A0900109909070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 52 Y | Female | Unknown | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Chills, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other disorders of electrolyte and fluid balance | Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Niaspan, Aspirin, PhosLo, Crestor, Ranitidine, Ergocalciferol, Senna, Insulin humalog, Synthroid, Insulin lantus, Trileptal, Metoprolol, Vanlafaxine, MiraLax | U/A | Yes Date of Vaccination: 5/20/2019 | No | Yes | |||||||||||||||||
| BBS0000-A0900109910070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 7.00 | $450.00 | 52 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 1, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Medical marijuana, Lactulose, Furosemide, Calcitriol, Vitamin D3, Nortriptyline, Glucagon, Carvedilol, Oxycodone, Omeprazole, Hydralazine, Ciclopirox loprox, Tamsulosin, Insulin novolog, Clonidine, Travatan, Insulin degludec, Zolpidem | U/A | No | No | No | |||||||||||||||||
| BBS0000-A0900109920070319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia, Fever, Morbid obesity, Protein-calorie malnutrition, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Pruritis, Hypercalcemia, Hyperkalemia, Secondary hyperparathyroidism, Iron deficiency anemia, Obstructive sleep apnea, Renal osteodystrophy | Aspirin, Auryxia, Lidocaine cream, Vitamin D3, Vidal, PhosLo, Renvela | No | No | No | No | |||||||||||||||||
| BBS0000-A0900109921080719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 58 Y | Male | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, Chills, End stage renal disease, Infection of amputation stump, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Bacteremia, Fluid overload, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition, Renal osteodystrophy | Hectorol, Liquacel, Venofer, Ascorbic acid, Methocarbamol, Aspirin, Midodrine, Atorvastatin, Carvedilol, Colace, Eliquis, Hydrocodone, Sennoside-docusate sodium, Insulin lispro, Pantoprazole, Insulin aspart, Polyethylene glycol, Isosorbide dinitrate, Renvela, Renvela, Lactulose, Senna | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900109922100419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 16.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Gabapentin, Alprazolam, Hydralazine, Ambien, Labetalol, Amiodarone, Lactulose, Amlodipine, Montelukast, Calcium acetate, Norco, Pantoprazole, Ergocalciferol, Prednisone, Escitalopram, Fluticasone | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110004072319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $150.00 | 65 Y | Female | Non-Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Portal hypertension, HCC | Xanax, Prozac, Prevacid, Zofran, Pseudoephedrine, Acetaminophen, Aldactone | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110005081319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $150.00 | 68 Y | Female | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Ascites due to alcoholic cirrhosis, Anasarca, Edema, Cellulitis, Preglaucoma, Senile nuclear sclerosis, Diabetes type 2, Atrial fibrillation, Hypertension, Hyperlipidemia | Furosemide, Metoprolol succinate, Spironolactone, Ursodiol, Warfarin | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110006082119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Alcholic cirrhosis, Peptic ulcer disease, Esophageal varices, Anemia | Ferrous sulfate, Furosemide, Omeprazole, Propranolol, Spironolactone | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110007062419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Non-alcoholic fatty liver disease, Cholecystitis, Ulcerative colitis, Macrocytosis, Elevated TSH, Glaucoma, Sick sinus syndrome, A-fib, Hypertension, Arthritis, Tendonitis, Erectile dysfunction, Seborrheic keratosis, Patent foramen ovale | Allopurinol, Xanax, Norvasc, Eliquis, Alphagan, Vitamin D3, Cosopt, Vitamin D2, Glucosamine, Norco, Hydrocortisone, Xalatan, Magnesium, Purinethol, Mesalamine, Multi-Vitamin Injection, Omega 3, Potassium, Revatio | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110018070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Bacteremia, Bronchitis, Anemia in chronic kidney disease, Chills, Cough, Acute nasopharyngitis, Disorders of phosphorus metabolism, End stage renal disease, Fever, Hypercalcemia, Hypertension, Fluid overload, Function dyspepsia, Hyperkalemia, Hyperlipidemia, HIV, Iron deficiency anemia, Nausea, Disorders of calcium metabolism, Disorders of electrolyte, Secondary hyperparathyroidism, Vitamin D deficiency, Sepsis, Diabetes type 2, Pruritus, Pneumonia | Acetaminophen, Amlodipine, Coumadin, Hydrocortisone, Dialyvite, Renvela, Juluca, Sensipar | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110018093019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Bicitra, Levothyroxine, Cholecalciferol, Sertraline, Sucroferric oxyhydroxide velphoro | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110019072919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 71 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hypothyroidism, Chills, Fever, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition | Epogen, Heparin, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Ondansetron, Allopurinol, Hydrocortisone, Bentyl, Oxycodone, Carvedilol, Pancrelipase, Docusate sodium, Pantoprazole, Folbee Plus, Pravastatin, Fosamax, Prednisone, Fosamax, Gabapentin, Tacrolimus, Humulin insulin, Thiamine, Ipratropium, Torsemide, Lactulose, Acetaminophen, Methocarbamol, Warfarin, Norco, Zinc salts | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110019092519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 61 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectorol, Parsabiv, Vancomycin, Acetaminophen, Clonidine, Diphenhydramine, Epinephrine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Ipratropium, Ambien, Aspirin, Pantoprazole, Coreg, Epivir, Rena-Vite, Fludrocortisone, Renvela, Kaletra, Stavudine, Norco | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110020070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 58 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Disorders of phosphorus metabolism, Hypercalcemia, Fluid overload, Hyperkalemia, Hypokalemia, Hyperglycemia, Iron deficiency anemia, Hypercholestrolemia, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes type 2, Protein-calorie malnutrition | Ferric citrate auryxia, Ergocalciferol, Vitamin D, Aspirin, Amlodipine, Lantus, Lisinopril, Folbee plus, Brilinta, Renvela, Humalog, Trazodone | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110020090619DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 67 Y | Male | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lisinopril, Cetirizine, Metoprolol, Minoxidil, Sevelamer, Hydralazine, Sensipar, Isosorbide mononitrate | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110021070819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 36 Y | Male | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $450.00 | Unknown | Anemia in chronic kidney disease, Encounter for immunization, Hyperkalemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 1 without complications and with chronic kidney disease, Dependence on renal dialysis, End stage renal disease, Iron deficiency anemia, Other fluid overload, | Atorvastatin, Omeprazole, Creon, Brilinta, Gabapentin, PhosLo, Midodrine, Ranitidine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110021090619DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 55 Y | Male | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Renal osteodystrophy (older co-morbidities listed in chart) | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Albuterol, Amlodipine, Lisinopril, Clopidogrel, Sevelamer, Furosemide, Sensipar, Lantus insulin, Simvastatin | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110022072919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 42 Y | Male | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Hypercalcemia, Hypocalcemia, Other disorders of calcium metabolism, Fluid overload, Renal osteodystrophy, Unspecified protein-calorie malnutrition, Vitamin D deficiency, Dependence on renal dialysis, Hyperkalemia, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Other disorders of protein-plasma metabolism, Secondary hyperparathyroidism | Acetaminophen, Clonidine, Diphenhydramine, Maalox, Lidociane, Nitroglycerin, Promethazine, Calcitriol, ProAir HFA, Carvedilol, PhosLo, Dialyvite | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110022091719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 16.00 | $450.00 | 46 Y | Male | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectoral, Acetaminophen, Benadryl, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcitriol, Sevellamer, Hydralazine, Sensipar, Labetalol, Tenapanor or placebo, Nifedipine | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110139090319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | 67 Y | Male | Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 75 U/L; ALP: 521 | $450.00 | Unknown | Colon cancer metastasized to liver, Status post bowel stent placement | Amlodipine, Chlorpromazine, Ondansetron, Potassium chloride | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110140081419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 24 Y | Female | Hispanic | <-70C | 14-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | AST: 34 U/L | $450.00 | Unknown | None | Hydrocodone-acetaminophen | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900110141082219DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 7.00 | $450.00 | 56 Y | Male | Non-Hispanic | <-70C | 22-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 115 U/L | ALT: 179 U/L | ALP: 142 U/L | $450.00 | Unknown | Obstructive sleep apnea, Diabetes mellitus, Chronic back pain, Neuropathy | Albuterol HFA, Atorvastatin, Colchicine, Cyclobenzaprine, Diclofenac sodium Duloxetine, Febuxostat, Fenofibrate, Finasteride, Folic acid, Aspart, Insulin lispro, Lantus SoloStar, Liraglutide, Magnesium oxide, Metolazone, Metoprolol tartrate, Naproxen, Polyethylene glycol, Potassium chloride, Pregabalin, Ranitidine, Tamulosin, Trazodone | Yes U/A | Yes 17-Jul-17 | No | No | ||||||||||||||||||
| BBS0000-A0900110142081919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 1.00 | $450.00 | 51 Y | Female | Hispanic | <-70C | 19-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 167 U/L | $450.00 | Unknown | End stage renal disease on hemodialysis, Myocardial infarction status post coronary artery bypass graft, Diabetes mellitus, Hypertension, Hypersensitivity lung disease | Acetaminophen, Amlodipine, Atorvastatin, Aspirin, Benazepril, Buspirone, Carvedilol, Cinacalcet, Clonidine, Dextromethorphan-guaifenesin, Epoetin alfa, Gabapentin, Humalog, Hydralazine, Insulin aspart, Isosorbide mononitrate, Lantus SoloStar, Lisinopril, Lorazepam, Mirtazapine, Nitroglycerin, Omeprazole, Oxycodone-acetaminophen, Ranolazine, Sertraline, Sevelamer carbonate, Sevelamer hydrochloride, Trazodone, Ventolin HFA | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110143082019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 76 Y | Female | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 35 U/L | ALP: 201 U/L | $450.00 | Unknown | Cirrhosis, Asthma, GERD, Lung cyst, Rheumatoid arthritis | Albuterol HFA, Baricitinib, Calcium carbonate, Cholecalciferol, Fluticasone-vilanterol, Folic acid, Hydroxychloroquine, Omeprazole, Prednisone | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110144082119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 18.00 | $450.00 | 74 Y | Female | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | ALT: 60 U/L | $450.00 | Unknown | Pancreatic cancer on chemo | Aspirin, Clonazepam, Colchicine, Dexamethasone, Diphenoxylate-atropine, Febuxostat, Folic acid, Gabapentin, Hydrocodone-acetaminophen, Lisinopril, Loperamide, Megestrol, Naloxone, Omega 3 acid, Omeprazole, Ondansetron, Prochlorperazine, Rosuvastatin | Yes 17-Mar-2000 | 24-Sep-1999 | Yes 17-Jul-63 | No | No | ||||||||||||||||||
| BBS0000-A0900110145081919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | 60 Y | Male | Non-Hispanic | <-70C | 19-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALT: 52 U/L | $450.00 | Unknown | Congestive heart failure with an ejection fraction of 10%, Status post biventricular ICD, Atrial fibrillation | Aspirin, Atorvastatin, Furosemide, Hydrocodone-acetaminophen, Metoprolol succinate, Sacubitril-valsartan, Warfarin | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110146080519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $450.00 | 77 Y | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Hypercalcemia, Diabetes type 2 with diabetic chronic kidney disease | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Allopurinol, Levaquin, Amlodipine, Levothyroxine, Aspirin, Omeprazole, Atorvastatin, Vitamin D2, Carvedilol, Renvela, Flomax, Sensipar, Imdur, Sertraline | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110159082719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 7.00 | $450.00 | 38 Y | Male | Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 47 U/L | $450.00 | Unknown | None | None | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110160082119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | 44 Y | Male | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 55 U/L | ALT: 60 U/L | ALP: 174 U/L | $450.00 | Unknown | Burn (75% post car accident), Stroke, Bovine aortic valve replacement | Ascorbic acid, Aspirin, Atorvastatin, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Vitamin B complex, Zinc sulfate, Zolpidem | U/A | Yes 31-Oct-92 | No | No | ||||||||||||||||||
| BBS0000-A0900110161081419DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 71 Y | Male | Hispanic | <-70C | 14-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 174 U/L | ALT: 80 U/L | $450.00 | Unknown | Congestive heart failure, Atrial fibrillation | Acetaminophen, Alprazolam, Amlodipine, Aspirin, Citalopram, Diclofenac sodium, Dicyclomine, Docusate sodium, Isosorbide mononitrate, Lactulose, Lisinopril, Metoprolol tartrate, Nitroglycerin, Rosuvastatin, Terazosin, Tramadol | U/A | U/A | No | No | ||||||||||||||||||
| BBS0000-A0900110162081519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 53 Y | Female | Hispanic | <-70C | 15-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 191 U/L | $450.00 | Unknown | Hypertension, Diabetes mellitus type 2, End stage renal disease on hemodialysis | Amlodipine, Aspirin, Atorvastatin, Benazepril, Calcium acetate, Cholecalciferol, Ferrous sulfate, Furosemide, Insulin glargine, Insulin lispro, Loperamide, Metoprolol, Multivitamin | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900110163082819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 47 Y | Male | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Chronic ischemic heart disease, Diabetes type 2, Anemia in chronic kidney disease, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Maalox, Promethazine, Aspirin, Atorvastatin, Carvedilol, Dialyvite, Fosrenol, PhosLo Kayexalate, Tenapanor, Lactulose | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110164080519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 69 Y | Female | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Abnormal weight loss, Anemia in chronic kidney disease, Cellulitis of lower limbs, Fever, Cough, Decreased white blood cell count, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Nausea, Other disorders of calcium metabolism, Renal osteodystrophy, Urinary tract infection, Chills, Dependence on renal dialysis, Essential hypertension, Hypercalcemia, Hypokalemia, Restless leg syndrome, | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Epinephrine, Maalox, Nitroglycerin, Promethazine, Albuterol, EMLA, Ambien, Gabapentin, Aspirin, Budesonide, Carvedilol, Singulair, Dialyvite, Spriiva, Elavil, Tramadol | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110196070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Chills, End stage renal disease, Hyperkalemia, Hyperlipidemia, Iron deficiency anemia, Vitamin D deficiency, Secondary hyperparathyroidism, Diabetes type 2, Protein-calorie malnutrition | Aspirin, Atorvastatin, Candesartan, Carvedilol, Clonidine, Clopidogrel, Ergocalciferol, Hydralazine, Lantus, Nifedipine, Nitroglycerin, Renvela, Sensipar, Tums | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110197093019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 59 Y | Female | Non-Hispanic | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus types 1 & 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Epinephrine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Naproxen, Amiodarone, Ondansetron, Amlodipine, Eliquis, Citalopram, Pantoprazole, Sensipar, Cyclobenzaprine, Sevelamer, Diltiazem, Tramadol, Valsartan, Hydralazine | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900110198080519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 8.00 | $450.00 | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Dependence on renal dialysis, Hypercalcemia, Hyperlipidemia, Hyperkalemia, Fever, Iron deficiency anemia, Fluid overload, Renal osteodystrophy, Shortness of breath, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Other disorders of phosphorus metabolism, Vitamin D deficiency | Epogen, Hectoral, Liquacel, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Ferrous glucontate, Sevelamer, Gabapentin | No | No | Yes | No | |||||||||||||||||||
| BBS0000-A0900110199070919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 51 Y | Male | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hyperkalemia, Iron deficiency anemia, Renal osteodystrophy, Diabetes mellitus type 2 without complications and with diabetic chronic kidney disease, Fluid overload, Secondary hyperparathyroidism of renal origin | Labetalol, Nifedipine, Losartan, PhosLo, Minoxidil | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110200082919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 34 Y | Female | Non-Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes type 2, Thyrotoxicosis, Vitamin D deficiency (older co-morbidities listed in chart) | Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Amlodipine, Cyclobenzaprine, Sevelamer, Losartan, Sensipar | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111704070519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 39 Y | Male | Non-Hispanic | <-70C | 05-Jul-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Bacteremia, Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hypercalcemia, Hyperkalemia, Hypermagnesemia, Polyuria, Tachycardia, Pruritus, Pseudomonas, Vomiting, Renal osteodystrophy, Chills without fever, Hypokalemia, Hypertension, Iron deficiency anemia, Nausea, A-Fib, Secondary hyperparathyroidism, Systemic lupus erythematosus, Protein-calorie malnutrition, Urgency of urination | Auryxia, Aspirin, Carvedilol, Clopidogrel, Hydralazine, Lisinopril, Norco, Lyrica, Tylenol with codeine, Prednisone, Renvela, Spiriva, Tizanidine, Tramadol | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111716082819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 16.00 | $450.00 | 60 Y | Female | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes type 2, Disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Epogen, Venofer, Acetaminophen, Clonidine, Lidocaine, Promethazine, Nitroglycerin, Apidra, Aspirin, Levemir, Calcium acetate, Nifedipine, Hydralazine, Pantoprazole, Ibuprofen | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111721081519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 82 Y | Male | Non-Hispanic | <-70C | 15-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 69 U/L | ALT: 119 U/L | $450.00 | Unknown | Diabetes mellitus, Hypertension, Cataracts, Myocardial infarction post stent placement | Amlodipine, Aspirin, Calcium carbonate, Diclofenac sodium, Docosahexaenoic acid, Fenofibrate, Fluocinolone, Glipizide, Hydrochlorothiazide, Ketoconazole, Latanoprost, Losartan, Metformin, Metoprolol, Nitroglycerin, Ranitidine, Scopolamine, Simvastatin | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111722082619DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $450.00 | 20 Y | Female | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes AST: 126 U/L | ALT: 192 U/L | ALP: 304 U/L | $450.00 | Unknown | Liver sarcoma, Cholecystectomy, Strictures and recurrent cholangitis | Duloxetine, Hydroxyzine | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900111723070319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism, Protein-calorie malnutrition | Amlodipine, Lorazepam, Metoprolol, Prezcobix, Triumeq, Pantoprazole, PhosLo | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111724070819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 38 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Bacteremia, Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Fever, Hypertension, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism, Lupus erythematosus, Renal osteodystrophy, Protein-calorie malnutrition | Carvedilol, Gabapentin, Hydroxyzine hydrochloride, Nifedipine, Pantoprazole, Sevelamer, Plaquenil, Zofran, Oxycodone, Promethazine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111725080719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 63 Y | Male | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Chronic kidney disease, Anemia in chronic kidney disease, End stage renal disease, Fluid overload, Cellulitis and abscess in foot, Bacteremia, Fever, Hypercalcemia, Hypocalcemia, Hyperkalemia, Hypokalemia, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Other disorders of calcium metabolism, Precipitous drop in hematocrit, Rash, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes mellitus type 2 | Epogen, Hectoral, Venofer, Novasource Renal, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Docusate, Lisinopril, Ergocalciferol, Nifedipine, Ferrous gluconate, Pantoprazole, Hydralazine | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111739082119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 31 Y | Female | Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Hypertension, Diabetes mellitus type 1 | Acetaminophen, Acetaminophen-Codeine, Albuterol HFA, Azithromycin, Benazepril, Benzonatate, Calcium acetate, Carvedilol, Docusate sodium, Ferrous sulfate, Fluoxetine, Fluticasone propionate, Furosemide, Glucagon, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Nifedipine, Ondansetron, Promethazine, Sodium bicarbonate | Yes U/A | Yes 30-Jul-98 | No | No | ||||||||||||||||||
| BBS0000-A0900111740082619DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $450.00 | 43 Y | Female | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 58 U/L | ALT: 98 U/L | $450.00 | Unknown | None | Cyclobenzaprine, Metformin | U/A U/A | U/A | No | No | ||||||||||||||||||
| BBS0000-A0900111741082919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 37 Y | Male | Non-Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient | Primary Signs and Symptoms | Dark colored urine | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectoral, Parsabiv, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Minoxidil, Aspirin, Carvedilol, Kayexalate, Nifedipine, Lamictal, Lisinopril, Sevelamer, Methadone, Theragran | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111742070819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 68 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Fever, Chills, Cough, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism, Diabetes type 2, Pruritus, Cellulite, Pain in unspecific joint, Obesity, Protein-calorie malnutrion, Renal osteodystrophy | Bisacodyl, Humulin, Clopidogrel bisulfate, Flonase, Gabapentin, Loratadine, Meclizine, Novolin, Eurcerin, Renvela, Ferrous sulfate, Glycolax powder, Senna, Multiplevitamin, Sertraline, Synthroid, Tamoxifen | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111743082819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 12.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 ,Recipient of clotting factor concentrates produced before 1987; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Complications of vascular and cardiac devices, Diabetes type 2, Disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Hectorol, Venofer, Acetaminophen, Clonidine, Lidocaine, Promethazine, Nitroglycerin, Calcium acetate, Eliquis, Midodrine, Gabapentin, Pravastatin, Niacin, Sensipar, Omeprazole, Tramadol | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111744091719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 33 Y | Male | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal Osteodystrophy, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Iron deficiency anemia | Epogen, Hectorol, Liquacel, Prevnar, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Hydralazine, Albuterol, Lisinopril, Atorvastatin, Nifedipine, Calcitriol, Sensipar, Carvedilol, Furosemide, Tramadol, Sucroferric oxyhydroxide velphoro | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111745082819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 66 Y | Female | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Diabetes type 2, Chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Amiodarone, Metoprolol, Apixiban, Isosorbide mononitrate, Aspirin, Sensipar, Atorvastatin, Ticagrelor | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111759080719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 70 Y | Female | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | Chronic kidney disease, End stage renal disease, Fluid overload, Cellulitis and abscess in upper arm, Bacteremia, Fever, Carbuncle and Furuncle, Chills, Hypercalcemia, Hyperkalemia, Hypokalemia, Hypothyroidism, Liver disease, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes mellitus types 1 and 2, Unspecified protein-calorie malnutrition, Tachy | Epogen, Parsabiv, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen, Rena-Vite, Renvela, Coreg | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111760080719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 77 Y | Female | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | Abnormal results of liver function studies, Dependence on renal dialysis, Gout, Hyperlipidemia, Iron deficiency anemia, Renal osteodystrophy, Unspecified protein-calorie malnutrition, Anemia in chronic kidney disease, End stage renal disease, Hyperkalemia, Hypothyroidism, Other disorders of plasma-protein metabolism, Secondary hyperparathyroidism | Engerix, Epogen, Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Dexilant, Atorvastatin, Febuxostat, Dialyvite, Proair HFA, Isosorbide mononitrate, Uloric, Lactulose, Pantoprazole, Levothyroxine, Sevelamer, Loratadine, Singulair, Metoprolol | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111761070819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 7.00 | $450.00 | 31 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, Encounter for screening for other viral diseases, Hyperkalemia, Other disorders of electrolyte and fluid balance, Other fluid overload, Secondary hyperparathyroidism of renal origin, Unspecified protein-calorie malnutrition, Dependence on renal dialysis, End stage renal disease, Iron deficiency anemia | Amlodipine, Renvela, Carlsoprodol, Sucralfate, Pantoprazole, Tylenol, Promethazine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111762070919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 3.00 | $450.00 | 45 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Chronic kidney disease, Dependence on renal dialsysis, End stage renal disease, Hyperkalemia, Disorders of phosphorus metabolism, Renal osteodystrophy, Other disorders of electrolyte and fluid balance, Other fluid overload, Hypercalcemia | Amlodipine, Sensipar, Cholecalciferol, Vitamin D3, Tenapanor, Coumadin, Vitamin B Complex, Renvela | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111763082819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 66 Y | Male | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Carrier or suspected carrier of Methicillin resistant staphylococcus aureus, Endocarditis (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Allopurinol, Metoprolol, Amiodarone, Atorvastatin, Psyllium, Ferric citrate auryxia, Sevelamer, Insulin lispro, Spironolactone | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111774080519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 6.00 | $450.00 | 63 Y | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Elevated PSA, Unspecified protein-calorie malnutrition, Fluid overload, Hypercalcemia, Hyperkalemia, Other disorders of phosphorus metabolism, Cellulitis of left toe, Renal osteodystrophy, Diabetes mellitus type 2, Hypertensive chronic kidney disease | Hectoral, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Pepcid, Auryxia, Sensipar, Gabapentin, Zolpidem, Kayexalate | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111775072919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Fluid overload, Anorexia, Diarrhea, Hyperkalemia, Unspecified dementia without behavioral disturbance | Epogen, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Minoxidil, Aspirin, Norco, Atorvastatin, Carvedilol, Biotin, Hydralazine, Pantoprazole, Isosorbide mononitrate, Renvela, Lisinopril | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111776070119DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 61 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Acute posthemorrhagic anemia, Fluid overload, Depression disorder, Nausea, Gout, Chronic obstructive pulmonary disease, Hyperkalemia, Hypokalemia, Hypothyroidism, Hypertension, Hyperlipidemia, Iron deficiency anemia, Sleep apnea, Disorders of plasma protein metabolism, Congestive heart failure, Gastrointestinal hemorrhage, Vitamin D deficiency, Disorders of electrolyte, Disorders of phosphorus metabolism, Renal osteodystrophy, Thromboc | Docusate sodium, Senna, Flexeril, Acetaminophen, Amlodipine, Aspirin, Atorvastatin, Benzonatate, Calcium acetate, Citalopram, Folic acid, Levalbuterol, Colcrys colchicine, Levothyroxine, Xopenex, Pantoprazole, PhosLo | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111777080519DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 13.00 | $450.00 | 73 Y | Female | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Cellulitis and abscess in leg and arm, Bacteremia, Fever, Furuncle, Hypocalcemia, Hyperkalemia, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Renal osteodystrophy, Thrombocytopenia, Sebaceous cyst, Secondary hyperparathyroidism, Diabetes mellitus type 2, Unspecified protein-calorie malnutrition | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Ergocalciferol, Levetiracetam, Bisacodyl, Nifedipine, Ondansetron, Dialyvite, Pantoprazole, Docusate sodium, Renvela, Furosemide, Sensipar, Gabapentin, Sucroferric oxyhydroxide velphoro, Isosorbide mononitrate | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111778072919DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 15.00 | $450.00 | 50 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Renal osteodystrophy, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Hypercalcemia, Other disorders of phosphorus metabolism | Hectoral, Liquicel, Parsabiv, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Dialyvite, Sidenofil, Metoprolol, Renvela | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111779070819DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $450.00 | 34 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Diabetes mellitus type 2 without complications and with diabetic chronic kidney disease, Chronic viral hepatitis B, Diabetes mellitus type 1 with hyperglycemia | Benadryl, Promethazine, Metoprolol, RenaGel, NovoLog insulin, Velphoro | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111829090319DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 10.00 | $450.00 | 43 Y | Male | Non-Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Coronary artery disease, Anxiety | Amlodipine, Atorvastatin, Escitalopram oxalate, Hydralazine, Levetiracetam, Lisinopril, Sevelamer carbonate, Sodium chloride | Yes U/A | Yes U/A | No | No | ||||||||||||||||||
| BBS0000-A0900111845071019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 9.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Obstructive sleep apnea, Hyperlipidemia, Glaucoma, Cataracts, Diabetes type 2, Psoriatic arthritis, Psoriasis, Arthritis | Farxiga, Cymbalta, Neurontin, Amaryl, Cozaar, Glucophage, Cosentyx, Zocor | No | No | No | No | ||||||||||||||||||
| BBS0000-A0900111846082019DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 14.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Cirrhois secondary to NASH, Hypothyroidism, Gastroesophageal reflux disease, Depression, Sinusitis, Hypertension, Diabetes, NAFLD, Hepatic enchphalopathy, Osteoarthritis left knee, Squamous cell carcinoma ear | Atarax, Lancets, Claritin-D, Diabetic pen needle, Xifaxan, Insulin aspart, Levothyroxine, Singulair, Zoloft, Hydrocortisone cream | Yes 4-Apr-18 | No | No | No | ||||||||||||||||||
| BBS0000-A0900111860082719DD | Suspect Hepatitis C (HCV) | Serum | 1.00 | 11.00 | $450.00 | 55 Y | Female | Non-Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | Pancreatitis, Pancreatic mass | Amlodipine, Cholecalciferol, Citalopram, Clopidogrel, Duloxetine, Gabapentin, Losartan, Magnesium oxide, Nicotine oxide, Nortriptyline, Oxycodone, Pancrelipase, Pantoprazole, Senna | No | No | No | No | ||||||||||||||||||
| BBS0000-BD900111817070519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 58 Y | Female | Non-Hispanic | <-70C | 05-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0000-BD900387749022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 56 Y | Male | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2 | 2020-02-27 | Insulin NovoLog | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387750022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 31 Y | Male | Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HIV | 2020-02-27 | Biktarvy | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387751030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 50 Y | Male | Hispanic | <-70C | 02-Mar-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HIV | 2020-03-02 | Symtuza | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387752022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 60 Y | Male | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-02-26 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387753022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 56 Y | Male | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Ulcers | 2020-02-27 | Protonix | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387754022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 54 Y | Male | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-02-27 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387755022820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 57 Y | Female | Non-Hispanic | <-70C | 28-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-02-28 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387756022420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 29 Y | Male | Non-Hispanic | <-70C | 24-Feb-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HIV | 2020-02-24 | Genvoya, Risperdal | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900387757022820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 4.00 | $450.00 | 57 Y | Male | Unknown | <-70C | 28-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-02-28 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900410502030320DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 5.00 | $150.00 | 36 Y | Female | Non-Hispanic | <-70C | 03-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | 2020-03-03 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900411410030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965; Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Dark colored urine | $150.00 | Unknown | Stomach ulcers; Pre-diabetes | 2020-03-05 | Protonix, Aspirin | U/A | U/A | No | No | No | |||||||||||||||
| BBS0000-BD900411411031120DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 11-Mar-20 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | 2020-03-11 | Genvoya | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418264061520DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 70 Y | Female | Non-Hispanic | <-70C | 15-Jun-20 | Subject Risk Information | Current or former user of IV drugs; HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Asthma, HIV | 2020-06-15 | Metformin, Genvoya | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418265061720DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 17-Jun-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-06-17 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418266061820DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 5.00 | $450.00 | 32 Y | Male | Non-Hispanic | <-70C | 18-Jun-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2020-06-18 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418270070220DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.25 | 5.00 | $450.00 | 60 Y | Male | Non-Hispanic | <-70C | 02-Jul-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Jaundice | $450.00 | Unknown | None | 2020-07-02 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418271062220DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 22-Jun-20 | Subject Risk Information | Current or former user of IV drugs; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HBV, HIV | 2020-06-22 | Lamivudine, Chantix, Tivicay, Viread | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418272072020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.25 | 5.00 | $450.00 | 65 Y | Male | Non-Hispanic | <-70C | 20-Jul-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | High blood pressure | 2020-07-20 | Aspirin | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418273062320DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 44 Y | Male | Non-Hispanic | <-70C | 23-Jun-20 | Subject Risk Information | Current or former user of IV drugs; HIV infected individual | Primary Signs and Symptoms | Jaundice | $450.00 | Unknown | Seizures, HIV | 2020-06-23 | Biktarvy, Keppra | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418274070720DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 5.00 | $450.00 | 33 Y | Male | Non-Hispanic | <-70C | 07-Jul-20 | Subject Risk Information | Current or former user of IV drugs; HIV infected individual | Primary Signs and Symptoms | N/A | $450.00 | Unknown | HIV | 2020-07-07 | Spironolactone, Estradiol, Biktarvy | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418275063020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 63 Y | Male | Non-Hispanic | <-70C | 30-Jun-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | High blood pressure | 2020-06-30 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900418276071520DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 15-Jul-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | N/A | $450.00 | Unknown | None | 2020-07-15 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900419915082520DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 33 Y | Male | Unknown | <-70C | 25-Aug-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | Jaundice | $150.00 | Unknown | None | 2020-08-25 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BD900420245082620DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 4.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 26-Aug-20 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | None | 2020-08-26 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 2.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0000-BU900376315022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Dysphagia, Emphysema, History of seizures, Knowledge deficit, Tobacco user, At risk for falls | 2020-02-26 | Acetaminophen, Albuterol, Amlodipine, Aspirin, Atorvastatin, Cholecalciferol, Ibuprofen | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900376316030220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 56 Y | Male | Non-Hispanic | <-70C | 02-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Cervical radiculopathy, Obesity | 2020-03-02 | None | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900376317022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 69 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hyperlipidemia, Hypertension, Tobacco user, Vitamin D deficiency | 2020-02-26 | Amlodipine, Atorvastatin, Ergocalciferol | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900376318022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 67 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Congestive heart failure, Diabetes mellitus, Hypertension, Morbid obesity, Sleep apnea, Tobacco user, Acid reflux, At risk for falls | 2020-02-26 | Acetaminophen, Aspirin, Albuterol, Flovent, Atorvastatin, Bumetanide, Carvedilol, Gabapentin, Insulin glargine, Lidocaine, Losartan, Nitroglycerin, Pantoprazole, Polyethylene glycol | U/A | U/A | U/A | U/A | Calcium - Vitamin D / Multivitamin | |||||||||||||||
| BBS0000-BU900376319022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 61 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Heart failure, Asthma, Anemia, Chronic pain, Diabetes mellitus, End stage renal disease, Hypertension, Hyperparathyroidism, Ineffective airway clearance | 2020-02-26 | Acetaminophen, Aspirin, Albuterol, Atorvastatin, Benzonatate, Cholecalciferol, Sevelamer, Cinacalcet, Nifedipine, Epoetin alfa, Fexofenadine, Flovent, Omeprazole, Gabapentin, Levothyroxine, Lisinopril, Montelukast | U/A | U/A | U/A | U/A | Multivitamin brand U/A | |||||||||||||||
| BBS0000-BU900382503030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 71 Y | Female | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Arthritis, Lumbar radiculopathy, Diabetes mellitus, Hyperlipidemia, Hypertension, Sacroiliitis, Biceps tendinitis of the right shoulder | 2020-03-05 | Amlodipine, Atenolol, Hydrochlorothiazide, Lantus, Lidoderm | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900382504030520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Asthma, COPD, At risk for falls, HIV, Hyperlipidemia, Hypertension, Obesity, Tobacco user, Arthritis in wrist, Total self-care deficit, Long term current use of opiate analgesic | 2020-03-05 | Albuterol, Albuterol Ipratropium, Aspirin, Atorvastatin, Bictegravir-Emtricitabine-Tenofovir, Budesonide Formoterol, Advair Diskus, Robafen, Lidocaine topical, Mometasone nasal, Oxybutynin, Prednisone, Spiriva Handihaler, Zolpidem | No | No | No | No | Multivitamin with iron | |||||||||||||||
| BBS0000-BU900382505030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 09-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hypertension, Tobacco user, Hypokalemia, Schizophrenia | 2020-03-09 | Acetaminophen, Amlodipine, Benztropine, Docusate, Hydrochlorothiazide, Ibuprofen, Loxapine, Metformin, Metoprolol, Olanzapine, Pantoprazole, Pravastatin, Biotene Saliva Substitute | U/A | U/A | U/A | U/A | No | |||||||||||||||
| BBS0000-BU900382507030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 09-Mar-20 | Subject Risk Information | HIV infected individual, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | HIV, Tobacco user | 2020-03-09 | Aspirin, Atorvastatin, Escitalopram, Fluticasone nasal | No | No | No | No | No | |||||||||||||||
| BBS0000-BU900382508030920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 23 Y | Male | Unknown | <-70C | 09-Mar-20 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $75.00 | Unknown | At risk for falls, Bipolar disorder, At high risk for violence, Severe depression, Bipolar with psychotic features, Polysubstance abuse, Tobacco user | 2020-03-09 | Naloxene | U/A | U/A | U/A | U/A | No | |||||||||||||||
| BBS0000-BU900382509031820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 73 Y | Male | Non-Hispanic | <-70C | 18-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2020-03-18 | None | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900382510031820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 58 Y | Male | Non-Hispanic | <-70C | 18-Mar-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Obesity, Tobacco user, Hypertension, Cheek swelling - dental abcess, Facial cellulitis | 2020-03-18 | Acetaminophen-Oxycodone, Amoxicillin Clavulanate, Gabapentin | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900399492022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Inguinal hernia repair, Zygomatic arch fracture, Inguinal hernioplasty | 2020-02-27 | None | U/A | U/A | U/A | U/A | No | |||||||||||||||
| BBS0000-BU900399493022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 73 Y | Female | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus, Hyperlipidemia, Hypertension, Obesity, Back surgery C3/C4 | 2020-02-27 | Atorvastatin, Metoprolol tartrate, Naproxen, Novolog pen, Pregabalin, Zolpidem, Tylenol | No | No | No | U/A | No | |||||||||||||||
| BBS0000-BU900399494022120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 21-Feb-20 | Subject Risk Information | Current or former user of IV drugs, Adult born from 1945 through 1965, HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Congestive heart failure, HIV, Cocaine abuse, Degenerative joint disease, Hypertension, Obesity, Schizoaffective disorder, Smoker, Cannabis use, Cervical fusion syndrome, Transgender, IV drug abuse | 2020-02-21 | Acyclovire, Albuterol, Nebs, Aspirin, Bupropion, Conjugated estrogen, Lasix, Progesterone, Darunavir/Cobicstat, Emtricitabine and Tenofovir alafenamide, Flovent HFA, Loratadine | U/A | U/A | U/A | U/A | No | |||||||||||||||
| BBS0000-BU900399506022520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 53 Y | Female | Non-Hispanic | <-70C | 25-Feb-20 | Subject Risk Information | HIV Infected Individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Asthma, HIV, COPD, Deviated nasal septum, Shingles, Tobacco user, Substance abuse crack cocaine, Left eye blindness, Bilateral hand neuropathy | 2020-02-25 | Albuterol, Gabapentin | U/A | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0000-BU900399507022720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 56 Y | Male | Non-Hispanic | <-70C | 27-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Hypertension, Diabetes | 2020-02-27 | Hydrochlorothiazide-Lisinopril, Metformin | No | No | No | No | U/A | |||||||||||||||
| BBS0000-BU900399508022820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 58 Y | Male | Non-Hispanic | <-70C | 28-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Abdominal hematoma, Cardiomyopathy, Acute Kidney Injury (AKI), Congestive heart failure, Morbid obesity, Tobacco user, Superficial thrombosis of legs | 2020-02-28 | Allopurinol, Atorvastatin, Bumetanide, Carvedilol, Eliquis, Potassium, Spironolactone | U/A | U/A | No | U/A | U/A | |||||||||||||||
| BBS0000-CC900024277100419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 82 Y | Female | Non-Hispanic | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Chronic kidney disease, Cutaneous abcess of right foot, (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Amlodipine, Fish oil, Ferric citrate, Coreg | No | No | Yes | No | |||||||||||||||||
| BBS0000-CC900024278091019DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Dependence of renal dialysis, Hyperkalemia, Secondary hyperparathyroidism (older co-morbidities listed in chart) | Engerix, Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Losartan, Bumetanide, Metoprolol, Ferrous sulfate, Pantoprazole, Furosemide, Sevelamer, Levothyroxine | No | No | No | No | |||||||||||||||||
| BBS0000-CC900024279091019DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 6.00 | $450.00 | 56 Y | Female | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Allopurinol, Creon, Aspirin, Atorvastatin, Lantus insulin, Ferric citrate, Carvedilol, Ramipril | No | No | No | No | |||||||||||||||||
| BBS0000-CC900024282092519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 60 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Cutaneous abcess of left foot, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Novasource, Hectorol, Parsabiv, Vancomycin, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Labetalol, Renvela, Lisinopril, Temazepam, Nifedipine | No | No | No | No | |||||||||||||||||
| BBS0000-CC900024283091719DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 56 Y | Female | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Pepcid, Clopidogrel, Humalog, Renvela, Labetalol, Senna, Levemir, Sensipar, Minoxidil, Telmisartan, Nifedipine | No | No | No | No | |||||||||||||||||
| BBS0000-CC900024284092419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $450.00 | 56 Y | Female | Non-Hispanic | <-70C | 24-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Systemic lupus erythematosus, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Lantus, Calcitriol, NovoLog, Dialyvite, Plavix, Gabapentin, Tums, Hydrocodone-acetaminophen | No | No | No | No | |||||||||||||||||
| BBS0000-CC900024286090619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 67 Y | Female | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hypocalcemia (older co-morbidities listed in chart) | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Iron, Carvedilol, Docusate, Polyethylene glycol, Furosemide, Nifedipine, Sevelamer, NovoLog insulin | No | No | No | No | |||||||||||||||||
| BBS0000-CC900107988061319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 69 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Guillain-Barre syndrome, Lyme disease, Multiple sclerosis, Myasthenia gravis, Peripheral arterial disease, Peripheral vascular disease, Raynaud's syndrome | Cyanocobalamin (vitamin B12), Ergocalciferol, Gabapentin, Magnesium hydroxide, Potassium acetate, Pregabalin | No | No | |||||||||||||||||
| BBS0000-CC900111838060419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $150.00 | 32 Y | Male | Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | None | Dextran hypomellose, Polymyxin B Sulfate-Trimethoprim drops | No | No | ||||||||||||||||||
| BBS0000-CC900361037020420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | Female | Unknown | <-70C | 04-Feb-20 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $75.00 | Unknown | 2020-02-04 | No | No | No | No | Prenatal vitamin plus low iron | ||||||||||||||||||
| BBS0000-CC900361038102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 32 Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Bell's palsy, Anemia, AIDS, Migraines, ADD | 2019-10-29 | Mepron, Biktarvy, DSS, Ferrous sulfate, Zofran, Compazine, Sulfamethoxazole-trimethoprim, Zantac, Phenergan | Yes 18-Oct-17 | Yes 12-Apr-00 | No | U/A | Prenatal multivitamin + DHA, Omega | |||||||||||||||
| BBS0000-CC900361039102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 31 Y | Female | Unknown | <-70C | 29-Oct-19 | Subject Risk Information | Current or former user of IV drugs; HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HPV, Ashtma | 2019-10-29 | Albuterol, Proventil, Biktarvy, Atarax, Zofran, Zoloft | No | No | No | No | Prenatal multivitamin | |||||||||||||||
| BBS0000-CC900361040101519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 23 Y | Female | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Iron deficiency anemia, Migraine with aura, Trichomonas, Gonorrhea | 2019-10-15 | Genvoya, Ferrous sulfate, Polyvinylalcohol, Vitamin B6, Flagyl | Yes 17-Sep-02 | Yes 9-Sep-97 | No | U/A | Prenatal vitamin-Iron-Folic acid | |||||||||||||||
| BBS0000-CC900361041110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 39 Y | Female | Non-Hispanic | <-70C | 05-Nov-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Asthma, Advanced maternal age, Trichomoniasis, History of preeclampsia, Obesity, Anemia, AIDS | 2019-11-05 | Albuterol, Zithromax, Genvoya, Sulfamethoxazole-trimethoprim | True | No | No | Yes 15-Aug-19 | U/A | Prenatal Vit-Sel-Fe-Fum-Fa | 3rd Trimester | |||||||||||||
| BBS0000-CC900361042010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $450.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-CC900361044010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $450.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-CC900361045010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 31 Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||||
| BBS0000-CC900361047010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-CC900361049010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $450.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-CC900361061112119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 35 Y | Female | Non-Hispanic | <-70C | 21-Nov-19 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Alcohol use, Obesity, Bacterial vaginosis, Advanced maternal age | 2019-11-21 | Flagyl | True | No | No | Yes 15-Aug-19 | U/A | Prenatal Vit-DSS-Fe-Cbn-Fa | 3rd Trimester | |||||||||||||
| BBS0000-CC900361062112119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 36 Y | Female | Non-Hispanic | <-70C | 21-Nov-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 1, HIV, Glaucoma, Neuropathy, Advanced maternal age - Multigravida | 2019-11-21 | Emtricitabine-tenofovir AF, Ezetimibe, Insulin aspart, Insulin NPH, Xalatan, Claritin, Raltegravir | True | Yes 11-May-15 | Yes 1-Sep-15 | No | No | Prenatal Vit-Vinate M | 1st Trimester | |||||||||||||
| BBS0000-CC900361063112119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 36 Y | Female | Hispanic | <-70C | 21-Nov-19 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Short interval pregnancy, Stroke history, Rh negative | 2019-11-21 | Aspirin | True | No | No | No | U/A | Prenatal Vit-Fe Fumarate-Fa | 2nd Trimester | |||||||||||||
| BBS0000-CF900099078091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $450.00 | 21 Y | Male | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Dark colored urine, Elevated liver enzymes | AST: 685 U/L | ALT: 235 U/L | 12-Sep-19 | $450.00 | Unknown | Anxiety, Depression, Meningitis | Ibuprofen | Yes U/A | Yes U/A | No | No | ||||||||||||||||
| BBS0000-CF900099079092519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 57 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Small cell lung cancer on chemotherapy | Albuterol, Dexamethasone, Famotidine, Hydrochlorothiazide, Hydrocodone-acetaminophen, Loratidine, Ondansetron, Prochlorperazine, Refresh tears | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099080091919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 74 Y | Male | Non-Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | AST: 60 U/L | ALP: 162 U/L | 17-Sep-19 | $450.00 | Unknown | Leukemia in remission, Iron overload syndrome, Pericardial effusion status post pericardia window, Ascites status post paracentesis | Amoxicillin, Fenofibrate, Furosemide, Mirtazapine, Pantoprazole, Polyethylene glycol, Spironolactone | U/A | U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900099081090519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 9.00 | $450.00 | 26 Y | Male | Non-Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | ALT: 107 | 4-Sep-19 | $450.00 | Unknown | Anxiety, Degenerative disc disease | Hydrocodone-acetaminophen; Ibuprofen | Yes 19-Jun-19 | Yes U/A | No | No | ||||||||||||||||
| BBS0000-CF900099082091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 66 Y | Male | Non-Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Asthma, Osteoarthritis, Adrenal insufficiency, Hypertension, Chronic kidney disease | Acetaminophen, Acetaminophen-Codeine, Albuterol HFA, Amlodipine, Azelastine, Budesonide, Bupropion, Cephalexin, Desvenlafaxine, Desvenlafaxine succinate, Eszopiclone, Fluticasone sammetro, Gabapentin, Hydrocortisone, Hyqvia, Levothyroxine, Lorazepam, Methocarbamol, Mometasone, Montelukast, Theragran, Naloxone, Omeprazole, Oxycodone, Pimechrolimus cream, Sertraline, Tamsulosin, Tiotropium, Ubidecarenone, Vitamin B complex | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099083092519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 72 Y | Female | Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Chronic kidney disease, Diabetes mellitus, Hypertension, GERD | Amlodipine, Aspirin, Calcitriol, Carvedilol, Clopidogrel, Esomeprazole, Ferrous sulfate, Furosemide, Gabapentin, Glipizide, Insulin degludec, Irbesartan, Nitrofurantoin, Pravastatin, Venlafaxine | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099084091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $450.00 | 44 Y | Female | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 50 U/L | 12-Sep-19 | $450.00 | Unknown | None | Ciprofloxacin, Docusate sodium, Metronidazole, Ondansetron | Yes U/A | Yes U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900099948100119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $450.00 | 37 Y | Female | Non-Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Hysterectomy, Rheumatoid arthritis, Skin cancer, Pulmonary embolism, Recurrent UTI, Care on immunosuppressants | Alprazolam, Oxycodone, Carisoprodol, Prednisione, Cephalexin, Gabapentin, Loratadine, Methotrexate | Yes U/A | No | Yes | No | |||||||||||||||||
| BBS0000-CF900099949101719DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 63 Y | Male | Non-Hispanic | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Congestive heart failure with an ejection fraction of 10%, Hypertension, Hypersensitivity lung disease, Prio methamphetamine and alcohol use | Acetaminophen, Aspirin, Atorvastatin, Carvedilol, Furosemide, Lisinopril | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099950100719DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 62 Y | Male | Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALP: 253 U/L | 7-Oct-2019 | $450.00 | Unknown | Non-ischemic cardiomyopathy likely secondary to methamphetamine use | Apixaban, Bumetanide, Furosemide | No | No | Yes | No | ||||||||||||||||
| BBS0000-CF900099951100919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $450.00 | 51 Y | Male | Hispanic | <-70C | 09-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 165 U/L | 9-Oct-2019 | $450.00 | Unknown | Hypertension, End stage renal disease, Diabetes mellitus, Congestive heart failure, Chronic kidney disease on hemodialysis, Hypersensitivity lung disease | Alteplase, Amiodarone, Atorvastatin, Balsam Peru castor oil, Calcium, acetate, Cholecalciferol, Clindamycin, Dobutamine, Docusate sodium, Ergocalciferol, Fentanyl, Hydrocodone-acetaminophen, Insulin glargine, Levothyroxine, Midodrine, Novolog, Polyethylene glycol, Rena Vite, Sevelamer carbonate, Vitamin B complex Vitamin C folate, Vitamin A & D ointment, Warfarin | No | No | Yes | No | ||||||||||||||||
| BBS0000-CF900099952091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 5.00 | $450.00 | 43 Y | Female | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Lupus nephritis status post right renal transplant, Heart disease | Furosemide, Mycophenolate, Omeprazole, Prednisone, Tacrolimus | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-CF900099953091919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 67 Y | Female | Non-Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | COPD with oxygen dependence, Diabetes mellitus, Chronic kidney disease | Acetaminophen, Albuterol, Apixaban, Aspirin, Beclomethasone, Carvedilol, Clonidine, Furosemide, Gabapentin, Hydralazine, Insulin glargine, Insulin lispro, Isosorbide dinitrite, Ondansetron, Pantoprazole, Prazosin, Simvastatin, Tobramycin-dexamethasone | No | No | Yes | No | |||||||||||||||||
| BBS0000-CF900099954091919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 27 Y | Female | Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 86 U/L | ALT: 79 U/L | 19-Sep-19 | $450.00 | Unknown | None | Gabapentin, Hydrocodone-acetaminophen, Methocarbanol, Senna docusate, Nitrofurantoin | No | No | No | No | ||||||||||||||||
| BBS0000-CF900100813092519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 6.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Myocardial infarction, Coronary artery disease | Aspirin, Atorvastatin, Hydrocodone-acetaminophen, Ibuprofen, Lisinopril, Metoprolol succinate, Ondansetron, Sertraline, Spironolactone, Warfarin | No | No | No | Yes | |||||||||||||||||
| BBS0000-CF900100814091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 65 Y | Female | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus, Hypertension | Atenolol, Insulin lispro | No | No | No | No | |||||||||||||||||
| BBS0000-CF900100815092419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 65 Y | Male | Non-Hispanic | <-70C | 24-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | NASH, Cirrhosis, Chronic kidney disease stage 4, Hypothyroidism | Albuterol, Aspirin, Atorvastatin, Beclomethasone, Cholecalciferol, Docusate sodium, Fluticasone propionate, Furosemide, Hydrocortisone, Rectal cream and suppository, Lactulose, Levothyroxine, Lidocaine, Olopatadine, Omeprazole, Rifaximin, Simethicone, Spironolactone | U/A | U/A | No | No | |||||||||||||||||
| BBS0000-CF900100816092619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 34 Y | Female | Non-Hispanic | <-70C | 26-Sep-19 | Subject Risk Information | Current or former user of IV drugs (former) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 139 U/L | ALT: 194 U/L | ALP: 235 U/L | 25-Sep-19 | $450.00 | Unknown | Recurrent deep vein thrombosis due to May-Thurner Syndrome, Recent admission and stent placement by IR | Apixaban, Aspirin, Docusate sodium Hydrocodone-acetaminophen, Naloxone, Oxycodone, Oxycodone-acetaminophen, Polyethylene glycol, Senna, Trazodone | No | No | No | No | ||||||||||||||||
| BBS0000-CF900107230091219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 65 Y | Female | Non-Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 31 U/L | 12-Sep-19 | $450.00 | Unknown | Hypertension, Rheumatoid arthritis | Amlodipine, Aspirin, Cyclobenzaprine, Diclorenac gel, Etanercept, Ibuprofen, Leflunomide, Loratadine, Losartan, Metoprolol succinate, Prednisone, Pregabalin, Rosuvastatin, Sulfamethoxazole-trimethoprim, Sumatriptan | Yes U/A | Yes U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900107231091019DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 66 Y | Female | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1981) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 57 U/L | 9-Sep-19 | $450.00 | Unknown | Spinal stenosis, Systemic lupus erythematosus | Acyclovir, Albuterol, Ascorbate calcium, B complex vitamins, Blue-green algae, Brimonidine, Cephalexin, Cholecalciferol, Escitalopram oxalate, Fluticasone, Fluticasone-salmeterol, Furosemide, Gabapentin, Grape seed extract, Hydrocodone-acetaminophen, Hydroxychloroquine, Ipratropium, Lidocaine, Multivitamin, Naproxen, Omega 3, Phenazopyrdine, Polyethylene glycol, Selenium, Tramadol, Zinc, Zoledronic, Plaquenil | No | No | No | Yes | ||||||||||||||||
| BBS0000-CF900107233100119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 36 Y | Male | Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ASP: 505 U/L | 30-Sep-19 | $450.00 | Unknown | Failed kidney transplant; End stage renal disease on hemodialysis | Amlodipine, Apixaban, Carvedilol, Hydralazine, Insulin glargine, Insulin lispro, Levothyroxine, Prednisone, Sevelamer carbonate, Tacrolimus | U/A | U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900107592101519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $450.00 | 68 Y | Male | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 225 U/L | 14-Oct-19 | $450.00 | Unknown | Diabetes mellitus, Hypertension, Coronary artery disease | Glipizide, Insulin glargine | No | No | No | No | ||||||||||||||||
| BBS0000-CF900107989070119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Enlarged liver | $150.00 | Unknown | Alcoholic liver disease, Autoimmune hepatitis, Decompensated cirrhosis | Calcium carbonate / Magnesium / Vitamin D3, Cyanocobalamin, Dexlansoprazole, Furosemide, Hydrocodone-acetaminophen, Levothyroxine, Lorazepam, Ondansetron, Propranolol, Rifaximin, Spironolactone | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | ||||||||||||||||
| BBS0000-CF900107990052919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $150.00 | 53 Y | Female | Unknown | <-70C | 29-May-19 | Subject Risk Information | N/A | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L; ALT: 47 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Thyroid disease | Aspirin, Famotidine, Levothyroxine | No | No | |||||||||||||||||
| BBS0000-CF900111828053019DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 177 U/L; AST: 74 U/L; ALT: 126 U/L:Test Date 30-May-2019 | $150.00 | Unknown | Anxiety, Arthritis, Cataract, Diabetes mellitus, Gastroesophageal reflux disease, Gout, Hypertension, Myositis of left upper extremity, Obesity unspecified, Obstructive sleep apnea, Other chronic nonalcoholic liver disease, Post-operative nausea and vomiting, Allergies | Solu-Medrol, Trulicity, Pepcid, Ibuprofen, Basaglar KwikPen, Claritin, Metformin, Toprol XL, Pyridium, Prednisone, Rituxan, Januvia, Ultram, Triamcinolone | No | No | |||||||||||||||||
| BBS0000-CF900111839062619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $150.00 | 48 Y | Male | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 (1987) | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver | $150.00 | Unknown | Iron deficieny anemia, Splenomegaly, Hepatomegaly, NASH cirrhosis, Diabetes mellitus, Esophageal varices, Morbid obesity, Myocardial infarction, GI bleed | Lactulose, Loratadine, Metformin, Multivitamin, Propranolol, Sitagliptin, Zinc | U/A | U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900352672112019DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 16.00 | $450.00 | 33 Y | Male | Hispanic | <-70C | 20-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 5265 U/L; ALT: 4113 U/L 19-Nov-2019 | $450.00 | Unknown | 2019-11-20 | No | No | No | No | U/A | |||||||||||||||||
| BBS0000-CF900352673112619DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 23.00 | $450.00 | 58 Y | Female | Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 229 U/L 25-Nov-2019 | $450.00 | Unknown | Diabetes mellitus, Hypertension, End stage renal disease on hemodialysis | 2019-11-26 | Amlodipine, Carvedilol, Ergocalciferol, Furosemide, Insulin glargine, Insulin lispro, Sodium bicarbonate, Topiramate | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900352674112619DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 20.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L 25-Nov-2019 | $450.00 | Unknown | Diabetes mellitus, Hypertension, Coronary artery disease, Myocardial infarction x2 | 2019-11-26 | Allopurinol, Aspirin, Calcium carbonate, Canagliflozin, Carvedilol, Cholecalcirerol, Clopidogrel, Dasatinib, DHA, Doxycycline, Fluticasone, Hydrocodone-acetaminophen, Ibuprofen, Insulin detemir, Ipratropium, Nitroglycerin, Novolog flexpen, Phentermine, Rosuvastatin, Triamcinolone, Salmeterol | No | No | No | No | Multivitamin, Gummies | |||||||||||||||
| BBS0000-CF900352675112619DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.80 | 18.00 | $450.00 | 60 Y | Female | Non-Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 373 U/L; ALT: 420 U/L; ALP: 275 U/L 25-Nov-2019 | $450.00 | Unknown | 2019-11-26 | Alprazolam, Sertraline HCl | No | No | No | No | No | ||||||||||||||||
| BBS0000-CF900352676112619DD | Suspect Hepatitis C (HCV) | United States | Serum | 2.00 | 8.00 | $450.00 | 58 Y | Female | Non-Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Aortic regurgitation, Atrial fibrillation, Dyslipidemia | 2019-11-26 | Apixaban, Ascorbic acid, Atorvastatin, Carvedilol, Docusate Polyethylene glycol, Torsemide | No | No | No | No | Theragran | |||||||||||||||
| BBS0000-CF900352677111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 16.00 | $450.00 | 75 Y | Male | Non-Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 139 U/L 19-Nov-2019 | $450.00 | Unknown | Diabetes mellitus, Hypertension, COPD, T6-T11 fusion of spine / epidural abcess, Fibromyalgia, Chronic pain disorder, Lumbar disc disease | 2019-11-19 | Atorvastatin, Baclofen, Benazepril, Finasteride, Heparin, Hydrocodone-acetaminophen, Hydroxyzine, Insulin glargine, Lidocaine, Morphine, Naloxone HCl, Pantoprazole, Senna, Tamalosin, Zinc sulfate | No | No | No | No | Theragran | |||||||||||||||
| BBS0000-CF900355510111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.80 | 15.00 | $450.00 | 38 Y | Male | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 55 U/L 19-Nov-2019 | $450.00 | Unknown | Chronic pancreatitis, Diabetes mellitus, Hypertension, Gastroparesis | 2019-11-19 | Acetaminophen, Aspirin, Atenolol, Dextran, Hypromellose, Dicyclomine, Docusate sodium, Enalapril, Hydrocortisone, Ibuprofen, Insulin glargine, Insulin lispro, Levetiracetam, Metformin, Ondansetron, Furosemide, Lactulose, Metoprolol succinate, Ondansetron, Pantoprazole, Tamulosin | U/A | U/A | Yes | No | No | |||||||||||||||
| BBS0000-CF900355514111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 21.00 | $450.00 | 61 Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Angina pectoris, Arthritis, Asthma, Bronchitis, Cerebrovascular accident, Chronic kidney disease, Diabetes mellitus, Gunshot wound, Herniated disc, Hypertension, Hypertriglyceridemia, Pancreatitis, Sciatica, Sleep apnea, Stroke (cerebrum) | 2019-11-19 | Albuterol HFA, Acetaminophen, Alogliptin, Aluminum-maghydroxide-simethicone, Aspirin, Atorvastatin, Benzonatate, Carvedilol, Cetirizine, Clopidogrel, Dicyclomine, Duloxetine, Ertugliflozin, Fluticasone, Gabapentin, Gemfibrozil, Hydrocodone-acetaminophen, Hydroxyzine, Insulin lispro, Lantus SoloStar, Lidocaine, Lisinopril, Methocarbamol, Narcan, Ranitidine, Senna, Trazodone | No | Yes 26-Feb-18 | Yes | No | No | |||||||||||||||
| BBS0000-CF900355515111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 15.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | Multiple sclerosis, Pancreatitis | 2019-11-19 | Acyclovir, Ascorbic acid, Bifidobacterium infantis, Calcium carbonate, Copper, oral, Cyanocobalamin, Dalfampridine, Folic acid, Hydrocodone-acetaminophen, Immunoglobulin, Iodine, Lidocaine, Manganese, Mirabegron, Modafinil, Nystatin, Omega 3, Panzyga, Potassium animobenzoate, Seleium, Taurine, Testosterone, Turmeric, Zinc | U/A | Yes 23-Sep-2019 | 6-Nov-2019 | No | No | Vitamin A, C and E-Lutein-Minerals, Vitamin A, Vitamin B complex, Cholecalciferol | |||||||||||||||
| BBS0000-CF900355516111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.50 | 17.00 | $450.00 | 43 Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 180 U/L; ALT: 90 U/L; ALP: 590 U/L19-Nov-2019 | $450.00 | Unknown | Anxiety, Hypertension | 2019-11-19 | Lorazepam | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900355517111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.80 | 11.00 | $450.00 | 22 Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 104 U/L; ALT: 56 U/L; ALP: 139 U/L 18-Nov-2019 | $450.00 | Unknown | Juvenile rheumatoid arthritis | 2019-11-19 | Epinephrine, Famotidine, Folic acid, Hydrocodone-acetaminophen, Ibuprofen, Leucovorin, Naproxen, Prednisone, Tramadol | No | No | Yes | No | Yes | U/A | |||||||||||||||
| BBS0000-CF900355518111919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.40 | 17.00 | $450.00 | 67 Y | Male | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Coronary artery bypass graft, Hypertension, Diabetes mellitus, Partial colectomy | 2019-11-19 | Acetaminophen, Aspirin, Atorvastatin, Benazepril, Fluocinonide, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Lidocaine, Metoprolol tartrate, Omeprazole | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900358438120319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 17.00 | $450.00 | 57 Y | Male | Hispanic | <-70C | 03-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Myocardial infarction, Status post stent placement 2 years ago, Diabetes mellitus, High cholesterol, Hypertension, End stage renal disease on hemodialysis | 2019-12-03 | Aspirin, Atorvastatin, B Complex vitamin, Folic acid, Clopidogrel, Decara, Diphenhydramine, Furosemide, Gabapentin, Hydrocodone-acetaminophen, Insulin aspart, Insulin lispro, Lisinopril, Metoprolol tartrate, Sevelamer carbonate, Sevelamer hydrochloride, Stool softener | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900358439120919DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | 1.00 | $450.00 | 59 Y | Female | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Pulmonary embolisms on Eliquis, Breast cancer not on current treatment, Cervical cancer in remission, Appendectomy, Total hysterectomy | 2019-12-09 | Albuterol HFA, Anastrozole, Apixaban, Atorvastatin, Bupropion, Cholecalciferol Vitamin D3, Cyclobenzaprine, Diclofenac sodium, Fluticasone-propionate-salmeterol, Gabapentin, Hydroxazine, Ketoconazole, Morphine, Naloxone, Omeprazole, Oxycodone | Yes | Yes | Yes | No | Centrum OTC | Promethazine, Quetiapine, Zolpidem | ||||||||||||||
| BBS0000-CF900358440120219DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 20.00 | $450.00 | 51 Y | Female | Non-Hispanic | <-70C | 02-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 31 U/L; ALP: 285 U/L | 2-Dec-19 | $450.00 | Unknown | Lupus, End stage renal disease on hemodialysis | 2019-12-02 | Albuterol HFA, Atorvastatin, Calcium carbonate, Calcium, Carvedilol, Clonidine HCl, Escitalopram oxalate, Furosemide, Hydralazine, Hydromorphone, Losartan, Morphine, Nifedipine, Pantoprazole, Quetiapine, Sevelamer carbonate, Zolpidem | Yes | Yes | Yes | Yes | No | ||||||||||||||
| BBS0000-CF900358441120919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.90 | 8.00 | $450.00 | 61 Y | Male | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Hypertension, COPD | 2019-12-09 | Acetaminophen, Allopurinol, Apixaban, Gabapentin, Lidocaine, Morphine, Pregabalin, Tramadol, Trazodone | Yes 1975 | No | No | No | B Complex with vitamin C | |||||||||||||||
| BBS0000-CF900358442120319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.20 | 4.00 | $450.00 | 57 Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1984); Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 157 U/L | 2-Dec-19 | $450.00 | Unknown | End stage renal disease secondary to diabetic neuropathy, Status post kidney transplant Jul-2019, Status post colectomy with ileostomy 1984, Left below knee amputation 2017 | 2019-12-03 | Ciprofloxacin HCl, Epoetin alfa, Ferrous sulfate, Fluoxetine, Hydrocodone-acetaminophen, Insulin aspart, Mycophenolate, Ondansetron, Oxybutynin, Pantoprazole, Patiromer calcium sorbitex, Prednisone, Pregabalin, Sodium bicarbonate, Tacrolimus | No | No | No | No | No | ||||||||||||||
| BBS0000-CF900358443120219DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 17.00 | $450.00 | 66 Y | Male | Unknown | <-70C | 02-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | 30-Nov-19 | $450.00 | Unknown | Aspergillus on voriconazole, COPD, Rheumatoid arthritis, Hypertension, Diastolic heart function | 2019-12-02 | Acetaminophen, Aspirin, Atorvastatin, Budesonide-formoterol, Dextromethorphan guaifenesin, Epinephrine, Finasteride, Folic acid, Gabapentin, Hydralazine, Hydromorphone, Ipratropium-albuterol, Losartan, Metformin, Naloxone, Nifedipine, Omalizumab | No | No | No | No | Centrum OTC, Theragran-M | Prednisone, Pregabalin, Senna, Silver sulfadiazine, Ventolin HFA, Voriconazole | |||||||||||||
| BBS0000-CF900358444120919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 11.00 | $450.00 | 68 Y | Male | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Lung cancer status post left lobectomy, COPD | 2019-12-09 | Acetaminophen, Albuterol HFA, Amlodipine, Cyclobenzaprine, Finasteride, Gabapentin, Hydrocodone acetaminophen, Levothyroxine, Mirtazapine, Naloxone, Quetiapine, Tamsulosin | U/A | U/A | Yes | No | No | |||||||||||||||
| BBS0000-CF900358474120319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 13.00 | $450.00 | 23 Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 44 U/L | 3-Dec-19 | $450.00 | Unknown | None | 2019-12-03 | Ibuprofen, Ondansetron | No | No | No | No | No | ||||||||||||||
| BBS0000-CF900358482121619DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.50 | 12.00 | $450.00 | 67 Y | Female | Unknown | <-70C | 16-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Arthritis, Chronic back pain, Chronic pain of right knee | 2019-12-16 | Albuterol HFA, Benzonatate, Diclofenac, Hydrocodone-acetaminophen, Hysingla ER, Polyethylene glycol, Prednisone, Suflamethoxazole, Voltaren | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900358483121019DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 64 Y | Male | Hispanic | <-70C | 10-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Diabetes mellitus, Hypertension | 2019-12-10 | Amlodipine, Carvedilol, Clonidine, Hydrochlorothiazide, Metformin, Lisinopril | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900359161102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 16.00 | $450.00 | 66 Y | Male | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2019-10-28 | Docusate sodium, Gabapentin, Hydrocodone-acetaminophen, Methocarbamol, Phenytoin | Yes U/A | Yes | Yes | No | No | |||||||||||||||
| BBS0000-CF900359162102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 17.00 | $450.00 | 71 Y | Female | Unknown | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 50 U/L | 2019-10-28 | $450.00 | Unknown | Dermatomyositis | 2019-10-29 | Gabapentin Levothyroxine, Prednisione | No | No | No | No | No | ||||||||||||||
| BBS0000-CF900359163102419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 24.00 | $450.00 | 69 Y | Male | Unknown | <-70C | 24-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 67 U/L | ALP: 189 U/L | 2019-10-23 | $450.00 | Unknown | Liver cirrhosis, End stage renal disease on dialysis, Diabetes mellitus, Thrombocytopenia | 2019-10-24 | Calcium carbonate, Carbamide peroxide, Cyclobenzaprine, Lactulose, Levemir FlexTouch insulin, NovoFine, Hydrocodone-acetaminophen | No | Yes | Yes | Yes | B Complex with vitamin C | ||||||||||||||
| BBS0000-CF900359164102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 16.00 | $450.00 | 31 Y | Female | Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 173 U/L | 2019-10-28 | $450.00 | Unknown | None | 2019-10-28 | Cephalexin | Yes U/A | Yes | No | No | Yes Unknown name and brand | ||||||||||||||
| BBS0000-CF900359170111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 13.00 | $450.00 | 61 Y | Male | Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Atrial fibrillation, Hypertension | 2019-11-13 | Aspirin, Carvedilol, Diltiazem, Lisinopril, Oseltamivir, Tramadol | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900359171111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 15.00 | $450.00 | 70 Y | Female | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Kidney transplant and failed transplant, Small-bowel obstruction, Anemia, Chronic kidney disease on peritoneal dialysis, Hypertension, Hernia repair | 2019-11-13 | Amlodipine, Aspirin, Carvedilol, Furosemide, Hydralazine, Levothyroxine, Minoxidil, Pantoprazole, Prednisone, Procrit, Tacrolimus | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900359172111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 68 Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | 2019-11-14 | Albuterol HFA, Denosumab, Ferric carboxymaltose, Ferrous sulfate, Lidocaine, Paroxetine, Triamcinolone | No | No | No | Yes | ||||||||||||||||
| BBS0000-CF900359173111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 18.00 | $450.00 | 38 Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | AST: 91 U/L | ALT: 80 U/L | ALP: 161 U/L | 2019-11-14 | $450.00 | Unknown | Liver transplant on immunosuppression, Recurrent hepatic epithelioid hemangioendothelioma with metastasis to lung, liver, spine | 2019-11-14 | Acetaminophen, Aspirin, Docusate sodium, Furosemide, Lactulose, Metoprolol succinate, Ondansetron, Oxycodone, Senna, Tacrolimus, Tramadol | Yes 2017 | Yes 2014 | Yes | No | |||||||||||||||
| BBS0000-CF900359174110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.50 | 19.00 | $450.00 | 62 Y | Female | Non-Hispanic | <-70C | 05-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 184 U/L | 2019-11-04 | $450.00 | Unknown | Multiple myeloma status post marrow transplant, Chronic kidney disease on dialysis | 2019-11-05 | Acyclovir, Bortezomib, Bumetanide, Calcium acetate, Cyclophosphamide, Dexamethasone, Hydrocortisone, Indapamide, Lidocaine, Metoprolol succinate, Midodrine, Pantoprazole, Senna, Sensipar, Sodium chloride with meropenem | Yes U/A | Yes | Yes | No | |||||||||||||||
| BBS0000-CF900359175120319DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.50 | 12.00 | $450.00 | 54 Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Hypertension | 2019-12-03 | Albuterol HFA, Atenolol, Atorvastatin, Fluticasone / Salmeterol, Gabapentin, Magnesium oxide, Naloxone, Omeprazole, Oxycodone, Oxycodone-acetaminophen, Polyvinyl alcohol, Prochlorperazine, Sertraline, Tizanidine, Topiramate, Trazadone, Verapamil | Yes | Yes | No | No | No | |||||||||||||||
| BBS0000-CF900359176102219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 66 Y | Female | Unknown | <-70C | 22-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Seizure, Hypertension, Prior hemorrhage CVA (stroke) status post stent placement with subsequent fungal infection status post removal | 2019-10-22 | Acetaminophen, Amitriptyline, Amlodipine, Ascorbic acid, Atorvastatin, Enoxaparin, Fluconazole, Gabapentin, Levetiracetam, Metoprolol tartrate, Polyethylene glycol, Potassium chloride, Propranolol, Psyllium, Sumatriptan | Yes U/A | Yes | Yes | No | Theragran | |||||||||||||||
| BBS0000-CF900359177102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 49 Y | Female | Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | ALT: 39 U/L | ALP: 186 U/L | 2019-10-27 | $450.00 | Unknown | Stage 4 Cholangiocarcinoma with metastasis to liver status post partial hepatectomy | 2019-10-28 | Docusate sodium, Famotidine, Gabapentin, Loratadine, Magnesium hydroxide, Ondansetron, Potassium chloride, Senna, Triamcinolone, Zolpidem | Yes U/A | Yes | Yes | No | No | ||||||||||||||
| BBS0000-CF900359178110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 56 Y | Female | Unknown | <-70C | 05-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 34 U/L | 2019-11-04 | $450.00 | Unknown | Hypertension, Diabetes mellitus type 2 | 2019-11-05 | Albuterol HFA, Alprazolam, Aspirin, Aspirin-acetaminophen-caffeine, Butalbital-acetaminophen-caffeine, Cyclobenzaprine, Fluticasone, Hydrocodone-acetaminophen, Losartan, Metoprolol tartrate, Naloxone, Naproxen sodium, Pantoprazole, Rosuvastatin, Senna, Sumatriptan | No | No | No | No | No | ||||||||||||||
| BBS0000-CF900359179110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 65 Y | Male | Unknown | <-70C | 05-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 1, Hypothyroidism, Chronic kidney disease | 2019-11-05 | Ascorbic acid, Aspirin, Atorvastatin, Carvedilol, Duloxetine, Epoetin, Ferrous sulfate, Iron, Glucagon, Hydralazine, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Levothyroxine, Mirtazapine, Naloxegol, Naloxone, Simethicone, Sodium bicarbonate, Tamsulosin, Testosterone cypionate, Tramadol, Vitamin D2, Zinc sulfate | No | No | Yes | No | ||||||||||||||||
| BBS0000-CF900359180111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 16.00 | $450.00 | 41 Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 U/L; ALT: 39 U/L | 2019-11-14 | $450.00 | Unknown | None | 2019-11-14 | Ferrous sulfate, Ibuprofen | No | No | No | No | |||||||||||||||
| BBS0000-CF900359181120919DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 50 Y | Male | Hispanic | <-70C | 09-Dec-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 162 U/L 9-Dec-2019 | $450.00 | Unknown | Hypertension, Deep vein thrombosis on coumadin | 2019-12-09 | Warfarin | Yes 2016 | Yes 2016 | No | No | No | |||||||||||||||
| BBS0000-CF900359182110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 16.00 | $450.00 | 26 Y | Female | Non-Hispanic | <-70C | 05-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 2019-11-04 | $450.00 | Unknown | Sickle cell disease, Previous acute chest syndrome | 2019-11-05 | Docusate sodium, Folic acid, Gabapentin, Glutamine, Hydroxyurea, Lidocaine, Morphine, Naloxone, Omeprazole, Oxycodone-acetaminophen, Polyethylene glycol, Senna, Tramadol | No | No | No | No | |||||||||||||||
| BBS0000-CF900359183102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 7.00 | $450.00 | 71 Y | Female | Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Back pain, Congestive heart failure, Chronic kidney disease stage 3, COPD, Diabetes mellitus type 2, Blood transfusion, Fibromyalgia, Heart failure unspecified, Mixed hyperlipidemia, Obesity unspecified, Obstructive sleep apnea, Osteopenia, Asthma, Essential hypertension, Glaucoma | 2019-10-29 | Albuterol HFA, Amlodipine, Carvedilol, Cholecalciferol, Clonidine, Docusate sodium, Fluoxetine, Fluticasone, Gabapentin, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Nitroglycerin, Omeprazole, Piperacillin sodium tazobactam, Polyethylene glycol, Quetiapine, Senna, Simvastatin | Yes U/A | Yes | Yes | No | Yes | |||||||||||||||
| BBS0000-CF900359184102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 26 Y | Male | Unknown | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzyme | AST: 79 U/L | ALT: 104 U/L | 2019-10-27 | $450.00 | Unknown | Alcohol abuse (ETOH) | 2019-10-28 | None | U/A | U/A | No | No | No | ||||||||||||||
| BBS0000-CF900359185102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.50 | 9.00 | $450.00 | 64 Y | Male | Unknown | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Esophageal cancer on Keytruda | 2019-10-29 | Acetaminophen, Amlodipine, Methocarbamol, Keytruda, Metoprolol tartrate, Omeprazole, Ondansetron, Prochlorperazine | U/A | U/A | Yes | No | No | |||||||||||||||
| BBS0000-CF900359186110419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 04-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Hypertension, Diabetes mellitus type 2, Focal segmental glomerulosclerosis status post renal transplant | 2019-11-04 | Aspirin, Cholecalciferol, Docusate sodium, Ezetimibe, Ferrous sulfate, Furosemide, Insulin lispro, Insulin NPH, Mycophenolate, Nitrofurantoin, Prednisone, Simvastatin, Tacrolimus, Tamsulosin | Yes U/A | Yes | Yes | No | No | |||||||||||||||
| BBS0000-CF900359187102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 18.00 | $450.00 | 75 Y | Female | Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Gastritis, Diverticulitis, Osteoarthritis | 2019-10-29 | Albuterol HFA, Aspirin, Calcium, Cetirizine, Cholecalciferol, Flovent HFA, Hydrocortisione, Ibandronate, Omeprazole | No | No | Yes | No | No | |||||||||||||||
| BBS0000-CF900359188102419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 26 Y | Male | Hispanic | <-70C | 24-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 127 U/L | ALT: 104 U/L | 2019-10-24 | $450.00 | Unknown | Alcoholic dilated cardiomyopathy, Hypertension | 2019-10-24 | Famotidine | U/A | U/A | No | No | No | ||||||||||||||
| BBS0000-CF900359189102319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 36 Y | Male | Hispanic | <-70C | 23-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 295 U/L | ALT: 68 U/L | 2019-10-24 | $450.00 | Unknown | Osteomyelitis of right hip status post gun shot would 7 years ago, Paraplegic, Opioid use, Ostomy bag placement 4 years ago | 2019-10-23 | Amitriptyline, Ascorbic acid, Baclofen, Docusate sodium, Duloxetine, Fentanyl, Lidocaine, Magnesium hydroxide, Methocarbamol, Naloxone, Polyethylene glycol, Pregabalin, Quetiapine, Senna, Simethicone, Valproic acid | U/A | U/A | No | No | Theragran | ||||||||||||||
| BBS0000-CF900359190102419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 6.00 | $450.00 | 61 Y | Male | Unknown | <-70C | 24-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Hypertension, Dyslipidemia, Prostate cancer status post surgery and chemo 15 years ago | 2019-10-24 | Amlodipine, Benazepril, Bisoprolol, Chlorthalidone, Hydrocodone-acetaminophen, TriLyte, Sildenafil, Valsartan | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900359191102219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 75 Y | Female | Unknown | <-70C | 22-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | 2019-10-21 | $450.00 | Unknown | Diabetes mellitus, Hypertension, Hypersensitivity lung disease, Chronic kidney disease secondary to DM not on dialysis, Coronary artery disease with right sided stents, Coronary artery bypass graft (quadruple bypass), Bilateral coronary stents | 2019-10-22 | Amiodarone HCl, Aspirin, Ergocalciferol, Furosemide, Levothyroxine, Metformin, Metoprolol tartrate, Spironolactone | U/A | U/A | No | Yes | Unknown name and brand | ||||||||||||||
| BBS0000-CF900359192102319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $450.00 | 42 Y | Female | Unknown | <-70C | 23-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 248 U/L | 2019-10-22 | $450.00 | Unknown | Congestive heart failure with an ejection fraction of 45%, Anorexia nervosa currently refeeding | 2019-10-23 | Alprazolam, Furosemide, Levothyroxine, Zolpidem | U/A | U/A | No | Yes | Alive! Max for women | ||||||||||||||
| BBS0000-CF900359193102219DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 44 Y | Female | Hispanic | <-70C | 22-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 213 U/L | 2019-10-22 | $450.00 | Unknown | Acute kidney injury, End stage renal disease on dialysis | 2019-10-22 | Albuterol HFA, Amlodipine, Atorvastatin, Cyanocobalamin, Cyclosporine, Fluorometholone, Hydrocodone-acetaminophen, Loteprednol etabonate, Melatonin, Ondansetron, Pantoprazole, Risperidone, Senna docusate, Sucralfate, Zolpidem | No | No | No | No | Multivitamin with iron and folate | ||||||||||||||
| BBS0000-CF900359194111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 62 Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Metastatic breast cancer | 2019-11-14 | Acetaminophen | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900359533121819DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 58 Y | Male | Non-Hispanic | <-70C | 18-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 366 U/L | ALT: 339 U/L | ALP: 483 U/L 18-Dec-2019 | $450.00 | Unknown | Hypertension, Chronic kidney disease stage 3, Colorectal cancer with recent surgery | 2019-12-18 | Apixaban, Aspirin, Atorvastatin, Dexamethasone, Docusate, Lidocaine, Lisinopril, Loperamide, Metoclopramide, Olanzapine, Omeprazole, Ondansetron, Polyethylene glycol, Prochlorperazine, Sodium chloride, Tamulosin, Tramadol | No | No | Yes | No | No | |||||||||||||||
| BBS0000-CF900364391012220DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 47 Y | Female | Non-Hispanic | <-70C | 22-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 894 U/L; ALT: 635 U/L; ALP: 414 U/L | 21-Jan-2020 | $450.00 | Unknown | Diabetes mellitus, Psoriasis | 2020-01-22 | Betamethasone dipropionate, Humica, Ibuprofen, Ketoconazole shampoo, Levemir, Lisinopril | No | No | Yes | No | No | ||||||||||||||||
| BBS0000-CF900364392012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $75.00 | 20 Y | Male | Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 82 U/L; ALT: 103 U/L; ALP: 251 U/L | 29-Jan-2020 | $75.00 | Unknown | Autoimmune enteropathy | 2020-01-29 | Tacrolimus | Yes 8-Jul-05 | Yes 2000 & 2001 | No | No | Centrum | ||||||||||||||||
| BBS0000-CF900364394011620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 52 Y | Female | Non-Hispanic | <-70C | 16-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes: ALP: 188 U/L | 15-Jan-2020 | $450.00 | Unknown | Paraplegia, Neurogenic bladder, Cardiac Foley catheter | 2020-01-16 | Amlodipine, Atorvastatin, Enoxaparin, Ferrous sulfate, Fluticasone propionate, Hydrocodone-acetaminophen, Losartan, Methocarbamol, Metoprolol succinate, Oxybutynin, Polyethylene glycol, Senna | Yes | Yes | No | Unknown | No | |||||||||||||||
| BBS0000-CF900364395012120DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 64 Y | Female | Unknown | <-70C | 21-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 93 U/L; ALT: 38 U/L; ALP: 142 U/L | 20-Jan-2020 | $450.00 | Unknown | Asthma, Hypertension | 2020-01-21 | Albuterol, Prednisone, Benzonatate | No | No | No | No | No | ||||||||||||||||
| BBS0000-CF900364396012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $75.00 | 61 Y | Female | Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes ALP: 140 U/L | 28-Jan-2020 | $75.00 | Unknown | Anemia, Chronic abdominal pain, Back and neck pain, Gastric ulcer, Duodenal ulcer, GERD, Methamphetamine abuse, Bipolar disorder, Depression, Benign pancreatic mass | 2020-01-29 | Acetaminophen, Ciprofloxacin, Duloxetine, Famotidine, Ferrous sulfate, Ondansetron | No | No | Yes | No | No | ||||||||||||||||
| BBS0000-CF900364397012120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 61 Y | Male | Hispanic | <-70C | 21-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 44 U/L; ALP: 254 U/L | 20-Jan-2020 | $450.00 | Unknown | Diabetes mellitus, Congestive heart failure on oxygen, Recent stroke | 2020-01-21 | Albuterol HFA, Aspirin, Atorvastatin, Carvedilol, Eplerenone, Furosemide, Insulin glargine, Insulin lispro, Magnesium oxide, Metformin, Pantoprazole, Potassium chloride, Sacubitril / Valsartan | Yes | Yes | No | No | No | |||||||||||||||
| BBS0000-CF900364398011620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 56 Y | Male | Unknown | <-70C | 16-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes: ALT: 50 U/L | 16-Jan-2020 | $450.00 | Unknown | Hypertension, Diabetes mellitus type 1, Multiple sclerosis, End stage renal disease on peritoneal dialysis | 2020-01-16 | Ascorbic acid, Aspirin, Atorvastatin, Carvedilol, Docusate sodium, Furosemide, Gabapentin, Hydralazine, Insulin lispro, Paracalcitol, Sertraline, Tolterodine | Yes | Yes | Yes | No | Cholecalciferol Vitamin D3 | |||||||||||||||
| BBS0000-CF900364399012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $75.00 | 54 Y | Male | Non-Hispanic | <-70C | 29-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 50 U/L; ALT: 133 U/L; ALP: 147 U/L | 28-Jan-2020 | $75.00 | Unknown | Diabetes mellitus, Asthma, Sarcoidosis, COPD, Pneumothorax status post chest tube in December | 2020-01-29 | Albuterol, Azithromycin, Fluticasone, Insulin glargine, Ipratropium, Metformin, Nicotine polacrilex, Omeprazole, Prednisone | Yes | Yes | Yes | No | No | ||||||||||||||||
| BBS0000-CF900364400012220DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 65 Y | Female | Non-Hispanic | <-70C | 22-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Small cell lung cancer on chemotherapy | 2020-01-22 | Enoxaparin | No | No | No | No | No | ||||||||||||||||
| BBS0000-CF900364401012220DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 47 Y | Male | Unknown | <-70C | 22-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 70 U/L; ALT: 133 U/L | 22-Jan-2020 | $450.00 | Unknown | Kidney stones, Cholecystectomy | 2020-01-22 | None | No | No | No | No | No | ||||||||||||||||
| BBS0000-CF900364402012120DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 35 Y | Female | Hispanic | <-70C | 21-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes ALP: 199 U/L | 20-Jan-2020 | $450.00 | Unknown | Renal agenesis, End stage renal disease on hemodialysis | 2020-01-21 | Acetaminophen, Amlodipine, Amoxicillin clavulanate, Azithromycin, Cinacalcet, Diphenhydramine, Fursemide, Gabapentin, Hydralazine, Hydrocortisone, Labetalol, Renvela | Yes | Yes | No | No | No | ||||||||||||||||
| BBS0000-CF900364403011520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 67 Y | Female | Unknown | <-70C | 15-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Osteoarthritis, Cerebrovascular Accident (CVA) in 2007 with residual right sided deficits | 2020-01-15 | Amlodipine, Atorvastatin, Benazepril, Docusate sodium, Fluoxetine, Hydrochlorothiazide, Ketorolac, Meloxicam, Metoprolol succinate, Ondansetron, Temazepam | Yes | Yes | No | No | Cholecalciferol Vitamin D3, Omega 3 fatty acids, Vitamin E | |||||||||||||||
| BBS0000-CF900364404012320DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 71 Y | Female | Non-Hispanic | <-70C | 23-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | COPD, Hypertension | 2020-01-23 | Amlodipine, Famotidine, Pantoprazole, Sucralfate | No | No | No | No | Centrum over 50 | ||||||||||||||||
| BBS0000-CF900364405012320DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 39 Y | Female | Hispanic | <-70C | 23-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes AST: 50 U/L; ALT: 50 U/L | 22-Jan-2020 | $450.00 | Unknown | Asthma | 2020-01-23 | Albuterol HFA, Fluticasone Propionate-Salmeterol, Fluticasone propionate, Loratadine | No | No | No | Yes | Vitamin D over the counter | ||||||||||||||||
| BBS0000-CF900364406012920DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $75.00 | 33 Y | Female | Unknown | <-70C | 29-Jan-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes ALT: 44 U/L | 29-Jan-2020 | $75.00 | Unknown | Obesity, Hypertension | 2020-01-29 | Ondansetron | No | No | No | No | No | ||||||||||||||||
| BBS0000-CF900364407011520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 182 U/L; ALT: 65 U/L | 15-Jan-2020 | $450.00 | Unknown | Hypertension, Myocardial infarction 20+ years ago, Thyroidectomy | 2020-01-15 | Aspirin, Atenolol, Levothyroxine | No | No | Yes | No | Unknown name and brand | |||||||||||||||
| BBS0000-CF900364410012120DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 56 Y | Female | Hispanic | <-70C | 21-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Asthma | 2020-01-21 | Albuterol, Amoxicillin clavulanate, Aspirin, Azelastine, Buspirone, Fluticasone propionate, Fluticasone salmeterol, Glipizide, Ipratropium, Losartan / Hydrochlorothiazide, Montelukast, Omeprazole, Ondansetron, Tiotropium bromide | Yes 7-Feb-02 | Yes 2018 & 2019 | Yes | Yes | Ergocalciferol | ||||||||||||||||
| BBS0000-CF900364411012020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 66 Y | Female | Hispanic | <-70C | 20-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | None | 2020-01-20 | None | Yes | Yes | Yes | No | Unknown name and brand | |||||||||||||||
| BBS0000-CF900365885020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 36 Y | Female | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 38 U/L; ALP: 36 U/L | 5-Feb-2020 | $75.00 | Unknown | Lupus, Kidney disease, HFpEF (heart failure with preserved ejection fraction) | 2020-02-06 | Albuterol, Amlodipine, Bupropion, Cetirizine, Clonidine, Cyclobenzaprine, Diphenhydramine, Fluticasone-salmeterol, Gabapentin, Hydrocodone-acetaminophen, Hydroxychloroquine, Ibuprofen, Labetalol, Mupirocin ointment, Naproxen, Nifedipine, Promethazine, Sertraline, Triamcinolone ointment | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900365891020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 25 Y | Female | Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after mucosal exposure to HCV positive blood | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2020-02-05 | Drospirenone and ethinyl estradiol | Yes 2002 | 2003 | Yes 1994 | 1998 | Yes | No | No | |||||||||||||||
| BBS0000-CF900365892020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 52 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after needle stick exposure to HCV positive blood in 1995 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Mixed hyperlipidemia, Dense breast tissue on mammogram, Vaginal atrophy, Dyspareunia due to medical condition in female | 2020-02-05 | Amoxicillin, Estradiol, Ondansetron | Yes | Yes U/A | No | No | No | |||||||||||||||
| BBS0000-CF900368910021020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 21 Y | Female | Hispanic | <-70C | 10-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALT: 83 U/L 10-Feb-2020 | $75.00 | Unknown | Kidney disease | 2020-02-10 | Baclofen, Nuproxen, Norgestimate-Ethinyl Estradiol | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900368911021120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 47 Y | Male | Unknown | <-70C | 11-Feb-20 | Subject Risk Information | Healthcare, emergency medical and public health worker after needle stick exposure to HCV positive blood. In 2005 or 2006 splashed in eye with HCV infected blood. | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Essential hypertension, Erectile dysfunction, Hyperglyceridemia, Decreased libido, Excessive consumption of soda, Lower UTI, Hypogonalism in male, Class 2 obesity with alveolar hypoventilation without serious comorbidity, Prediabetes, Hyperinsulinemia, Obstructive sleep apnea | 2020-02-11 | Amlopidine, Lisinopril, Tadalafil | No | Yes in 1996 and 1997 | No | No | Centrum, One A Day for Men | |||||||||||||||
| BBS0000-CF900368913021220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 44 Y | Male | Non-Hispanic | <-70C | 12-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension, Asthma, End stage renal disease, Insulin-dependent diabetes mellitus | 2020-02-12 | Albuterol HFA, Amlodipine, Atenolol, Beclomethasone, Sevelamer carbonate | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900368917021320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 68 Y | Female | Unknown | <-70C | 13-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Delirium, COPD, Anemia, Frequent UTI | 2020-02-13 | Acetaminophen, Albuterol, Amoxicillin clavulanate, Aspirin, Baclofen, Cranberry fruit, Ferrous sulfate, Iron, Gabapentin, Ibuprofen, Lorazepam, Nortriptyline, Polyethylene glycol, Pyridoxine, Quetiapine, Temazepam | No | No | No | No | Centrum, Multivitamin with minerals | |||||||||||||||
| BBS0000-CF900368918021220DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 62 Y | Male | Unknown | <-70C | 12-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Constipation, Benign prostatic hyperplasia, Osteomyelitis, Foley catheter dependent | 2020-02-12 | Acetaminophen, Ascorbic acid, Aspirin, Baclofen, Bisacodyl, Cefazolin sodium, Celecoxib, Cephalexin, Docusate sodium, Gabapentin, Hydromorphone, Methocarbamol, Morphine, Naloxone, Polyethylene glycol, Sulfamethoxazole/Trimethoprim, Tamsulosin | No | No | No | Yes | Theragran, Vitamin C | |||||||||||||||
| BBS0000-CF900368919021320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 60 Y | Male | Non-Hispanic | <-70C | 13-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension, Cerebrovascular accident | 2020-02-13 | Aixaban, Diltiazem, Divalproex, Gabapentin, Hydrocodone-acetaminophen, Methocarbamol | No | No | No | No | Centrum | |||||||||||||||
| BBS0000-CF900368920021020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $75.00 | 31 Y | Female | Hispanic | <-70C | 10-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 42 U/L; ALT: 39 U/L 10-Feb-2020 | $75.00 | Unknown | Anxiety, Depression, History of Cerebrovascular accident with residual deficit, Hypertension, Keratoconus B/L, Pneumonia at age 8, Rape trauma syndrome | 2020-02-10 | Amlodipine, Dicyclomine, Erythromycin ophthalmic ointment, Famotidine, Flarex ophthalmic solution, Hydrochlorothiazide, Hydrocodone-acetaminophen, Hydrocodone, Ibuprofen, Omeprazole | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900373248010620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 79 Y | Female | Unknown | <-70C | 06-Jan-20 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | 5-Jan-20 | $75.00 | Unknown | Atrial fibrillation on Xarelto, Recurrent breast cancer currently on chemo | 2020-01-06 | Acetaminophen, Azelastine, Calcium carbonate, Cetirizine, Diclofenac sodium, Everolimus, Exemestane, Fluticasone, Levothyroxine, Losartan, Magnesium oxide, Melatonin, Omeprazole, Oseltamivir, Ranitidine, Rivaroxaban, Toprol | No | No | Yes | No | Multivitamin tablet | ||||||||||||||
| BBS0000-CF900373249010620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $75.00 | 61 Y | Male | Unknown | <-70C | 06-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 175 U/L | 6-Jan-20 | $75.00 | Unknown | Crohn's disease, Gastrointestinal stromal tumor, Cholangitis status post colectomy | 2020-01-06 | Calcipotriene-Betamethasone, Ciprofloxacin ophthalmic solution, Desonide, Diclofenac, Hydrocortisone rectal cream, Ketoconazole, Lidocaine, Prednisolone acetate, Vedolizumab | No | Yes 20-Oct-15 | No | No | Yes | U/A | ||||||||||||||
| BBS0000-CF900373250010920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $75.00 | 57 Y | Female | Non-Hispanic | <-70C | 09-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Diabetes mellitus, Hypertension, Hypersensitivity lung disease, End stage renal disease on hemodialysis | 2020-01-09 | Amlodipine, Aspirin, Atorvastatin, Glipizide, Lisinopril | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900373252010720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $75.00 | 38 Y | Female | Non-Hispanic | <-70C | 07-Jan-20 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes AST: 32 U/L | ALP: 153 U/L | 6-Jan-20 | $75.00 | Unknown | Nonischemic dilated cardiomyopathy, Hypertension, Recent stroke, Diabetes mellitus type 2, Heart transplant | 2020-01-07 | Apixaban, Cholecalciferol, Cyclosporine, Gabapentin, Insulin glargine, Levothyroxine, Metoprolol, Mexiletine, Mycophenolate, Nystatin, Omeprazole, Prednisone, Trazodone, Valganciclovir | Yes U/A | Yes U/A | No | No | No | ||||||||||||||
| BBS0000-CF900373253010920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $75.00 | 57 Y | Male | Unknown | <-70C | 09-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 147 U/L | 8-Jan-20 | $75.00 | Unknown | Paraplegia at T5 level status post gunshot wound | 2020-01-09 | Albuterol, Amikacin, Apixaban, Ascorbate calcium, Atorvastatin, Azithromycin, Budesonide, Buprenorphine-Naloxone, Cephalexin, Cholestyramine, Ciprofloxacin, Clindamycin, Collagenase, Cyclobenzaprine, Daptomycin, Diclofenac sodium, Fluconazole, Fluticasone propionate, Gabapentin, Hydralazine, Ibuprofen, Insulin lispro, Loperamide, Meropenem, Metformin, Mometasone, Mupirocin ointment, Naloxone, Nystatin, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Promethazine, Senna, Sodium chloride, Sufl | No | No | No | No | Cyanocobalamin, Multivitamin | ||||||||||||||
| BBS0000-CF900406408061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 2.00 | 4.00 | $150.00 | 16 Y | Female | Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Cholecystitis | 2020-06-16 | Ibuprofen | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900406409061820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 16 Y | Male | Hispanic | <-70C | 18-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 80 U/L; ALT: 170 U/L | 18-Jun-2020 | $150.00 | Unknown | None | 2020-06-18 | None | Yes | Yes | No | No | No | |||||||||||||||
| BBS0000-CF900406410052720DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 4.00 | $150.00 | 36 Y | Female | Non-Hispanic | <-70C | 27-May-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L | 27-May-2020 | $150.00 | Unknown | Hypertension, Ovarian cyst | 2020-05-27 | Atenolol, Hydrocodone acetaminophen, Ibuprofen, Losartan | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900406411060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 4.00 | $150.00 | 52 Y | Female | Hispanic | <-70C | 09-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 139 U/L | 8-Jun-2020 | $150.00 | Unknown | Bilateral above the knee amputations, End stage renal disease on dialysis, Coronary artery disease, Hypertension, Diabetes mellitus, Cerebrovascular accident with mild left sided deficits | 2020-06-09 | Aspirin, Atorvastatin, Benazepril, Carvedilol, Clonidine, Clopidogrel, Docusate sodium, Erythromycin ophthalmic, Famotidine, Glipizide, Hydralazine, Isosorbide dinitrate, Isosorbide mononitrate, Loratadine, Metoclopramide, Metoprolol tartrate, Nifedipine, Nitroglycerin, Triamcinolone, Venlafaxine, Zinc sulfate | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900406412061020DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 4.00 | $150.00 | 65 Y | Female | Unknown | <-70C | 10-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L; ALP: 316 U/L | 10-Jun-2020 | $150.00 | Unknown | Fibromyalgia, Hyperlipidemia, Diverticulitis | 2020-06-10 | Alprazolam, Aspirin, Atorvastatin, Escitalopram oxalate, Tramadol | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900408140060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | 2.00 | $150.00 | 46 Y | Female | Unknown | <-70C | 09-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L | 8-Jun-2020 | $150.00 | Unknown | Polysubstance abuse, Previous infection | 2020-06-09 | None | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900409231062320DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 12 Y | Male | Hispanic | <-70C | 23-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes AST: 776 IU/L; ALT: 980 IU/L; ALP: 672 IU/L 8-Jun-2020 | $150.00 | Unknown | Autism, Primary sclerosing cholangitis | 2020-06-23 | Acetaminophen, Clonazepam, Diphenhydramine, Famotidine, Fluocinolone, Fluticasone propionate, Hydrocortisone, Ketoconazole, Triamcinolone, Ursodiol, Vancomycin | Yes in 2008 & 2009 | Yes in 2007 & 2008 | No | No | Chewable multivitamin with iron and minerals | |||||||||||||||
| BBS0000-CF900409232062920DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 14 Y | Female | Hispanic | <-70C | 29-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 91 U/L | 29-Jun-2020 | $150.00 | Unknown | Asthma, BMI ? 95% for her age | 2020-06-29 | Albuterol, Azithromycin, Ibuprofen, Penicillin V potassium, Prednisone | Yes in 2007 | Yes in 2006 | No | No | No | |||||||||||||||
| BBS0000-CF900409233063020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 11 Y | Male | Hispanic | <-70C | 30-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | 30-Jun-2020 | $150.00 | Unknown | None | 2020-06-30 | None | Unknown | Unknown | No | No | No | |||||||||||||||
| BBS0000-CF900409234061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | 4.00 | $150.00 | 45 Y | Male | Unknown | <-70C | 16-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | None | 2020-06-16 | Omeprazole | No | No | No | No | No | |||||||||||||||
| BBS0000-CF900413871062520DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 4.00 | $150.00 | 15 Y | Male | Non-Hispanic | <-70C | 25-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 162 IU/L | 25-Jun-2020 | $150.00 | Unknown | None | 2020-06-25 | Clindamycin, Hydrocortisone | Yes in 2006, 2008 & 2009 | Yes in 2005 | No | No | No | |||||||||||||||
| BBS0000-CF900414583062920DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 4.00 | $150.00 | 11 Y | Female | Hispanic | <-70C | 29-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 227 IU/L | 29-Jun-2020 | $150.00 | Unknown | None | 2020-06-29 | None | Unknown | Unknown | No | No | No | |||||||||||||||
| BBS0000-CF900415391060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 8 Y | Female | Hispanic | <-70C | 09-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 148 U/L | 8-Jun-2020 | $150.00 | Unknown | Asthma | 2020-06-09 | Albuterol, Nebu nebuliser solution | Unknown | Unknown | No | No | Probiotic gummies, Over the counter unknown name and brand | |||||||||||||||
| BBS0000-CF900415397061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 2.00 | 4.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease on dialysis; Afibrillation on diltiazem | 2020-06-16 | Allopurinol, Aspirin, Calcium acetate, Diltiazem, Levetiracetam, Losartan, Metoprolol succinate, Pantoprazole | Yes in 2019 & 2020 | Yes in 2013 & 2016 | Yes unknown date | No | Folic acid / Vitamin B complex and C, Cholecalciferol | |||||||||||||||
| BBS0000-CF900415398061020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $150.00 | 15 Y | Male | Hispanic | <-70C | 10-Jun-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 201 U/L | 9-Jun-2020 | $150.00 | Unknown | None | 2020-06-10 | Clindamycin, Ibuprofen, Oxycodone, Polyethylene glycol | Yes | Yes | No | No | No | |||||||||||||||
| BBS0000-DA900361936010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 13.00 | $450.00 | 69 Y | Female | Hispanic | <-70C | 01-Jan-00 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | 2019-11-26 | Yes 1-May-18 | Yes 06-Mar-17 | No | No | No | |||||||||||||||||
| BBS0000-DA900361954102219DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 16.00 | $450.00 | 71 Y | Female | Non-Hispanic | <-70C | 22-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes, Hypertension, Hyperlipidemia, Carpal tunnel syndrome, Hiatal hernia, Suggestive NAFLD | Aspirin, Cozaar, Lipitor, Ursodiol, Vitamin D, Tiazac, Glucotrol, Neurontin, IMDUR, Claritin | No | No | Yes | No | No | ||||||||||||||||
| BBS0000-DA900361955010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 12.00 | $450.00 | Female | Non-Hispanic | <-70C | 01-Jan-00 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | 2019-11-20 | No | No | No | No | No | ||||||||||||||||||
| BBS0000-DA900362398111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 16.00 | $450.00 | 71 Y | Female | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Autoimmune hepatitis, Arthritis, Back pain, Diabetes, Glaucoma, Hyperlipidemia, Hypertension, Sleep apnea | 2019-11-13 | Imuran, Lantus SoloStar, Mobic, Lopressor, Novolog, Pravachol, Altace, Travatan Z, Keflex, Farxiga | Yes 29-Jan-19 | No | No | No | No | |||||||||||||||
| BBS0000-DA900362399110619DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 13.00 | $450.00 | 59 Y | Male | Unknown | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Autoimmune hepatitis | Xanax, Imuran, Flomax | No | No | No | No | No | ||||||||||||||||
| BBS0000-DA900363231010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.50 | 11.00 | $450.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $450.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-DA900363232102219DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 11.00 | $450.00 | 63 Y | Female | Unknown | <-70C | 22-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 41 IU/L | ALT: 59 IU/L | 25-Jul-19 | $450.00 | Unknown | Anxiety, Arthritis, Asthma, Depression, Hypertension, Hyperlipidemia, Gastro-esophageal reflux, Inflammatory bowel disease, Varicose veins, Migraines, Low back pain, Schatzki's ring | Albuterol, Colace, Trileptal, Vitamin C, Epipen, Zoloft, Bilberry oral, Allegra, Zocor, Vitamin D3, Norco, Calcium oral, Fiber (Dextrin), Catapres, Omega 3 DHA, Premarin, Prilosec OTC | No | No | No | U/A | Inulin (Fiber gummies), Multivitamin capsule (unknown brand) | |||||||||||||||
| BBS0000-DA900363233110619DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 57 Y | Female | Unknown | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Autoimmune hepatitis, Hypothyroidism, Osteopenia, Primary biliary cirrhosis | Os-Cal, Calcium carbonate, Vitamin D, Vitamin D2, CellCept, Armour thyroid, Actigall | No | No | No | No | No | ||||||||||||||||
| BBS0000-DA900363234110619DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 11.00 | $450.00 | 73 Y | Male | Unknown | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | Total bilirubin: 3.3 mg/dl | 8-Oct-19 | $450.00 | Unknown | Macular degeneration | Lipitor, Glucosamine, Lopressor, Revatio, Ocuvite, Vitamin B complex | No | No | No | Yes | No | |||||||||||||||
| BBS0000-DA900363235010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 13.00 | $450.00 | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $450.00 | Unknown | ||||||||||||||||||||||||||||
| BBS0000-DA900363236110519DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 70 Y | Female | Unknown | <-70C | 05-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 58 IU/L | ALT: 98 IU/L | 8-Aug-19 | $450.00 | Unknown | CREST syndrome, Hyperlipidemia, Memory deficit, Vitamin D deficiency | Elavil, Lipitor, Ibuprofen | No | No | No | No | Multivitamin unknown brand | |||||||||||||||
| BBS0000-DA900363237100819DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 61 Y | Male | Unknown | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Enlarged liver | Elevated liver enzymes | AST: 59 IU/L | ALT: 62 IU/L | 24-Sep-19 | $450.00 | Unknown | Atrial fibrillation, Cerebral infarction, Cirrhosis, Coronary atherosclerosis, Diabetes type 2, Leukemia, Anemia, Graft-versus-host disease | Eliquis, Folic acid, Prevacid, Metformin, Corgard, Zocor, Januvia | No | No | No | No | No | |||||||||||||||
| BBS0000-DA900363238010100DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 13.00 | $450.00 | 61 Y | Female | Non-Hispanic | <-70C | 01-Jan-00 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 36 IU/L 31-Aug-2019 | $450.00 | Unknown | 2019-11-26 | Yes 11-Apr-11 | Yes 11-Apr-11 | Yes | No | No | |||||||||||||||||
| BBS0000-DA900363239111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 58 Y | Male | Unknown | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Cirrhosis, NASH, Anemia, Diabetes, Gastro-esophageal reflux, Hyperlipidemia, Hypertension | 2019-11-13 | Insulin glargine, Insulin lispro, Lisinopril, Prilosec, Farxiga, Ferrous sulfate | No | No | No | No | No | |||||||||||||||
| BBS0000-DA900363240111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 65 Y | Female | Unknown | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 IU/L | 18-Sep-19 | $450.00 | Unknown | Anxiety, Arthritis, Cholelithiasis without obstruction, Congestive heart failure, Depression, Diabetes, Diabetic retinopathy, Liver problem, Vertigo, Sleep apnea, Back pain, DLBCL, GERD, Nephrolithiasis, Obesity, Hyperlipidemia, Hypertension, Hypothyroidism, Neuropathy | Albuterol, Aspirin, Celexa, Lantus SoloStar Insulin, Levothyroxine, Victoza, Lisinopril, Magnesium oxide, Melatonin, Protonix, Zantor, Metformin, Zocor | Yes | No | No | No | No | |||||||||||||||
| BBS0000-DA900363241111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 13.00 | $450.00 | 73 Y | Female | Unknown | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Cryptogenic liver disease, Arthritis, Hepatitis | Aspirin, Allegra, Culturelle kids probiotics | Yes 12-Oct-16 | Yes 12-Oct-16 | Yes | No | No | ||||||||||||||||
| BBS0000-FH900358406101619DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.50 | 19.00 | $450.00 | 73 Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Diabetes mellitus type 2, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | 2019-10-16 | Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcium acetate, Carvedilol, Eliquis, Lactulose, Senna, Levothyroxine, Sevelamer, Linzess, Simvastatin, Losartan, Terazosine, MiraLax, Tramadol, Norco | No | No | Yes | No | No | |||||||||||||||
| BBS0000-FH900358407102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 74 Y | Male | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Atorvastatin, Omega 3, Ferrous sulfate, Veltassa, Gabapentin, PhosLo, Midodrine, Sertraline, Nateglinide, Metoprolol succinate | No | No | Yes 21-Sep-19 | No | Vitamin B complex, Men's multivitamin, Vitamins E,C & D | |||||||||||||||
| BBS0000-FH900358408102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 77 Y | Male | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient; Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-28 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Ferrous sulfate, Nexium, Gabapentin, Januvia, Metoprolol, Renvela, Midodrine | No | No | Yes 18-Sep-19 | No | No | |||||||||||||||
| BBS0000-FH900358409110119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 45 Y | Male | Non-Hispanic | <-70C | 01-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus types 1 & 2, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | 2019-11-01 | Hectorol, Liquacel, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lantus, Aspirin, Atorvastatin, NovoLog, Carvedilol, Renvela, Clopidogrel, Warfarin, Fluticasone, Zetia | No | No | Yes 8-Oct-19 | No | Calcitriol | |||||||||||||||
| BBS0000-FH900358410103119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $450.00 | 83 Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Secondary hyperparathyroidism of renal origin | 2019-10-31 | Engerix, Epogen, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Promethazine, Aspirin, Isosorbide mononitrate, Azelastine, Omeprazole, Bumetanide, Restasis, Uloric, Hydralazine | No | Yes 15-Oct-19 | Yes 21-Sep-19 | No | Dialybite | |||||||||||||||
| BBS0000-FH900358411101119DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 20.00 | $450.00 | 67 Y | Female | Hispanic | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperkalemia, Other disorders of calcium metabolism (older co-morbidities listed in chart) | 2019-10-11 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lantus, Levothyroxine, Losartan, Lovenox, Meclizine, Norco, Famotidine, NovoLog, Simvastatin | No | No | Yes 18-Sep-19 | No | Cyanocobalamin, Vitamin B12, Cholecalciferol, Vitamin D | |||||||||||||||
| BBS0000-FH900358412102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 90 Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987, Long term hemodialysis patient, Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hyperkalemia, Hypokalemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen, Eliquis, Warfarin, Bengay, DuoNeb, Febuxostat, Meloxicam, Midodrine, Senna, Sensipar, Levothyroxine | No | No | Yes 21-Sep-19 | No | No | |||||||||||||||
| BBS0000-FH900358413101419DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.50 | 19.00 | $450.00 | 38 Y | Female | Hispanic | <-70C | 14-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperkalemia, Iron deficiency anemia, Unspecified protein-calorie malnutrion, Hypkalemia, Secondary hyperparathyroidism | 2019-10-14 | Engerix, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Asprin, Atorvastatin, Insulin detemir, Bisoprolol, Lactulose, MiraLax, EMLA, Nifedipine, Famotidine, Sevelamer, Ferrous sulfate, Sodium bicarbonate | No | Yes 17-Jul-19 | No | No | Folbee Plus | |||||||||||||||
| BBS0000-FH900358414101619DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 17.00 | $450.00 | 38 Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2019-10-16 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Losartan, Norvasc, Renvela, Lasix, Sucroferric oxyhydroxide velphoro | No | No | Yes 21-Oct-19 | No | Dialyvite tablet / Ultra D | |||||||||||||||
| BBS0000-FH900358415103119DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 49 Y | Female | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient, Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Amiodarone, Atorvastatin, Metoprolol, Eliquis, Auryxia, Plavix, Bumetanide, Renvela, Ferrous sulfate, Sertraline, Irbesartan, Tramadol, Medroxyprogesterone | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900358416103119DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 18.00 | $450.00 | 81 Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Cellulitus of left finger and left upper limb, Hypokalemia, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcium acetate, Eliquis, Latanoprost, Losartan, Simvastatin | No | No | Yes 19-Sep-19 | No | Dialyvite, Vitamin B complex, Vitamin D | |||||||||||||||
| BBS0000-FH900358417103119DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 16.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Recipient of clotting factor concentrates produced before 1987 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Secondary hyperparathyroidism, Hypokalemia, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Bumetanide, Eliquis, Januvia, Clopidogrel | No | Yes 26-Sep-19 | No | No | Dialyvite, Vitamin D | |||||||||||||||
| BBS0000-FH900358418102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 82 Y | Male | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperlipidemia, Vitamin D deficiency, Hypocalcemia, Renal osteodystrophy (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amiodarone, Calcium acetate, Omeprazole, Tums, Warfarin | No | No | Yes 19-Sep-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900358419102819DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 58 Y | Female | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hyperkalemia (older co-morbidities listed in chart) | 2019-10-28 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Azathioprine, Hydrocodone-acetaminophen, Calcium acetate, Xtampza, Carvedilol, Sensipar, Gabapentin, Zolpidem, Levothyroxine | No | No | Yes 21-Oct-19 | No | No | |||||||||||||||
| BBS0000-FH900358420101119DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.50 | 15.00 | $450.00 | 71 Y | Male | Non-Hispanic | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; HIV infected individual; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Chronic kidney disease stage 4, Vitamin D deficiency, Anemia, Iron deficiency anemia, Unspecified protein-calorie malnutrition, Secondary Hyperparathyroidism of renal origin | 2019-10-11 | Epogen, Venofer, Amlodipine, Lopinavir, Mometasone furoate, Clonidine, Fexofenadine, Sevelamer, Hydralazine, Tylenol, Imodium, Xanax, Carvedilol, Kelletra, Benadryl | No | No | Yes 18-Sep-19 | No | Centrum chewables; Omega | |||||||||||||||
| BBS0000-FH900359165102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $450.00 | 80 Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Atorvastatin, Midodrine, Azathioprine, Prednisone, Calcium acetate | No | No | Yes 19-Sep-19 | No | Dialybite | |||||||||||||||
| BBS0000-FH900359166101619DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.50 | 19.00 | $450.00 | 78 Y | Female | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-16 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Levothyroxine, Carvedilol, Metolazone, Januvia, Clopidogrel, Crestor, Magnesium, Diclofenac, Renvela, Tamsulosin, Lantus, Zolpidem | No | No | Yes 18-Sep-19 | No | Vitamin D2; Centrum silver | |||||||||||||||
| BBS0000-FH900359167103019DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 71 Y | Female | Non-Hispanic | <-70C | 30-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood. | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-30 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Loperamide, Meclizine, Clopidogrel, Nifedipine, Fluticasone, Furosemide,Pantoprazole, Isosorbide dinitrate | No | No | No | No | Vitamin D2 | |||||||||||||||
| BBS0000-FH900359168121319DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.50 | 11.00 | $450.00 | 50 Y | Male | Non-Hispanic | <-70C | 13-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hypotension, Diabetes mellitus types 1 & 2, Hypothyroidism (older co-morbidities listed in chart) | 2019-12-09 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Mirtazapine, Levothyroxine, Omeprazole, Metoclopramide, Renvela, Midodrine | No | No | Yes 2019-11-11 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900359169102919DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.50 | 20.00 | $450.00 | 50 Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypotension of hemodialysis, Calcinosis cutis, Other disorders of calcium metabolism (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Amitriptyline, Aspirin, Lyrica, Dulcolax, Eliquis, Fludrocortisone, Ropinirole, Midodrine, Nexium, Tramadol, Tums | No | No | Yes 24-Oct-19 | No | Vitamin D | |||||||||||||||
| BBS0000-FH900359196121319DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 14.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 13-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2019-12-09 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Advair, Losartan, Aspirin, Metoprolol, Atorvastatin, Ventolin HFA, Combivent | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900359197121219DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 20.00 | $450.00 | 51 Y | Female | Hispanic | <-70C | 12-Dec-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient | Primary Signs and Symptoms | Upper right side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Disorders of electrolyte and fluid balance, Disorders of phosphorus metabolism, Renal osteodystrophy (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Fentanyl, Aspirin, Pregabalin, Atorvastatin, Sevelamer, Buspirone, Tizanidine, Sodium bicarbonate | No | No | Yes 2019-11-12 | No | Vitamin B complex, Vitamin B1 | |||||||||||||||
| BBS0000-FH900359198121219DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 16.00 | $450.00 | 76 Y | Female | Non-Hispanic | <-70C | 12-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Hectorol, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Atorvastatin, Cinacalcet, Megestrol, Pantoprazole, Pregabalin, Methocarbamol, Sevelamer, Neosporin, Synthroid, Albuterol sulfate, Tramadol | No | No | Yes 2019-09-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900359532121319DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | $450.00 | 46 Y | Male | Non-Hispanic | <-70C | 13-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy, Unspecified protein-calorie malnutrition (older co-morbidities listed in chart) | 2019-12-04 | Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Nifedipine, Norco, Colchicine, Renvela, Sensipar, Hydrocodone | No | No | No | No | Dialyvite Ultra D | ||||||||||||||||
| BBS0000-FH900363221111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 47 Y | Male | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Chronic ischemic heart disease, Diabetes mellitus type 2, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | 2019-11-13 | Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Renvela, Lipitor, Sensipar, Metoprolol, Tums | No | No | Yes 21-Oct-19 | No | Cholecalciferol, Vitamin D3, RenaVite | |||||||||||||||
| BBS0000-FH900363222111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 52 Y | Male | Non-Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Dark colored urine | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-11-14 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Amlodipine, Losartan, Metoprolol, Nortriptyline, Auryxia, Codeine, PhosLo, Furosemide, Sevelamer, Insulin, Sensipar | No | No | No | No | Multivitamin (brand not specified) | |||||||||||||||
| BBS0000-FH900363223110619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 78 Y | Male | Non-Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hypocalcemia (older co-morbidities listed in chart) | 2019-11-06 | Epogen, Hectorol, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Ferrous gluconate, Atorvastatin, Kayexalate, Carvedilol, Lisinopril, Sensipar, Tums | No | No | Yes 18-Sep-19 | No | Cholecalciferol, Vitamin D3, Dialyvite | |||||||||||||||
| BBS0000-FH900363224111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-11-14 | Hectorol, Novasource renal, Parsabiv, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amiodarone, Metoprolol, Sevelamer, Tums | No | No | No | No | Cholecalciferol Vitamin D | |||||||||||||||
| BBS0000-FH900363225111519DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 19.00 | $450.00 | 71 Y | Male | Non-Hispanic | <-70C | 15-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anorexia, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperlipidemia (older co-morbidities listed in chart) | 2019-11-15 | Epogen, Hectorol, Pneumococal vaccine, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Amlodipine besylate, Aspirin, Sevelamer, Atorvastatin, Sensipar, Carvedilol, Simvastatin, Gabapentin, Tramadol, Lisinopril, Tums, Meloxicam, Zolpidem | No | No | Yes 18-Sep-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900363226111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $450.00 | 84 Y | Female | Non-Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | 2019-11-14 | Epogen, Parsabiv, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Nifedipine, Carvedilol, Omeprazole, Hydralazine, Zinc, Irbesartan, Sevelamer, Tums, Atorvastatin, Sucralfate, Melatonin | No | No | Yes 18-Sep-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900363227111419DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 17.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia (older co-morbidities listed in chart) | 2019-11-14 | Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Maalox, Nitroglycerin, Promethazine, Velphoro, Veltassa, Middodrine, PhosLo | No | No | Yes 22-Oct-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900363228110619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Current or former user of IV drugs, Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Heart failure (older co-morbidities listed in chart) | 2019-11-06 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Nifedipine, Bumetanide, Renvela, Carvedilol, Sensipar, Hydralazine | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900363229111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-11-13 | Hectorol, Novasource renal, Parsabiv, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Lyrica, Tradjenta, Metoprolol, Brilinta, Renvela, Aspirin | No | No | Yes 21-Oct-19 | No | Vitamin D, Dialyvite | |||||||||||||||
| BBS0000-FH900363230111319DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 66 Y | Female | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood. | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2019-11-13 | Benadryl, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Metoprolol, Hydroxyzine, Esomeprazole, Renvela, Flexeril, Lorazepam | No | No | Yes 14-Oct-19 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900364393012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 3.00 | $450.00 | 66 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood. | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Vitamin D deficiency, Hypocalcemia (older co-morbidities listed in chart) | 2020-01-22 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Allopurinol, Lisinopril, Aspirin, Carvedilol, Pantoprazole, Renvela, Folic acid, Sensipar, Hydralazine, Tums, Latanoprost, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900364469011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 34.00 | $450.00 | 53 Y | Male | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Essential hypertension, Diabetes mellitus type 2, Secondary hyperparathyroidism, Hypocalcemia, Vitamin D deficiency | 2020-01-08 | Calcium carbonate, Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Losartan, EMLA, Nifedipine, Hydralazine, PhosLo, Lopressor, Sucroferric oxyhydroxide velphoro, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900364470011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 24.00 | $450.00 | 42 Y | Female | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-01-08 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Amlodipine, Metoprolol, Montelukast, Losartan, Insulin lantus, Tradjenta Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900364471011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 15.00 | $450.00 | 43 Y | Male | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-01-08 | Calcium carbonate, Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Gabapentin, Calcium acetate, Sensipar, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900364472011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 23.00 | $450.00 | 57 Y | Female | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy, Hypokalemia, Secondary hyperparathyroidism | 2020-01-08 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Amlodipine, Prednisolone, Aspirin, Promethazine, Atorvastatin, Sirolimus, Spironolactone, Tacrolimus, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900364473011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 22.00 | $450.00 | 76 Y | Male | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy, Essential hypertension, Diabetes mellitus type 2, Secondary hyperparathyroidism (older co-morbidities listed in chart) | 2020-01-08 | Epogen, Hectoral, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Clopidogrel, Coreg, Nifedipine, Doxazosin, Sevelamer, Insulin lantus, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900365424122319DD | Suspect Hepatitis C (HCV) | United States | Serum | 7.00 | 20.00 | $150.00 | 45 Y | Male | Unknown | <-70C | 23-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Hypokalemia (older co-morbidities listed in chart) | 2019-12-16 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Heparin | No | No | Yes 2019-10-23 | No | No | |||||||||||||||
| BBS0000-FH900365440011420DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 17.00 | $450.00 | 56 Y | Female | Non-Hispanic | <-70C | 14-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Cellulitis of right lower limb, Diabetes mellitus type 2, Anemia, Chronic kidney disease, GERD (other co-morbidities listed in chart) | 2020-01-09 | Heparin, Hectorol, Novasource, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Midodrine, Alprazolam, Aripiprazole, Potassium chloride, Aspirin, Pantoprazole, Fludrocortisone, Plavix, Fluticasone, Benzonatae, Gabapentin, Trazodone, Hydroxyzine, Levothyroxine | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900365442011420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 26.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 14-Jan-20 | Subject Risk Information | HIV infected individual; Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Chronic congestive heart failure, Anemia in chronic kidney disease, Methicillin resistant staphylococcus aureus infection (older co-morbidities listed in chart) | 2020-01-09 | Epogen, Hectoral, Parsabiv, Venofer, Calcium carbonate, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Azithromycin, Epivir, Lactulose, Lisinopril, Megace, Renvela, Metoprolol, Sustiva, Minoxidil, Viread | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900365443011420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 25.00 | $450.00 | 32 Y | Male | Non-Hispanic | <-70C | 14-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Secondary hyperparathyroidism, Diabetes mellitus type 2, Vitamin D deficiency, Renal osteodystrophy | 2020-01-09 | Epogen, Hectoral, Novasource renal, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Atorvastatin, Lyrica, Isosorbide, Renvela, Eliquis, Sensipar | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900365444011420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 22.00 | $450.00 | 40 Y | Male | Non-Hispanic | <-70C | 14-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Essential hypertension, Heart failure, Hypokalemia, Morbid obesity, Obstructive sleep apnea, Seconday hyperparathyroidism, Vitamin D deficiency, Enlarged prostate, Gout, Hypocalcemia | 2020-01-09 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Cetirizine, Lisinopril, Sertraline, Ferrous gluconate, Senna, Bumetanide, Carvedilol, Nifedipine, Heparin | No | Yes 27-Nov-19 | No | No | Ergocalciferol, Vitamin D2 | |||||||||||||||
| BBS0000-FH900365893122419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 24-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-19 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen with codeine, Hydrocortisone, Isosorbide dinitrate, Allopurinol, Ketoconazole, Amiodaraone, Amlodipine | No | No | Yes 2019-10-13 | No | Dialyvite | |||||||||||||||
| BBS0000-FH900365933122419DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 24-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-19 | Epogen, Hectorol, Heparin, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Insulin Lispro, Lactobacillus floranex, Ertapenem, Dificid, Gabapentin, Insulin lantus, Renvela | No | No | Yes 2019-11-12 | No | Vitamin B complex, C Folbee, Vitamin B | |||||||||||||||
| BBS0000-FH900365934121919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $150.00 | 73 Y | Female | Non-Hispanic | <-70C | 19-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Carvedilol, Estradiol, Eliquis, Pantoprazole, Losartan, Renvela, MiraLax, Sensipar, Simvastatin, Temazepam, Erlotinib | No | No | Yes 2019-09-19 | No | No | |||||||||||||||
| BBS0000-FH900369819020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 43 Y | Male | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Vitamin D deficiency, Methicillin susceptible Staphylococcus aureus infection (older co-morbidities listed in chart) | 2020-02-06 | Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900369902012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $450.00 | 63 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-01-20 | Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Pantoprazole, Gabapentin, Plavix, Rosuvastatin, Sevelamer, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900369903012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 55 Y | Female | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hypocalcemia (older co-morbidities listed in chart) | 2020-01-22 | Calcium carbonate, Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Midodrine, Hydroxychloroquine, Neoral, Kayexalate, Pantoprazole, Metoprolol, Sevelamer, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900369904012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 54 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Renal osteodystrophy, Vitamin D deficiency (older co-morbidities listed in chart) | 2020-01-22 | Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Amlodipine, Lisinopril, Renvela, Ferric citrate, Tamsulosin, Hydralazine, Heparin | No | Yes 25-Nov-19 | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900369964020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 57 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy, Diabetes mellitus types 1 and 2 (older co-morbidities listed in chart) | 2020-02-05 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Amlodipine, Gabapentin, Atorvastatin, Hydralazine, Calcium acetate, Insulin Lantus, Carvedilol, Clopidogrel, Proventil, Renvela, Docusate, Sensipar, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900370560020320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 64 Y | Male | Unknown | <-70C | 03-Feb-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Iron deficiency anemia, Renal osteodystrophy, Atherosclerotic heart disease, Hyperkalemia, Secondary hyperparathyroidism | 2020-01-20 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Atorvastatin, Coreg, Vitamin D2, Flomax, Plavix, Sevelamer, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900370561020420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 69 Y | Male | Unknown | <-70C | 04-Feb-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Chronic kidney disease stage 5, Hyperkalemia, Renal osteodystrophy (older co-morbidities listed in chart) | 2020-01-23 | Calcium carbonate, Hectorol, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Clopidogrel, Lisinopril, Pravastatin, Nifedipine, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900370562020420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 04-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperkalemia (older co-morbidities listed in chart) | 2020-01-28 | Hectorol, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Metoprolol, Midodrine, Norco, Gabapentin, Hydroxyzine, Insulin lispro, Sevelamer, Torsemide, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900373028011720DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 14.00 | $450.00 | 73 Y | Female | Non-Hispanic | <-70C | 17-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2020-01-08 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Renvela, Sensipar | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900373029012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 23.00 | $450.00 | 41 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy (older co-morbidities listed in chart) | 2020-01-17 | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Calcitriol, Carvedilol, Nifedipine, Calcium citrate, Hydralazine, Tums, Isosorbide dinitrate, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900373030012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 60 Y | Female | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Acute kidney disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2020-01-20 | Calcium carbonate, Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, PhosLo, Mycophenolate, Pravastatin, Ondansetron, Sildenafil, Tacrolimus, Pantoprazole, Warfarin, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900373031012420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 50 Y | Male | Non-Hispanic | <-70C | 24-Jan-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2020-01-17 | Calcium carbonate, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Alprazolam, Renvela, Labetalol, Tums, Minoxidil, Norco, Heparin | No | No | No | No | Vitamin A & D | |||||||||||||||
| BBS0000-FH900373057020320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 66 Y | Male | Non-Hispanic | <-70C | 03-Feb-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Vitamin D deficiency (older co-morbidities listed in chart) | 2020-01-28 | Calcium carbonate, Hectorol, Parsabiv, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Plavix, Mupirocin, Velphoro, Heparin | No | No | No | No | Nephro-Vite | |||||||||||||||
| BBS0000-FH900373058020420DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 44 Y | Female | Non-Hispanic | <-70C | 04-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Abnormal weight gain, Acute kidney failure, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hypocalcemia (older co-morbidities listed in chart) | 2020-01-23 | Epogen, Hectorol, Venofer, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Ferrous sulfate, Atorvastatin, Gabapentin, Carvedilol, Imdur, Clopidogrel, Insulin aspart, Insulin detemir, Sevelamer, Heparin | No | No | No | No | Ergocalciferol, Vitamin D2 | |||||||||||||||
| BBS0000-FH900373059020320DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 51 Y | Male | Non-Hispanic | <-70C | 03-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-01-20 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amtriptyline, Aspirin, Polyethylene glycol, Pregbalin, Docusate, Protonix, Duloxetine, Proventil HFA, Hydralazine, Sevelamer, Levemir, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900376782020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Other disorders of phosphorus metabolism, Renal osteodystrophy, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-02-06 | Epogen, Hectorol, Novasource renal, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Metoprolol, Atorvastatin, NovoLog, Besacodyl, Famotidine, Victoza, Gabapentin, Fenofibric acid, Isosorbide mononitrate, Velphoro, Keppra, Topamax, Levemir, Heparin | No | No | No | No | Centrum Men's | |||||||||||||||
| BBS0000-FH900376783020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 29 Y | Female | Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Essential hypertension, Hyperglycemia, Hypocalcemia, Major depressive disorder, Seizures, Anxiety disorder, Gout, Hypokalemia, Hyperparathyroidism, Obesity, Vitamin D deficiency (other older co-morbidities listed in chart) | 2020-02-05 | Epogen, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Apixaban, Tradjenta, Bactrim, Calcitriol, Pantoprazole, Hydrocodone-acetaminophen, Phenytoin, Levetiracetam, Prednisone, Renvela, Levothyroxine, Sulfamethoxazole, Valganciclovir, Melatonin, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900376784020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 21.00 | $450.00 | 39 Y | Male | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Chronic kidney disease stage 5, Anemia in chronic kidney disease, Diabetes mellitus type 1 (older co-morbidities listed in chart) | 2020-02-06 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Atorvastatin, Lisinopril, Carvedilol, Nifedipine, Humalog insulin, Hydralazine, Sevelamer, Lantus insulin, Torsemide, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900376785020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 81 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Other disorders of phosphorus metabolism, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-02-05 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Atorvastatin, Hydralazine, Amlodipine, Medrol, Aspirin, Pantoprazole, Tramadol, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900376786020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 53 Y | Female | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Cardiomegaly, Renal osteodystrophy, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-02-05 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Aspirin, Lantus insulin, Atorvastatin, Combivent, Nifedipine, Renvela, Heparin | No | No | No | No | Ergocalciferol, Vitamin D2 | |||||||||||||||
| BBS0000-FH900376838120619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $75.00 | 46 Y | Male | Non-Hispanic | <-70C | 06-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of plasma-protein metabolism, Postprocedural hypoparathyroidism (older co-morbidities listed in chart) | 2019-12-04 | Hectoral, Heparin, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Lisinopril, Aspirin, Metoprolol, Promethazine, Docusate sodium, Tramadol | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900376850020520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 05-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Dark colored urine | $450.00 | Unknown | End stage renal disease, Hyperkalemia, Hyperlipidemia, Acute congestive heart failure, Diabetes mellitus type 2, Inflammatory liver disease, Kidney transplant failure, Renal osteodystrophy (older co-morbidities listed in chart) | 2020-01-23 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Aluminum hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Norvasc, Carvedilol, Plavix, Clindamycin phosphate gel, Pravastatin, Docusate sodium, Prednisone, Fluocinonide, Warfarin, Cyclosporine, Heparin | No | Yes 27-Jan-20 | No | No | No | |||||||||||||||
| BBS0000-FH900376877120619DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 61 Y | Male | Hispanic | <-70C | 06-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | 2019-12-04 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Ferric citrate, Eliquis, Bisoprolol, Glipizide, Sensipar, Minoxidil, Simvastatin | No | No | Yes 23-Oct-19 | No | No | |||||||||||||||
| BBS0000-FH900376878120619DD | Suspect Hepatitis C (HCV) | United States | Serum | 6.00 | 4.00 | $450.00 | 42 Y | Female | Non-Hispanic | <-70C | 06-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anorexia, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | 2019-12-04 | Epogen, Hectoral, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Levalbuterol, Cetirizine, Pantaprazole, Gabapentin, Prednisone, Hydroxychloroquine, Ipratropium, Tramadol | No | No | Yes 21-Oct-19 | No | No | |||||||||||||||
| BBS0000-FH900379065022520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 67 Y | Male | Non-Hispanic | <-70C | 25-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965; HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, HIV (other older co-morbidities listed in chart) | 2020-02-20 | Hectorol, Venofer, Liquacel, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Allopurinol, Carvedilol, Renvela, Sensipar, Nifedipine, Prezcobix, Tamsulosin, Heparin | No | No | No | No | Rena-Vite | |||||||||||||||
| BBS0000-FH900379066022520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 7.00 | $450.00 | 61 Y | Male | Non-Hispanic | <-70C | 25-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965; HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, HIV, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-20 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Auryxia, Nifedipine, Metoprolol, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379067022520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 9.00 | $450.00 | 37 Y | Female | Non-Hispanic | <-70C | 25-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-20 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Probiotica, Meclizine, Pantoprazole, Renvela, Ondansetron, Sensipar, Ropinirole, Heparin | No | No | No | No | Nephro-Vite, Cholecalciferol, Vitamin D3 | |||||||||||||||
| BBS0000-FH900379068022520DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 76 Y | Female | Non-Hispanic | <-70C | 25-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-02-20 | Epogen, Hectorol, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amiodarone, Midodrine, Apixaban, Aspirin, Metoprolol, Rosuvastatin, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900379201022120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 55 Y | Female | Non-Hispanic | <-70C | 21-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal osteodystrophy, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-19 | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Pantoprazole, Labetalol, Renvela, Sensipar, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379202022020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 42 Y | Female | Non-Hispanic | <-70C | 20-Feb-20 | Subject Risk Information | Long term hemodialysis patient; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Fibromyalgia, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-18 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Calcium acetate, Pantoprazole, Pregabalin, Hydroxyzine, Sevelamer, Sensipar, Ondansetron, Tramadol, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379203022120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 73 Y | Male | Unknown | <-70C | 21-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-17 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Albuterol, Ipratropium, Azelastine, Adempas, Bumetanide, Letairis, Carvedilol, Eliquis, Cyanocobalamin, Restasis, Pantoprazole, Dicyclomine, Pravastatin, Hydrocortisone, Psyllium husk, Ondansetron, Sevelamer, Januvia, Spiriva, Albuterol sulfate, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379204022020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 19.00 | $450.00 | 58 Y | Female | Non-Hispanic | <-70C | 20-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Secondary hyperparathyroidism of renal origin, Iron deficiency anemia | 2020-02-18 | Epogen, Hectorol, Novasource renal, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Metoprolol, Colace, Renvela, Heparin | No | Yes 26-Dec-19 | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379205021820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 37 Y | Female | Unknown | <-70C | 18-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Dark colored urine, Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Alcoholic cirrhosis of liver, Anxiety disorder, Essential hypertension, Liver, disease, Major depressive disorder, Portal hypertension, Secondary hyperparathyroidism of renal origin, Alcohol dependence, Anemia, Chronic kidney disease, Psoriasis, Vitamin D deficiency, Liver transplant status | 2020-02-13 | Epogen, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Acyclovir, Amlodipine, Pantoprazole, Insulin humulin, Prednisone, Thiamine, Levetiracetam, Ursodiol, Metoprolol, Prograf, Magnesium, Heparin | No | No | Yes 28-Jan-20 | No | Nephro-Vite | |||||||||||||||
| BBS0000-FH900379206022120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 67 Y | Female | Non-Hispanic | <-70C | 21-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-02-17 | Epogen, Liquicel, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Levetiracetam, Atorvastatin, Carvedilol, Losartan, Nifedipine, PhosLo, Furosemide, Tramadol, Hydralazine, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379207022120DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 81 Y | Male | Non-Hispanic | <-70C | 21-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-02-17 | Hectoral, Novasource renal, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Nifedipine, Hydralazine, Renvela, Lasix, Tamsulosin, Loratadine, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379208021920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 15.00 | $450.00 | 71 Y | Male | Non-Hispanic | <-70C | 19-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-12 | Epogen, Hectoral, Novasource renal, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Levothyroxine, Losartan, Hydralazine, Metronidazole, Hydrocortisone, Nifedipine, Lactobaillus, Sevelamer, Heparin | No | No | No | No | Renal vitamin | |||||||||||||||
| BBS0000-FH900379209021920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 74 Y | Female | Non-Hispanic | <-70C | 19-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Leukemia in remission (other older co-morbidities listed in chart) | 2020-02-12 | Epogen, Hectoral, Novasource renal, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Sodium bicarbonate, Potassium chloride, PhosLo, Carvedilol, Hydralazine, Calcium carbonate, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900379210021920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 10.00 | $450.00 | 57 Y | Female | Non-Hispanic | <-70C | 19-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965, Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-12 | Epogen, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Auryxia, Midodrine, Tramadol, Prednisone, Heparin | No | No | No | No | Rena-Vite | |||||||||||||||
| BBS0000-FH900379211021820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 49 Y | Female | Non-Hispanic | <-70C | 18-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-02-13 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Aspirin, Lisinopril, Coreg, Renvela, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900379212021820DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 45 Y | Female | Non-Hispanic | <-70C | 18-Feb-20 | Subject Risk Information | Long term hemodialysis patient, HIV infected individual | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Vitamin D deficiency (older co-morbidities listed in chart) | 2020-01-23 | Hectorol, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Atovaquone, Dolutegravir, Calcium acetate, Trazodone, Carvedilol, Warfarin, Kayexalate, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900379535020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 75 Y | Female | Non-Hispanic | <-70C | 06-Feb-20 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Hypocalcemia, Cerebral infarction, Other disorders of phosphorus metabolism, Vitamin D deficiency (other older co-morbidities listed in chart) | 2020-02-06 | Epogen, Hectorol, Novasource renal, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Atorvastatin, Nifedipine, Carvedilol, Turmeric, Folic acid, Sensipar Heparin | No | No | No | No | Biotin, Vitamin B12, Vitamin C | |||||||||||||||
| BBS0000-FH900379536020620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 30 Y | Female | Unknown | <-70C | 06-Feb-20 | Subject Risk Information | N/A | Primary Signs and Symptoms | Dark colored urine, Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia, Portal hypertension, Unspecified protein-calorie malnutrition, Alcoholic liver disease, Chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Vitamin D deficiency | 2020-02-06 | Epogen, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Acyclovir, Magnesium oxide, Bactrim, Nystain, Prednisone, Famotidine, Prograf, Fluoxetine, Tylenol #3, Insulin, Urso, Levothyroxine, Heparin | No | No | Yes | 28-Jan-2020 | No | Calcium with Vitamin D | |||||||||||||||
| BBS0000-FH900388307022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 49 Y | Female | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diverticulitis, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-20 | Calcium carbonate, Epogen, Hectorol, Liquacel, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Carvedilol, Pantoprazole, Clonazepam, Renvela, Sensipar, Minoxidil, Nifedipine, Trazodone | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900388308022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 54 Y | Male | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-02-24 | Hectorol, Liquacel, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Gabapentin, Amiodarone, Lactulose, Aspirin, Midodrine, Atorvastatin, Carvedilol, Famotidine, Velphoro, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900388309022620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 16.00 | $450.00 | 69 Y | Male | Non-Hispanic | <-70C | 26-Feb-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-24 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Carvedilol, Renvela, Ipratropium, Febuxostat, Docusate sodium, Pantoprazole, Hydralazine, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388312031920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 8.00 | $450.00 | 74 Y | Male | Non-Hispanic | <-70C | 19-Mar-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-03-12 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Amlodipine, Levemir insulin, Metoprolol, Renvela, Hydralazine, Sensipar, Isosorbide mononitrate, Simvastatin, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900388313031920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 46 Y | Female | Non-Hispanic | <-70C | 19-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-03-12 | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Albuterol, Aspirin, Amlodipine, Metoprolol, Amiodarone, Midodrine, Atorvastatin, Pantoprazole, Budesonide, Prednisone, Fluticasone Vilantero, Hydralazine, Sensipar, Lisinopril, Sevelamer, Heparin | No | No | No | No | RenaVite | |||||||||||||||
| BBS0000-FH900388314031920DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 80 Y | Male | Non-Hispanic | <-70C | 19-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-03-12 | Epogen, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Allopurinol, Midodrine, Amiodarone, Pantoprazole, Renvela, Sensipar, Docusate sodium, Simvastatin, Folic acid, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388315031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 52 Y | Male | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-03-05 | Epogen, Hectorol, Parsabiv, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Hydralazine, Aspirin, Insulin Aspart, Atorvastatin, Isosorbide dinitrate, Calcium acetate, Levemir, Carvedilol, Lisinopril, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388316031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 11.00 | $450.00 | 59 Y | Male | Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-03-05 | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Nifedipine, Atorvastatin, Omeprazole, Clopidogrel, Brilinta, Veltassa, Famotidine, Renvela, Fluoxetine, Sensipar, Insulin lantus, Valsartan, Metoprolol, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388317031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Heart failure, Hypotension (other older co-morbidities listed in chart) | 2020-02-25 | Epogen, Hectorol, Novasource Renal, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Aspirin, Lisinopril, Metoprolol tartrate, Senna, Hydrocodone-acetaminophen, Insulin glargine, Renvela, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388318031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 17.00 | $450.00 | 77 Y | Male | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease (other older co-morbidities listed in chart) | 2020-03-05 | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Allopurinol, Furosemide, Antivert, Irbesartan, Aspirin, Atorvastatin, Nifedipine, Auryxia, CoQ10, Ezetimibe, Fish oil, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388319030620DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 69 Y | Male | Non-Hispanic | <-70C | 06-Mar-20 | Subject Risk Information | Long term hemodialysis patient, Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-26 | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Novolin, Aspirin, Lyrica, Atorvastatin, Metoprolol, Clopidogrel, Pantoprazole, Lantus, Sucroferrio oxyhydroxide, Midodrine, Heparin | No | No | No | No | Nephro-Vite | |||||||||||||||
| BBS0000-FH900388320031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 18.00 | $450.00 | 36 Y | Female | Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Chronic systolic heart failure (other older co-morbidities listed in chart) | 2020-02-25 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Hydralazine, Carvedilol, Losartan, Renvela, Gabapentin, Rosuvastatin, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900388321031020DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 20.00 | $450.00 | 85 Y | Male | Non-Hispanic | <-70C | 10-Mar-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (other older co-morbidities listed in chart) | 2020-02-20 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Renvela, Heparin | No | No | No | No | Cholecalciferol, Vitamin D, Rena-Vite | |||||||||||||||
| BBS0000-FH900416042060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 61 Y | Male | Unknown | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Diabetes mellitus type 2, Atherosclerotic heart disease (older co-morbidities listed in chart) | 2020-06-03 | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Midodrine, Cod liver oil, NovoLog, Digoxin, Entresto, Gabapentin, Renvela, Isosorbide mononitrate, Sensipar, Levemir, Metoprolol | No | No | No | No | Centrum silver | |||||||||||||||
| BBS0000-FH900416043060920DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 76 Y | Female | Non-Hispanic | <-70C | 09-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension (older co-morbidities listed in chart) | 2020-06-04 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Albuterol, Midodrine, Amlodipine, Aspirin, Atorvastatin, Pantoprazole, Budesonide, Fluticasone, Sensipar, Hydralazine, Sevelamer, Lisinopril, Tramadol, Metoprolol, Heparin | No | No | No | No | RenaVite | |||||||||||||||
| BBS0000-FH900416044060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 5.00 | $450.00 | 69 Y | Male | Unknown | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Essential hypertension (older co-morbidities listed in chart) | 2020-06-03 | Hectoral, Calcium carbonate, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Atenolol, Fluoxetine, Atorvastatin, Hydrocodone, Calcium acetate, Ibuprofen, Clonazepam, Veltassa, Fexofenadine, Fludrocortisone, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416045060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 70 Y | Male | Non-Hispanic | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-06-08 | Epogen, Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Hydralazine, Isosorbide mononitarte, Sevelamer, Lisinopril, Simvastatin, Metoprolol, Heparin | No | No | No | No | Vitamin D3 | |||||||||||||||
| BBS0000-FH900416046060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 52 Y | Male | Unknown | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Vitamin D deficiency (older co-morbidities listed in chart) | 2020-06-03 | Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Carvedilol, Losartan, Citalopram, Furosemide, Plavix, Gabapentin, Renvela, Hydralazine, Sensipar, Kayexalate, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416047061720DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 79 Y | Female | Non-Hispanic | <-70C | 17-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Acute kidney failure, Essential hypertension, Gout, Iron deficiency anemia, Osteoarthritis of knee, Pure hypercholesterolemia, Type 2 diabetes melllitus, Chronic congestive heart failure, Glaucoma, Hyperlipidemia, Obesity, Secondary hyperparathyroidism | 2020-06-11 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Allopurinol, Humulin, Calcitriol, Lispro, Carvedilol, Simvastatin, Heparin | No | Yes | No | No | Centrum silver | |||||||||||||||
| BBS0000-FH900416048061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 4.00 | $450.00 | 48 Y | Male | Non-Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-06-09 | Epogen, Hectoral, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Furosemide, Carvedilol, Humalog, Cortef, Ondansetron, Dicyclomine, Renvela, Erythromycin, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416049060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 67 Y | Male | Unknown | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Inflammatory liver disease (older co-morbidities listed in chart) | 2020-06-03 | Hectoral, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Amiodarone, Atorvastatin, NovoLog, Auryxia, Omeprazole, Diltiazem, Eliquis, Levemir, Velphoro, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416050060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 5.00 | $450.00 | 60 Y | Male | Hispanic | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Chronic ischemic heart disease, Essential hypertension (older co-morbidities listed in chart) | 2020-06-03 | Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Midodrine, Atorvastatin, Gabapentin, Clopidogrel, Glimepiride, Isosorbide dinitrate, Velphoro, Lantus, Lisinopril, Pramipexole, Metoprolol, Renvela, Sensipar, Heparin | No | No | No | No | Renaplex | |||||||||||||||
| BBS0000-FH900416051060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 63 Y | Female | Non-Hispanic | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Chronic obstructive pulmonary disease, Diastolic heart failure, Essential hypertension, Glaucoma (older co-morbidities listed in chart) | 2020-06-03 | Epogen, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Albuterol, Latanoprost, Aspirin, Loratadine, Atorvastatin, Nifedipine, Bumetanide, Symbicort, Carvedilol, Renvela, Combivent, Timolol, Lantus, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416052061820DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 6.00 | $450.00 | 32 Y | Male | Unknown | <-70C | 18-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2020-06-17 | Hectoral, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Tacrolimus, Mag-Ox, Heparin | No | No | No | No | Dialyvite | |||||||||||||||
| BBS0000-FH900416053061620DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 59 Y | Male | Hispanic | <-70C | 16-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Diabetes mellitus type 2, Vitamin D deficiency (older co-morbidities listed in chart) | 2020-06-09 | Hectoral, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Glipizide, Coreg, Lantus, Losartan, MiraLax, Crestor, NovoLog, Veltassa, Sensipar, Fish oil, Velphoro, Gabapentin, Heparin | No | No | No | No | Dialyvite, Ergocalciferol, Vitamin D2 | |||||||||||||||
| BBS0000-FH900416054061820DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 77 Y | Female | Non-Hispanic | <-70C | 18-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Dementia, Presence of cardiac pacemaker, Iron deficiency anemia, Type 2 diabetes melllitus, Cerebrovascular disease, Secondary hyperparathyroidism | 2020-06-11 | Epogen, Hectoral, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Apixaban, Glipizide, Aspirin, Omeprazole, Atorvastatin, Remeron, Buspirone, Rosuvastatin, Donepezil, Heparin | No | Yes | No | No | No | |||||||||||||||
| BBS0000-FH900416055060820DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | 5.00 | $450.00 | 66 Y | Female | Non-Hispanic | <-70C | 08-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus types 1 & 2, Chronic ischemic heart disease, Essential hypertension, Amputation (older co-morbidities listed in chart) | 2020-06-03 | Hectoral, Parsabiv, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Apixaban, Aspirin, Carvedilol, Pantoprazole, Clopidogrel, Pregabalin, Promethazine, HumaLog, Ondansetron, Renvela, Simvastatin, Basalanger, Tramadol, Heparin | No | No | No | No | Ergocalciferol, Vitamin D2, RenaVite | |||||||||||||||
| BBS0000-FH900416057070120DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 4.00 | $450.00 | 54 Y | Male | Hispanic | <-70C | 01-Jul-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-06-24 | Calcium carbonate, Hectoral, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amiodarone, Clotrimazole, Apixaban, Losartan, Aspirin, Metoprolol, Atorvastatin, Benzonatate, Renvela, Zolpidem, Heparin | No | No | No | No | No | |||||||||||||||
| BBS0000-FH900416058063020DD | Suspect Hepatitis C (HCV) | United States | Serum | 4.00 | 5.00 | $450.00 | 71 Y | Male | Non-Hispanic | <-70C | 30-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Chronic viral hepatitis C (older co-morbidities listed in chart) | 2020-06-16 | Epogen, Hectoral, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Hydralazine, Atorvastatin, Loratadine, Nifedipine, Carvedilol, Velphoro, Folic acid, Heparin | No | No | No | No | B complex with Vitamin B12 | |||||||||||||||
| BBS0000-FH900416059062220DD | Suspect Hepatitis C (HCV) | United States | Serum | 3.00 | 5.00 | $450.00 | 86 Y | Male | Non-Hispanic | <-70C | 22-Jun-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Essential hypertension, Gout, Acquired absence of kidney, Pure hypercholesterolemia, Secondary hyperparathyroidism (older co-morbidities listed in chart) | 2020-06-19 | Epogen, Hectoral, Venofer, Acetaminophen, Aluminum hyroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Irbesartan, Eliquis, Renvela, Heparin | No | No | No | No | Vitamin D3 | |||||||||||||||
| BBS0000-FH900416060070120DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 4.00 | $450.00 | 62 Y | Male | Non-Hispanic | <-70C | 01-Jul-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Cataracts, Atherosclerotic heart disease, Iron deficiency anemia, Secondary hyperparathyroidism, Congestive heart failure, Essential hypertension, Pure hypercholesterolemia, Transient cerebral ischemic attack | 2020-06-24 | Hectoral, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Amlodipine, Carvedilol, Aspirin, Atorvastatin, Levemir, Heparin | No | No | No | No | Dialyvite plus D | |||||||||||||||
| BBS0000-FH900416061063020DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 85 Y | Male | Non-Hispanic | <-70C | 30-Jun-20 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2020-06-16 | Epogen, Hectoral, Novasource, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Insulin Aspart, Atorvastatin, Isosorbide, Carvedilol, Latanoprost, Saxagliptin, Dorzolamide, Timolol, Sevelamer, Tamsulosin, Gabapentin, Tiotropium, Heparin | No | No | No | No | Cholecalciferol, Vitamin D3 | |||||||||||||||
| BBS0000-FH900416062070120DD | Suspect Hepatitis C (HCV) | United States | Serum | 5.00 | 5.00 | $450.00 | 74 Y | Female | Non-Hispanic | <-70C | 01-Jul-20 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Essential hypertension (other older co-morbidities listed in chart) | 2020-06-24 | Epogen, Novasource, Venofer, Acetaminophen, Aluminum hydroxide, Magnesium hydroxide, Clonidine, Diphenhydramine, Lidocaine, Loperamide, Nitroglycerin, Tums, Aspirin, Nifedipine, Benzonatate, Clindamycin, Prorenal, Velphoro, Clopidogrel, Combivent, Ipratropium, Renvela, Losartan, Sensipar, Metoprolol, Terazosin, Heparin | No | No | No | No | Vitamin B6 | |||||||||||||||
| BBS0000-FI900105625070919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 13.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||||
| BBS0000-FI900105626070919DD | Suspect Hepatitis C (HCV) | United States | Serum | 1.00 | 12.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Yes U/A | Yes U/A | |||||||||||||||||||
| BBS0005-AC900057148051312DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 53 U/L | 14 U/L | 7 U/L ALP | AST | ALT 6.4 g/dL | 3.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||||
| BBS0005-AC900057149041012DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Fever / chills; Elevated LFTs | Positive | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 107 U/L | 173 U/L | 25 U/L ALP | AST | ALT 5.1 g/dL | 1.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||||
| BBS0005-AC900064076091512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 49 Y | Female | Unknown | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Jaundice; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 35 U/L | 7 U/L ALP | AST | ALT 6.9 g/dL | 2.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Sex worker | |||||||||||||||||
| BBS0005-AC900065317050613DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 35 Y | Female | Unknown | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Elevated LFTs | Positive | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 97 U/L | 27 U/L | 20 U/L ALP | AST | ALT 5.2 g/dL | 2.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners | |||||||||||||||||
| BBS0005-AC900065318032913DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 22 Y | Male | Unknown | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.4 mg/dL TBIL | DBIL 265 U/L | 31 U/L | 8 U/L ALP | AST | ALT 4.8 g/dL | 1.8 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||||
| BBS0005-AC900069462100512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 19 Y | Male | Unknown | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.6 mg/dL TBIL | DBIL 442 U/L | 42 U/L | 9 U/L ALP | AST | ALT 5.3 g/dL | 1.7 g/dL Protein | Albumin | Homosexual M | |||||||||||||||||
| BBS0005-AC900074789081912DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Fatigue; Nausea; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 3.6 mg/dL | 2.3 mg/dL TBIL | DBIL 132 U/L | 32 U/L | 6 U/L ALP | AST | ALT 3.8 g/dL | 1.6 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||||
| BBS0005-BD900023627092519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 25 Y | Male | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026637092019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $450.00 | 30 Y | Male | Non-Hispanic | <-70C | 20-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Dovato | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026638091019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $450.00 | 27 Y | Male | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Triumeq | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026639090919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 44 Y | Male | Non-Hispanic | <-70C | 09-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026640091619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $450.00 | 45 Y | Female | Non-Hispanic | <-70C | 16-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Chronic kidney disease | Rilpivirine, Tivicay, Seroquel | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026641091219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $450.00 | 21 Y | Male | Non-Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026642090319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 27 Y | Male | Non-Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027871082619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 29 Y | Male | Non-Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027872080519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 59 Y | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Prezista, Norvir, Isentress | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027873082619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $450.00 | 57 Y | Male | Non-Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual, Subject Risk Information includes “Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027874080619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 06-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Complera | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027875072919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 49 Y | Male | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027876080519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 18.00 | $450.00 | 40 Y | Female | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027877071919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 35 Y | Male | Non-Hispanic | <-70C | 19-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Evotaz, Descovy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027878070119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 16.00 | $450.00 | 33 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Odefsey, Descovy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027879072219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 54 Y | Female | Non-Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Kidney disease | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027880070219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 18.00 | $450.00 | 46 Y | Male | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Genvoya, Klonopin | No | No | No | No | |||||||||||||||||
| BBS0005-BU900032895101812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 39 Y | Male | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Chills;Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 47 U/L | 15 U/L | 12 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Body punctures (Tattooing); Haemodialysis patient | |||||||||||||||||
| BBS0005-BU900032896080212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 54 U/L | 58 U/L | 41 U/L ALP | AST | ALT 8.3 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners | |||||||||||||||||
| BBS0005-BU900032903010713DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 33 U/L | 17 U/L | 11 U/L ALP | AST | ALT 8 g/dL | 4.1 g/dL Protein | Albumin | Hemolized | |||||||||||||||||
| BBS0005-BU900032906020413DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.6 mg/dL TBIL | DBIL 47 U/L | 19 U/L | 12 U/L ALP | AST | ALT 6.8 g/dL | 44 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||||
| BBS0005-BU900032907021413DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 62 U/L | 24 U/L | 26 U/L ALP | AST | ALT 7.4 g/dL | 4.5 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||||
| BBS0005-BU900036004013014DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia) | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 132 U/L | 28 U/L | 17 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||||||
| BBS0005-BU900036005092513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | N/A | 1 mg/dL | 0.4 mg/dL TBIL | DBIL 116 U/L | 119 U/L | 52 U/L ALP | AST | ALT 9.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||||
| BBS0005-BU900036007121113DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Chills | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 32 U/L | 19 U/L ALP | AST | ALT 7.7 g/dL | 4.3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0005-BU900036888031213DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 11.3 mg/dL | 0.6 mg/dL TBIL | DBIL 54 U/L | 13 U/L | 12 U/L ALP | AST | ALT 6.5 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmited diseases (STD); Multiple sex partners | |||||||||||||||||
| BBS0005-BU900036889111512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 0.6 mg/dL | 0.4 mg/dL TBIL | DBIL 58 U/L | 19 U/L | 9 U/L ALP | AST | ALT 4.6 g/dL | 2.8 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||||
| BBS0005-BU900036891112312DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Elevated LFTs | N/A | 1.6 mg/dL | 1.1 mg/dL TBIL | DBIL 812 U/L | 71 U/L | 40 U/L ALP | AST | ALT 6.6 g/dL | 3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0005-BU900036900110512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 49 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.1 g/dL | 3.8 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900042698120512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 41 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900042703120712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine; Elevated LFTs | N/A | 0.8 mg/dL | 0.5 mg/dL TBIL | DBIL 66 U/L | 3245 U/L | 316 U/L ALP | AST | ALT 8.1 g/dL | 3.9 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Occupational contact with blood (Trained as medical assistant); Body punctures (Piercing, human bite); Household contacts of HBV or HCV infected person | |||||||||||||||||
| BBS0005-BU900050689122712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 71 U/L | 28 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing, human bite); Household contacts of HBVor HCV infected person | |||||||||||||||||
| BBS0005-BU900050690111612DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Fever / chills; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 84 U/L | 61 U/L | 9 U/L ALP | AST | ALT 9.1 g/dL | 5.5 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing) | |||||||||||||||||
| BBS0005-BU900050691012813DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 17 U/L | 14 U/L ALP | AST | ALT 6.2 g/dL | 3.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Occupational contact (Medical or dental workers); Body punctures (Tattooing, piercing, human bite); Institutionalized population (Prisoners) | |||||||||||||||||
| BBS0005-BU900052406022812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.8 mg/dL | 0.4 mg/dL TBIL | DBIL 166 U/L | 194 U/L | 24 U/L ALP | AST | ALT 7.2 g/dL | 3.9 g/dL Protein | Albumin | Haemodialysis patient | |||||||||||||||||
| BBS0005-BU900052417061412DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 276 U/L | 50 U/L | 19 U/L ALP | AST | ALT 7.6 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900057146031912DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.1 mg/dL | 0.4 mg/dL TBIL | DBIL 27 U/L | 11 U/L | 14 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900057147032012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 22 Y | Male | Non-Hispanic | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 1.3 mg/dL | 0.4 mg/dL TBIL | DBIL 49 U/L | 10 U/L | <6 U/L ALP | AST | ALT 8.2 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900057174043013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 42 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 63 U/L | 10 U/L | 17 U/L ALP | AST | ALT 6.1 g/dL | 4.2 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Acupuncture, piercing) | |||||||||||||||||
| BBS0005-BU900057176061013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 32 Y | Male | Non-Hispanic | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.5 mg/dL TBIL | DBIL 65 U/L | 9 U/L | 8 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0005-BU900057177041713DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Chills; Elevated LFTs | N/A | 1.8 mg/dL | 0.9 mg/dL TBIL | DBIL 59 U/L | 86 U/L | 48 U/L ALP | AST | ALT 6.6 g/dL | 4.1 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0005-BU900064064041212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 15 U/L | 8 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BU900066340112513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 87 U/L | 37 U/L | 22 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Intravenous drug user; Body punctures (Tattooing, piercing); Institutionalized population (Prisoners) | |||||||||||||||||
| BBS0005-BU900074796091012DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 47 U/L | 20 U/L | 15 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | |||||||||||||||||
| BBS0005-BU900074797091412DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills;Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 66 U/L | 28 U/L | 13 U/L ALP | AST | ALT 7.8 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Dental workers); Body punctures (Acupuncture, tattooing) | |||||||||||||||||
| BBS0005-BU900079066090512DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 83 U/L | 33 U/L | 12 U/L ALP | AST | ALT 8.8 g/dL | 5.1 g/dL Protein | Albumin | Haemodialysis patient; Household contacts of HBV or HCV infected person | |||||||||||||||||
| BBS0005-BU900079077100812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Female | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.4 mg/dL | 0.7 mg/dL TBIL | DBIL 138 U/L | 1323 U/L | 688 U/L ALP | AST | ALT 8.7 g/dL | 5.4 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing); | |||||||||||||||||
| BBS0005-BU900079079102212DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Abdominal pains; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 14 U/L | 9 U/L ALP | AST | ALT 7.6 g/dL | 4.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0005-BU900079080091712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains;Dark color urine; Elevated LFTs | N/A | 0.7 mg/dL | 0.5 mg/dL TBIL | DBIL 63 U/L | 276 U/L | 42 U/L ALP | AST | ALT 6.4 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||||
| BBS0005-BV900066338083013DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Diarrhea;Elevated LFTs | Positive | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 67 U/L | 16 U/L | 10 U/L ALP | AST | ALT 8.2 g/dL | 4.9 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures | |||||||||||||||||
| BBS0005-BV900069486052113DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 41 Y | Male | Non-Hispanic | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 41 U/L | 15 U/L | <6 U/L ALP | AST | ALT 5.1 g/dL | 3.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M; Body punctures | |||||||||||||||||
| BBS0005-CC900022537061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Congestive heart failure, Cerebrovascular accident, Cardiomyopathy 2° to substance abuse, Atrial fibrillaiton | Aspirin, Atorvastatin, Enoxaprin, Fluoxetine, Furosemide, Metoprolol tartrate, Warfarin | No | No | |||||||||||||||||
| BBS0005-CC900022542060419DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 27 Y | Male | Non-Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 80 U/L; ALT: 108 U/L; ALP: 802 U/L: Test Date 4-Jun-2019 | $450.00 | Unknown | Billary atresia, Encounter for blood transfusion, Hypokalemia, Renal papillary necrosis, Sickle cell anemia, | Folvite, Gabapentin, Glutamine powder, Hydromorphone, Hydrea, Eucerin, Naloxone, Miralax, Senna | No | U/A | |||||||||||||||||
| BBS0005-CC900024128061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALP: 364 U/L Test Date: 11-Jun-2019 | $150.00 | Unknown | Atrial fibrillation, Valve replacement, Pneumonia, Atrial septal defect, Cardiomyopathy, Congestive heart failure, Encounter for blood transfusion, Essential hypertension, Secondary biliary cirrhosis, Severe tricuspid valve insufficiency, Hypothyroidism | Amoxicillin, Aspirin, Bumetanide, Famotidine, Ferrous sulfate, Gabapentin, Levothyroxine, Magnesium chloride, Potassium chloride, Senna docusate, Spironolactone, Warfarin | U/A | U/A | |||||||||||||||||
| BBS0005-CC900024131061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $450.00 | 84 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 33 U/L: Test Date 11-Jun-2019 | $450.00 | Unknown | Diabetic ketoacidosis, Chronic kidney disease, Hypertensive heart and kidney disease, Anemia, Diabetes mellitus, Atrial fibrillation, Congestive heart failure, Coronary artery diseae, Cystocele, Hypertension, Hypothyroidism, Myocardial infarction, Obstructive sleep apnea, Osteoarthritis | Tylenol, Amiodarone, Eliquis, Atorvastatin, Benazepril, Colace, Robitussin, Lantus, Insulin lispro, Bidil, Levothyroxine, Melatonin, Metoprolol succinate, Miralax, Polyvinyl alcohol, Potassium chloride, Senna, Torsemide, Tramadol, Triamcinolone | No | No | |||||||||||||||||
| BBS0005-CC900024279070119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $450.00 | 29 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $450.00 | Unknown | None | Bendryl, Docusate sodium, Ferrous sulfate, Diflucan, Genvoya, Mycostatin, PNV-DHA-Docusate, Terbinafine cream | No | No | No | No | |||||||||||||||||
| BBS0005-CC900024283043019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $450.00 | 25 Y | Female | Non-Hispanic | <-70C | 30-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | None | Complera, Ferrous sulfate, Prenatal Multi DHA | No | No | ||||||||||||||||
| BBS0005-CC900024286042519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $450.00 | 25 Y | Female | Non-Hispanic | <-70C | 25-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | None | Triumeq, Fioricet, Zofran, Prenatal vitamin | No | No | ||||||||||||||||
| BBS0005-CC900024287042519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $450.00 | 26 Y | Female | Non-Hispanic | <-70C | 25-Apr-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | Asthma, Migraines, Anemia, Thrombocytopenia | Aspirin, Fioricet, Flexeril, Ferrous sulfate, Prenatal multivitamin, Proair HFA, Zoloft, Magnesium oxide | Alzheimers | No | No | |||||||||||||||
| BBS0005-CC900024288041119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $450.00 | 33 Y | Female | Non-Hispanic | <-70C | 11-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $450.00 | Unknown | None | Fioricet, Zofran | Alzheimers | No | No | |||||||||||||||
| BBS0005-CC900027863061319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 64 Y | Male | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 160 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Diabetes Mellitus | None | U/A | U/A | |||||||||||||||||
| BBS0005-CC900027865061319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 19 Y | Male | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | AST: 85 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | None | Acetaminophen, Ibuprofen | U/A | U/A | |||||||||||||||||
| BBS0005-CC900027866061119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Small bowel obstruction, Arachnoiditis, Arthritis, Fracture of L1 vertebra, Herniation of intervertebral disc between L5 and S1, Retinal detachment, Urinary tract infection unresolved with antibiotics | Amitriptyline, Cyclobenzaprine, Hydrocodone acetaminophen, Ibuprofen, Levothyroxine, Mirabegron, Multivitamin, Omeprazole, Zonisamide | No | No | ||||||||||||||||||
| BBS0005-CC900028030042319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $450.00 | 19 Y | Female | Non-Hispanic | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $450.00 | Unknown | Syphilis, Hypertension, Herpes simplex virus | Acyclovir, Keflex, Colace, Zofran, Prenatal vitamins, Zantac | Alzheimers | No | No | |||||||||||||||
| BBS0005-CC900028031042319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $450.00 | 27 Y | Female | Non-Hispanic | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | Hypothyroid | Flexeril, Ferrous sulfate, Zofran, Zanta, Levothyroxine | Alzheimers | No | No | |||||||||||||||
| BBS0005-CC900028033052819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $450.00 | 30 Y | Female | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | Asthma | Prezcobix, Descovy, Ferrous sulfate, Ibuprofen, Zofran, Prenatal vitamin, Proair HFA, Phenergan, Bactrim DS | Alzheimers | No | No | No | No | |||||||||||||
| BBS0005-CC900028034060619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $450.00 | 21 Y | Female | Non-Hispanic | <-70C | 06-Jun-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | Hypothyroidism | Descovy, Synthroid, Prenatal multivitamin with FA-DHA, Vitamin D | No | No | No | No | ||||||||||||||
| BBS0005-CC900028042052019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $450.00 | 35 Y | Female | Non-Hispanic | <-70C | 20-May-19 | Subject Risk Information | HIV infected individuals, Previous laparoscopic sleeve gastrectomy in the past | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $450.00 | Unknown | Anemia | Prenatal multivitamin with FA-DHA | No | No | No | No | ||||||||||||||
| BBS0005-CC900031093061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 57 Y | Male | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Osteomyelitis, Chronic right foot wound | Aspirin, Atorvastatin, Furosemide, Gabapentin, Glimepiride, Humalog, Tramadol, Insulin glargine, Ketorolac, Losartan, Omeprazole, Steglatro, Sulfamethoxazole trimethoprim, Tamsulosin | U/A | No | ||||||||||||||||||
| BBS0005-CC900031096060519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 65 U/L: Test Date 5-Jun-2019 | $150.00 | Unknown | None | Ondansetron | No | No | |||||||||||||||||
| BBS0005-CC900032897080712DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Fatigue; Nausea; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | |||||||||||||||||
| BBS0005-CC900037605061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Elevated liver enzymes | AST: 97 U/L; ALT: 65 U/L:Test Date 12-Jun-2019 | $150.00 | Unknown | Chronic kidney disease, Diabetes mellitus, Hypertension, Malignant neoplasm liver cancer | Ciproflxacin, Furosemide, Lactulose, Metformin, Xifaxan, Spironolactone | U/A | U/A | |||||||||||||||||
| BBS0005-CC900037606061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 25 Y | Female | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Long term hemodialysis patients | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Lupus, Congestive heart failure, Renal transplant, End-stage renal disease on dialysis, Cardiomyopathy Hypertension, Lupus nephritis | Amlodipine, Beclomethasone, Calcium acetate, Carvedilol, Clonidine, Sevelamer carbonate, Senna docusate, Hydrocodone acetaminophen, Levofloxacin, Lisinopril, Loratadine, Prednisone, Tacrolimus, Warfarin | YES | U/A | Yes | 2017 | ||||||||||||||||||
| BBS0005-CC900037607061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 102 U/L; ALP: 1697 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Arthritis, Bilateral lower extremity edema, Coronary artery disease, Cirrhosis, Diabetes mellitus, Encounter for blood transfusion, Gastrointestinal hemorrhage with hematemesis, Glaucoma, Hypertension, Myocardial infarction, Neuromyopathy | Maalox plus, Aspirin, Atorvastatin, Clotrimazole lotrimin, Diclofenac sodium, Ergocalciferol, Flonase, Lasix, Gabapentin, Robitussin, Atarax, Insulin glargine, Lactulose, Multivitamin, Mycostatin, Prilosec, Xifaxan, Gas-X, Spironolactone, Timoptic, Trazodone | U/A | Yes | 27-Feb-2018 | |||||||||||||||||
| BBS0005-CC900041238060519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 196 U/L; ALT: 52 U/L; ALP: 830 U/L: Test Date 4-Jun-2019 | $150.00 | Unknown | Colon cancer metastasized to liver | Docusate sodium, Hydromorphone, Spironolactone, Trazodone | No | No | |||||||||||||||||
| BBS0005-CC900041244061219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine; Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 65 U/L; ALT: 155 U/L; ALP: 140 U/L:Test Date 11-Jun-2019 | $150.00 | Unknown | History of hepatitis B virus infection, Laryngopharyngeal reflux, Myocardial infarction | Aspirin, Ranitidine | U/A | U/A | |||||||||||||||||
| BBS0005-CC900041246061119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 56 Y | Male | Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Hypertension, GERD, Pneumonia, Seizure | Albuterol, Carvedilol, Famotidine, Fluoxetine, Hydralazine, Hydrocortisone, Hydroxyzine, Omeprazole, Quetiapine fumarate | YES | U/A | YES | U/A | ||||||||||||||||||
| BBS0005-CC900046340061019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 59 Y | Female | Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 93 U/L; ALT: 187 U/L; ALP: 247 U/L: Test Date 8-Jun-2019 | $150.00 | Unknown | Arthritis, Carpal tunnel syndrome, Disc degeneration, lumbar | None | No | No | |||||||||||||||||
| BBS0005-CC900069459051812DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chlls; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 1 U/L | 6 U/L ALP | AST | ALT 6.1 g/dL | 3.9 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures | |||||||||||||||||
| BBS0005-CC900069460052912DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Liver cirrhosis; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chills; Dark color urine / light color feces; Elevated LFTs | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 52 U/L | 13 U/L | 10 U/L ALP | AST | ALT 7.6 g/dL | 4.2 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures | |||||||||||||||||
| BBS0005-CC900069835061119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $450.00 | 61 Y | Female | Non-Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Kidney transplant, Cataract, Congestive heart failure, Chronic renal insufficiency, Diabetic neuropathy, Diabetes mellitus, End-stage renal disease, Fibromyalgia, Hyperlipidemia, Hypertension, Rheumatoid arthritis | Acetaminophen, Albuterol, Ascorbic acid, Carvedilol, Cholecalciferol, Insulin aspart, Insulin glargine, Mycophenolate, Lorazepam, Pantoprazole, Prednisone, Simethicone, Sulfamethoxazole trimethoprim, Tacrolimus, Olopatadine | No | No | ||||||||||||||||||
| BBS0005-CD900064062011513DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 75 U/L | 29 U/L ALP | AST | ALT 8.6 g/dL | 4.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person (Mom) | |||||||||||||||||
| BBS0005-CF900022538062519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 307 U/L; ALT: 132 U/L | 25-Jun-19 | $150.00 | Unknown | Congestive heart failure, COPD, Hypertension, Cholangitis, Disorder of thyroid, Kidney disorder, Transient ischemic attack | Dicyclomine, Docusate sodium, Gabapentin, Levothyroxine, Lisinopril, Pantoprazole, Promethazine | No | U/A | No | No | |||||||||||||||
| BBS0005-CF900022539071019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $450.00 | 21 Y | Female | Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L; ALT: 73 | 9-Jul-19 | $450.00 | Unknown | Cardiac transplant, Diabetes mellitus, Hypertension | Aluminum hydroxide, Magnesium hydroxide, Simethicone, Amoxicillin, Aspirin, Budesonide-Formoterol, Calcium carb & citrate, Vitamin D3, Cetirizine, Cyproheptadine, Hydrocortisone, Ipratropium, Levalbuterol, Magnesium oxide, Metoprolol succinate, Mometasone, Montelukast, Pantoprazole, Sirolimus, Tacrolimus | Yes Date of Vaccination: 6-Jun-2002 | Yes Date of Vaccination: 5/20/1998 | No | No | |||||||||||||||
| BBS0005-CF900022540052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $450.00 | 54 Y | Female | Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $450.00 | Unknown | Acute gastric ulcer, Anxiety, Complex care coordination, Diabetes Mellitus, Hypertension, Major depressive disorder without psychotic features, Malignant neoplasm breast cancer left breast | Acetaminophen, Atorvastatin, Benzocaine-Menthol, Cholecalciferol, Cyclobenzaprine, Gabapentin, Guaifenesin, Metformin, Midodrine, Naproxen, Polyethylene glycol, Senna | U/A | U/A | ||||||||||||||||||
| BBS0005-CF900022541072219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 59 Y | Male | Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 51 U/L; ALP: 216 U/L | 21-Jul-19 | $450.00 | Unknown | Coronary artery disease s/p PCI, Congestive heart failure, Diabetes mellitus type 2, Hypersensitivity lung disease | Aspirin, Atorvastatin, Carvedilol, Diphenhydramine, Furosemide, Hydralazine, Insulin glargine | No | No | No | No | |||||||||||||||
| BBS0005-CF900022543072219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 17.00 | $450.00 | 25 Y | Female | Non-Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 89 U/L | 21-Jul-19 | $450.00 | Unknown | Lupus, Acute encephalopathy, Ascites, Hypertension, Ileus, Nephrotic syndrome, Pancreatitis, Tachycardia | Acetaminophen, Amlodipine, Antovaquone, Calcium carbonate, Cholecalciferol, Vitamin D3, Dextromethorphan guaifenesin, Dronabinol, Hydroxychloroquine, Magnesium oxide, Melatonin, Ondansetron, Pantoprazole, Senna | Yes Date of Vaccination: 2001 & 2007 | Yes Date of Vaccination: 1994, 1997 & 1998 | No | No | |||||||||||||||
| BBS0005-CF900022544071819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $450.00 | 70 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 34 U/L; ALP: 245 U/L | 18-Jul-19 | $450.00 | Unknown | Hypertension, Asthma | Lisinopril-Hydrochlorothiazide, Risedronate | No | No | No | No | |||||||||||||||
| BBS0005-CF900022545070219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $450.00 | 66 Y | Male | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus type 2, Dyslipidemia, End-stage renal failure on dialysis, Hypertension, Renal transplant (2017) | Aspirin, Chlorthalidone, Lisinopril, Metoprolol tartrate, Insulin aspart, Insulin glargine, Latanoprost, Mycophenolate, Prednisone, Simvastatin, Tacrolimus | Yes Date of Vaccination: U/A | Yes Date of Vaccination: 1-Oct-2015 and 1-Jan-2016 | No | No | ||||||||||||||||
| BBS0005-CF900022546070919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $450.00 | 76 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 64 U/L; ALT: 61 U/L | 9-Jul-19 | $450.00 | Unknown | Hypertension | None | No | No | No | No | |||||||||||||||
| BBS0005-CF900023452071119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $450.00 | 33 Y | Female | Non-Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 10-Jul-19 | $450.00 | Unknown | Diabetes mellitus, Coronary stents, Myocardial infarction (twice) | Amitriptyline, Aspirin, Atorvastatin, Benazepril, Carvedilol, Insulin glargine, Multivitamin | U/A | Yes Date of Vaccination: 10/6/2016 | No | Yes | |||||||||||||||
| BBS0005-CF900023453091019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 4.00 | $450.00 | 23 Y | Female | Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $450.00 | Unknown | Abnormal menstrual periods | Aluminum-magnesium-hydroxide-simethicone, Hydrocodone-acetaminophen, Ondansetron, Pantoprazole | Yes U/A | Yes U/A | No | Yes | |||||||||||||||||
| BBS0005-CF900023454090519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 5.00 | $450.00 | 56 Y | Female | Non-Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 42 U/L | ALT: 83 U/L | 4-Sep-2019 | $450.00 | Unknown | Stents in brachial cephalic vein, Cardiac stents, Hyperlipidemia, GERD, End stage renal disease, Heart failure, COPD, Epilepsy, On oxygen nasal cannula | Allopurinol, Aspirin, Atorvastatin, Budesonide, Calcium acetate, Citalopram, Clonidine, Diphenhydramine, Fluticasone Furoate-vilanterol, Gabapentin, Hydrocodone-acetaminophen, Lactulose, Levothyroxine, Loperamide, Metoclopramide, Metoprolol succinate, Metoprolol tartrate, Nifedipine, Olanzapine, Pantoprazole, Patiromer calcium sorbitex, Promethazine, Sevelamer carbonate, Simvastatin, Vitamin B complex, Zolpidem | No | No | No | No | ||||||||||||||||
| BBS0005-CF900023455072319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $450.00 | 37 Y | Male | Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L; ALT: 59 | 23-Jul-19 | $450.00 | Unknown | Heart transplant | Escitalopram, Losartan, Metformin, Omeprazole, Ondansetron, Sirolimus, Tacrolimus, Trazodone | Yes Date of Vaccination: 8-Apr-12 | Yes Date of Vaccination: 9-Apr-12 | No | No | |||||||||||||||
| BBS0005-CF900023456100919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $450.00 | 24 Y | Female | Hispanic | <-70C | 09-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 95 U/L | ALT: 66 U/L | 8-Oct-19 | $450.00 | Unknown | Cholecystectomy | None | Yes 26-Jan-01 | Yes U/A | No | No | ||||||||||||||||
| BBS0005-CF900023457100119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 12.00 | $450.00 | 34 Y | Female | Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L | 30-Sep-19 | $450.00 | Unknown | Lupus, Seizures, Hyperthyroidism, Bipolar disorder | Albuterol, Azithromycin, Alprazalam, Baclofen, Bethomethasone, Benzonatate, Cholecalciferol, Diclofenac sodium, Divalproex, Epinephrine, Ferrous sulfate, Iron, Fluticasone, Folic acid, Hydrocodone-acetaminophen, Hydroxychloroquine, Ipratropium-albuterol, Levothyroxine, Lisinopril, Lurasidone, Multivitamin with iron and minerals, Mycophenolate, Omeprazole, Prednisone, Senna, Sertraline, Zolpidem | No | No | No | No | ||||||||||||||||
| BBS0005-CF900023458101519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $450.00 | 70 Y | Female | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Chronic lymphocytic leukemia (no treatment) | Albuterol, Allopurinol, Aspirin, Carvedilol, Cholecalciferol, Clobetasol, Colchicine, Flucinonide, Furosemide, Gabapentin, Ibuprofen, Ipratropium-albuterol, Mupirocin ointment, Potassium chloride, Secukinumab, Sertraline, Triamcinolone | No | No | No | No | |||||||||||||||||
| BBS0005-CF900023459100219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 184 U/L; ALT: 126 U/L | 1-Oct-19 | $450.00 | Unknown | Hiatal hernia; Hypertension | Amlodipine, Aspirin, Docusate sodium, Hydrocodone-acetaminophen | No | No | No | No | ||||||||||||||||
| BBS0005-CF900024129060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 57 Y | Female | Non-Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 218 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Absolute anemia, Chronic obstructive pulmonary disease, Congestive heart failure, Diabetes mellitus, Dialysis patient (non-compliant), End stage renal disease, GERD, Hypertension, Hypotension, Non-ST elevation myocardial infarction, Paroxysmal atrial fibrillation, Pulmonary hypertension, Umbilical hernia | Albuterol, Albuterol HFA, Aspirin, Atorvastatin, Dulcolax, Cetirizine, Cholecalciferol, Vitamin D3, Flexeril, Dicyclomine, Fluconazole, Folic acid, Combivent, Synthroid, Lidocaine, Lopressor, Proamatine, Protonix, Veltassa, Miralax, Lyrica, Senna, Renvela | No | No | |||||||||||||||||
| BBS0005-CF900024130071119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $450.00 | 43 Y | Male | Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 40 U/L; ALT: 58 U/L | 10-Jul-19 | $450.00 | Unknown | HLP, GERD | Ciclopirox, Omeprazole, Polyethylene glycol | Yes Date of Vaccination: 3-Jun-2013 | U/A | No | No | |||||||||||||||
| BBS0005-CF900024132072919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 16.00 | $450.00 | 29 Y | Female | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 42 U/L | 29-Jul-2019 | $450.00 | Unknown | Central nervous system lymphoma | Acyclovir, Docusate sodium, Levofloxacin, Ondansetron, Polyethylene glycol, Prochlorperazine, Sulfamethoxazole | Yes Date of Vaccination: 12-Jun-09 | U/A | No | No | |||||||||||||||
| BBS0005-CF900024133100819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $450.00 | 58 Y | Female | Hispanic | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Osteoporosis | Unknown | No | No | No | No | |||||||||||||||||
| BBS0005-CF900024134091819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 9.00 | $450.00 | 55 Y | Male | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Diabetes mellitus, Cerebrovascular accident, COPD, Coronary artery disease, Benign prostatic hyperplasia, Hypertension | Atorvastatin, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Losartan, Metformin, Tamulosin, Tramadol | Yes 2017 | Yes U/A | Yes | No | |||||||||||||||||
| BBS0005-CF900024135101519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 3.00 | $450.00 | 68 Y | Male | Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 60 U/L | ALT: 65 U/ | ALP: 150 U/L | 14-Oct-19 | $450.00 | Unknown | None | Amoxicillin / potassium clav | No | No | Yes | No | ||||||||||||||||
| BBS0005-CF900024136100719DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 16.00 | $450.00 | 67 Y | Male | Non-Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Hypersensitivity lung disease, Hypertension, Neuroendocrine tumor status post resection of pancreatic mesentery mass en bloc with distal pancreas, spleen, Fourth portion of duodenum, Duodenoileostomy, Gastrostomy and Jejunostomy tube placement | Ascorbic acid, Aspirin, Atorvastatin, Hydrochlorothiazide, Insulin lispro, Insulin NPH, Lidocaine, Losartan, Metrocarbamol, Metronidazole, Oxycodone, Pancrelipase, Vitamin D3 | Yes 9-Jul-05 | Yes 9-Jul-05 | Yes | No | |||||||||||||||||
| BBS0005-CF900026482100219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $450.00 | 72 Y | Male | Non-Hispanic | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $450.00 | Unknown | Metastatic bladder cancer status post radical cystoprostatectomy with urostomy; Pulmonary embolism | Acetaminophen, Diphenoxylate-atropine, Methadone, Ondansetron, Oxycodone-acetaminophen, Polyethylene glycol, Prednisone, Rivaroxaban, Senna | U/A | U/A | No | No | |||||||||||||||||
| BBS0005-CF900027862062719DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 73 Y | Female | Non-Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALP: 60 U/L | 27-Jun-19 | $150.00 | Unknown | Diabetes mellitus, Thyroid disorder, Dyslipidemia, Hypertension | Aspirin, Atenolol, Atorvastatin, Chlorhexidine, Glipizide, Hydrochlorothiazide, Ibuprofen, Insulin glargine, Insulin lispro, Liraglutide, Losartan, Metformin, Methimazole, Mupirocin ointment | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0005-CF900027864070319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 75 Y | Male | Non-Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 46 U/L | 2-Jul-19 | $150.00 | Unknown | Congestive heart failure, Arterial fibrillation, Multiple myeloma, Recent UTI | Acetaminophen, Acyclovir, Alfuzosin, Allopurinol, Apixaban, Benazepril, Cephalexin, Cholecalciferol, Vitamin D3, Cyanocobalamin, Finasteride, Insulin glargine, Insulin lispro, Magnesium oxide, Melatonin, Metoprolol succinate, Morphine, Pantoprazole, Polyethylene glycol, Senna, Sodium chloride, Sulfamethoxazole trimethoprim, Tamsulosin, Tramadol, Zinc sulfate | U/A | U/A | No | No | |||||||||||||||
| BBS0005-CF900027867053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 35 Y | Male | Hispanic | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 52 U/L: Test Date 30-May-2019 | $150.00 | Unknown | Hypertension, Wolf parkinson white syndrome | Lorazepam | No | No | |||||||||||||||||
| BBS0005-CF900027868060319DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 51 Y | Male | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 59 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Arthritis, Uncontrolled Diabetes Type 2 | Remeron, Nicoderm CQ | No | No | |||||||||||||||||
| BBS0005-CF900027869062619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 69 Y | Male | Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 64 U/L; ALT: 79 U/L; ALP: 634 U/L | 26-Jun-19 | $150.00 | Unknown | Pancreatic adenocarcinoma, Duodenal stricture, Obstructive jaundice | Acetaminophen, Dexamethasone, Ferrous sulfate, Ibuprofen, Insulin glargine, Ondansetron, Polyethylene, Potassium chloride, Prochlorperazine, Sertraline | No | No | No | No | |||||||||||||||
| BBS0005-CF900027870062519DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 66 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 171 U/L | 24-Jun-19 | $150.00 | Unknown | Hypertension, Diabetes mellitus, Anemia | Acetaminophen, Albuterol, Aprdra Solostar insulin, Baclofen, Carvediol, Docusate sodium, Omeprazole, Feburostat, Ferrous sulfate, Furosemide, Hydralazine, Hydrocodone-acetaminophen, Insuin aspart, Metoclopramide, Simvastatin, Spironolactone, Tramadol | U/A | U/A | No | No | |||||||||||||||
| BBS0005-CF900031091073019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 77 Y | Male | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 558 U/L; ALT: 355 U/L; ALP: 177 U/L | 29-Jul-2019 | $150.00 | Unknown | Diabetes mellitus, Hypersensitivity lung disease, Non-Hodgkin's Lymphoma after chemo, Mandible squamous cell cancer | Albuterol, Aspirin, Ibuprofen, Clonazepam, Finasteride, Fluoxetine | No | No | No | Yes | |||||||||||||||
| BBS0005-CF900031092071819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 70 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | 18-Jul-19 | $150.00 | Unknown | Hypertension, Gout, Anxiety | Allopurinol, Aspirin, Atorvastatin, Fluoxetine, Lisinopril, Terazosin | No | No | No | No | |||||||||||||||
| BBS0005-CF900031094072419DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 151 U/L | 24-Jul-19 | $150.00 | Unknown | Heart transplant, Lymphoma | Acyclovir, Allopurinol, Docusate sodium, Etoposide, Fluconazole, Gabapentin, Hydrocodone-acetaminophen, Insulin aspart, Levofloxacin, Loperamide, Magnesium oxide, Metoclopramide, Metoprolol succinate, Mirtazapine, Omeprazole, Ondansetron, Polyethylene glycol, Prednisone, Prochlorperazine, Senna, Sulfamethoxazole-trimethoprim, Tachrolimus | Yes Date of Vaccination: 14-May-15 | Yes U/A | No | No | |||||||||||||||
| BBS0005-CF900031095070219DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 0.60 | 1.00 | $150.00 | 22 Y | Female | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 1-Jul-19 | $150.00 | Unknown | Spina bifida, Obesity, Steatosis of liver, Arthritis, Tonsillar hypertrophy, Paraplegia, Obstructive sleep apnea, Atopic dermatitis, Urinary retention, Juvenile plantar dermatosis, Cellulitis, Recurrent urinary tract infections / pyelonephritis, Chiari malformation type II, Adjustment disorder with depressed mood, Hydrocephalus, Myelomeningocele, Asthma | Acetaminophen, Epinephrine, Albuterol, Escitalopram oxalate, Fluticasone, Gabapentin, Lidocaine, Loperamide, Morphine, Naloxone, Nystatin, Ondansetron, Oxybutynin, Polyethylene glycol, Trazodone | No | No | No | No | |||||||||||||||
| BBS0005-CF900031097062619DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 83 Y | Female | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 58 U/L | 26-Jun-19 | $150.00 | Unknown | Multiple myeloma on chemo, Recent c.diff infection, Arthritis, Cholelithiasis, Breast cancer, Cataract, Diabetes mellitus, Fatty liver, Hypertension, Hyperlipidemia, Osteoarthritis, Obesity, Tinea pedis | Acyclovir, Aspirin, Atovaquone, Cyanocobalamin, Dexamethasone, Fidaxomicin, Gabapentin, Glucosamine sulfate, Ixazomib, Lenalidomide, Levothyroxine, Oxybutynin, Potassium chloride | No | No | U/A | No | |||||||||||||||
| BBS0005-CF900031098071719DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 31 Y | Female | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 287 U/L; ALT: 69 U/L; ALP: 455 U/L | 17-Jul-19 | $150.00 | Unknown | Liver cirrhosis after liver transplant | Sirolimus, Tacrolimus | Yes U/A | Yes U/A | No | U/A | |||||||||||||||
| BBS0005-CF900037603052819DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | BMI 36.0-36.9, Cerebrovascular accident, Coronary artery calcification seen on CAT scan, Thyroid disorder, Hypertension | Amlodipine, Atorvastatin, Aspirin, Isosorbide mononitrate, Levothyroxine, Topiramate | U/A | U/A | ||||||||||||||||||
| BBS0005-CF900037604070119DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 48 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 59 U/L | 30-Jun-19 | $150.00 | Unknown | Diabetes mellitus type 1, Asthma, Gastroesophageal reflux without esophagitis, Hypertension, Kidney disease, Myocardial infarction | Acetaminophen, Albuterol, Amlodipine, Aspirin, Cyclobenzaprine, Diphenhydramine, Docusate sodium, Ferrous sulfate, Fluticasone, Glucagon, Glucose, Insulin aspart, Insulin Glargine, Lisinopril, Loratadine, Magnesium oxide, Metoclopramide, Metoprolol succinate, Nitroglycerin, Omeprazole, Ondansetron, Tiopropium bromide, Tolterodine, Vitamin B complex | No | No | No | No | |||||||||||||||
| BBS0005-CF900037608052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Vertigo, Hypertension, Arthritis, Asthma, Carpal tunnel syndrome, Diverticulitis, Fatigue, Fibromyalgia, Glaucoma, Hiatal hernia, Migraines, Obstructive sleep apnea, Patent foramen ovale, Premature ventricular contractions, Transient ischemic attack | Alprazolam, Budesonide, Clopidogrel, Fluoxetine, Insulin Glargine, Insulin Lispro, Magnesium oxide, Metoprolol, Semaglutide, Pravastatin, Zolpidem | U/A | U/A | ||||||||||||||||||
| BBS0005-CF900037609052919DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice, Elevated liver enzymes | AST: 94 U/L; ALT: 85 U/L; ALP: 445 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Dysphonia, Dysphagia, Muscle tension dysphonia, Edema of larynx, Globus sensation, Laryngopharyngeal reflux, Reinke's edema of vocal folds, Tinnitus | Amlodipine, Aspirin, Benazepril, Omeprazole, Hydrochlorothiazide | Yes | Yes | |||||||||||||||||
| BBS0005-CF900037610053019DD | Suspect Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 50 Y | Male | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Umbilical hernia | None | Yes | 2009 | Yes | 2009 |